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“Tudo tem a sua ocasião própria e há tempo para todo propósito debaixo do céu. Há tempo de 
nascer e tempo de morrer; tempo de plantar e tempo de arrancar o que se plantou; tempo 
de matar e tempo de curar; tempo de derrubar e tempo de edificar; tempo de chorar e 
tempo de rir; tempo de prantear e tempo de dançar; tempo de espalhar pedras e tempo de 
ajuntar pedras; tempo de abraçar e tempo de abster-se de abraçar; tempo de buscar e 
tempo de perder; tempo de guardar e tempo de deitar fora; tempo de rasgar e tempo de 
coser; tempo de estar calado e tempo de falar; tempo de amar e tempo de odiar; tempo de 
guerra e tempo de paz.” 
                                               Eclesiastes (capítulo 3); Antigo Testamento 
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RESUMO 
Cromossomas marcadores supranumerários (sSMCs, do inglês, small Supernumerary 
Marker Chromosomes) são pequenos cromossomas estruturalmente anormais que 
aparecem adicionalmente aos 46 cromossomas humanos e que não podem ser 
identificados ou caracterizados por citogenética convencional, tendo um tamanho 
inferior a um cromossoma 20 da mesma placa metafásica. Os sSMCs constituem um 
grupo heterógeneo de cromossomas anómalos que podem ter diferentes formas, 
como cromossomas duplicados invertidos (inv dup), cromossomas minute cêntricos 
(min) e cromossomas em anel (r). 
O risco de alterações fenotípicas associadas à presença de um sSMC depende de vários 
factores, como a hereditariedade, a origem do cromossoma, a morfologia, o conteúdo 
genético, a presença de dissomia uniparental ou o grau de mosaicismo. De facto, os 
fenótipos associados a um sSMC são variáveis, desde normais a severamente 
afectados.  
Os sSMCs podem ser detectados em diagnóstico pós-natal ou em pré-natal 
constituindo, sobretudo no último caso, um problema complexo para a investigação 
citogenética e o aconselhamento genético. Tendo em conta dados publicados na 
literatura que estimam uma frequência de 0.044% recém-nascidos portadores de um 
sSMC e que a população mundial é estimada actualmente em cerca de 6 823 000 000 
pessoas, pode-se extrapolar o número de aproximadamente 3 milhões de indíviduos 
no mundo portadores de um sSMC. A grande maioria destes indíviduos não tem 
manifestações fenotípicas aparentes, no entanto cerca de 26% dos casos de indivíduos 
com um sSMC terão manifestações fenotípicas que poderão ser mais ou menos 
severas. 
A maioria dos cromossomas marcadores publicados na literatura não têm uma 
caracterização citogenética detalhada, quer da origem quer do conteúdo genético, que 
permita uma correlação robusta com o fenótipo esperado. Este facto dificulta o 
aconselhamento genético quando é encontrado um sSMC, sobretudo em diagnóstico 
pré-natal. Neste domínio é essencial sistematizar o conhecimento sobre o conteúdo 
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genético envolvido nos sSMC e a descriminação das manifestações fenotípicas 
expectáveis de um indivíduo ou grupo de indivíduos, sejam elas normais ou anormais. 
Com este trabalho pretendeu-se contribuir para esta sistematização, procedendo-se à 
caracterização por citogenética molecular de um grupo de cromossomas marcadores 
supranumerários derivados de vários cromossomas, nomeadamente dos cromossomas 
1, 2, 5, 11, 13, 15, 16, 17, 18 e 22. Pretendeu-se validar a técnica de hibridização 
Genómica Comparativa por array (array CGH, do inglês array Comparative Genomic 
Hybrydization) para caracterização da extensão genética do cromossoma marcador, 
após a sua microdissecção e amplificação. Concluiu-se que esta técnica será de grande 
utilidade para a correcta caracterização de sSMCs sobretudo quando o cromossoma 
marcador está presente em mosaico de baixa expressão. Após caracterização 
molecular do grupo de sSMC em estudo estabeleceu-se, na medida do possível, uma 
relação genótipo/fenótipo, comparando cada caso com outros casos reportados na 
literatura. Neste trabalho propõem-se ainda linhas de orientação para lidar com casos 
de sSMC num laboratório de diagnóstico em citogenética, tendo em consideração 
factores como por exemplo o tempo para a caracterização citogenética, o grau de 
mosaicismo e as técnicas disponíveis no laboratório. O trabalho incluído nesta 
dissertação reforça e clarifica a necessidade de uma caracterização citogenética 
molecular detalhada de cromossomas marcadores supranumerários, recorrendo 
nomeadamente a técnicas de M-FISH e de array CGH. Esta caracterização possibilita o 
estabelecimento de relações genótipo/fenótipo cada vez mais precisas e essenciais 
para um correcto aconselhamento genético, por parte do Geneticista Clínico.  
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ABSTRACT 
Small supernumerary marker chromosomes (sSMCs) are small structurally abnormal 
chromosomes that occur in addition to the 46 human chromosomes, that cannot be 
identified or characterized unambiguously by conventional banding cytogenetics 
alone, and are (in general) equal in size or smaller than a chromosome 20 of the same 
metaphase spread. sSMCs are a morphologically heterogeneous group of structural 
abnormal chromosomes that can appear in different shapes: inverted duplicated 
chromosomes (inv dup), centric minute chromosomes (min) and ring chromosomes (r). 
The risk for phenotypic abnormalities associated with a sSMC depends on several 
factors, including inheritance, chromosomal origin, morphology, genetic content, 
presence of uniparental disomy or grade of mosaicism. In fact, phenotypes associated 
with a sSMC are variable, from normal to severely affected. 
sSMCs can be detected postnatally or prenatally, the last being a major problem for 
cytogenetic investigation and genetic counselling. Taking into account data in the 
literature that estimate a 0.044% frequency of newborns with a sSMC and that the 
estimated world population is 6 823 000 000 people, there will be at present 
approximately 3 million living sSMC carriers. The great majority of these carriers will 
not have apparent phenotypical consequences. However, about 26% of individuals 
with a sSMC will have phenotypical manifestations, more or less severe. 
The majority of sSMCs published in the literature do not have an accurate cytogenetics 
characterization, of the origin and genetic content of the marker, which allows a 
robust correlation with the expected phenotype. This is a difficulty for genetic 
counselling when a sSMC is encountered, especially at prenatal diagnosis. It is essential 
to systematize the knowledge of the genetic content of markers and the phenotypical 
manifestations encountered, normal or abnormal. 
With this work we want to contribute to this systematization, by doing a detailed 
molecular cytogenetic characterization of a group of sSMC derived from different 
chromosomes, namely chromosomes 1, 2, 5, 11, 13, 15, 16, 17, 18 and 22. We aimed 
to validate array CGH technique, after the microdissection and amplification of the 
marker, for the characterization of the genetic extension of the sSMC. We concluded 
16 
 
that this technique is of great value for an accurate characterization of the marker, 
especially when the sSMC is present in low levels of mosaicism. 
After the characterization of the group of sSMCs cases in study, it was established a 
genotype/phenotype correlation, whenever possible, and a comparison of each case 
with those described in the literature was done. In this work, guidelines are proposed 
for the management of sSMCs in a diagnostic cytogenetic laboratory, taking into 
account several factors, like time available for the cytogenetic characterization, levels 
of mosaicism and techniques availability in the lab. This work reinforces and clarifies 
the need of an accurate molecular cytogenetic characterization of sSMCs, using 
particularly M- FISH techniques or array CGH. This characterization allows the 
establishment of more precise genotype/phenotype correlations, which are essential 
for an accurate genetic counselling by the Clinic Geneticist. 
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Introduction 
 
19 
 
1.1. CYTOGENETICS – state of the art 
1.1.1. Historical Perspective 
Cytogenetics is the field of genetics that concerns the study of chromosomes’ structure 
and function. The discovery of the number of human chromosomes on embryonic lung 
tissue in 1955 by Tjio was the fundamental step for the birth of human cytogenetics 
(Fig. 1.1.). This finding, that the diploid number of chromosomes in humans is 46, was 
published by Tjio and Levan in 1956 [Tjio and Levan, 1956], and that same year the 
number was confirmed by examining meiotic chromosomes [Ford and Hamerton, 1956]. 
This milestone occurred at the moment the hypotonic chromosome spreading 
procedure described by Hsu [Hsu, 1952] was made possible thanks to significant 
advances in techniques, later being improved through the use of phytohemaglutinin 
[Moorhead et al., 1960]. Given the simplicity of the procedure to observe human 
chromosomes, the study of certain syndromes of genetic origin began immediately, 
revealing the chromosomal origin of some of them by the end of the 1950s [Garcia-
Sagredo, 2008]. In fact in 1959, Lejeune and collaborators reported the first autosomal 
aneuploidy, trisomy 21, associated with a characteristic phenotype [Lejeune et al., 
1959]. This marked the beginning of clinical cytogenetics and soon after other 
descriptions of aneuploidies associated with syndromes were published, like Edwards 
syndrome (trissomy 18), Patau syndrome (trisomy 13), Klinefelter syndrome (47,XXY) 
or Turner syndrome (45,X). In tumour cytogenetics, one of the most exciting findings 
was the identification in 1960 of a minute chromosome, later named the Philadelphia 
chromosome, which was regularly found in the peripheral blood of patients with 
chronic myeloid leukaemia [Nowell and Hungerford, 1960]. 
 
Figure 1.1. - A human metaphase plate, from the original Tjio (in the photo) and Levan paper, shows 46 
chromosomes [from Gartler, 2006]. 
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The discovery of chromosome banding techniques and structural chromosomal 
rearrangements soon followed. As revised by Garcia-Sagredo [Garcia-Sagredo, 2008], at 
the end of the 1960s, several banding techniques were discovered which allowed 
chromosomes to be individually identified. Using fluorescence or digestion with 
trypsin, it was possible to obtain the characteristic pattern of Q and G band, producing 
a karyotype with a pattern of 500 bands [Caspersson et al., 1970; Seabright, 1971]. Over 
time, higher resolution became necessary and in 1976, a high-resolution band method 
using prometaphase chromosomes that can reach 1000 bands was published, allowing 
cytogenetic anomalies to be better identified [Yunis, 1976].  
To facilitate the identification of chromosomes and to prevent confusion in reporting 
cytogenetic results, an International System for Human Cytogenetic Nomenclature 
(ISCN) was created. The first steps for this system were done at “The Denver’s 
Conference”, USA, in 1960, when a group of researchers joined to propose a standard 
system for the nomenclature of human mitotic chromosomes. In 1978 the first 
“International System for Human Cytogenetic Nomenclature” was published. This 
Nomenclature System has been periodically revised, namely in 1981, 1985, 1995, 2005, 
being the last update done in 2009 [ISCN 2009 - Shaffer et al., 2009].  
 
1.1.2. Conventional Cytogenetics 
Traditionally, the term cytogenetics has referred to studies of the cellular aspects of 
heredity, especially the description of chromosome structure and the identification of 
genomic aberrations that cause disease. Cytogenetics has been used for many years 
for various applications, from clinical diagnostics to basic genomic research. 
Conventional chromosome analysis, which is based on banding and was developed in 
the 1970s is still widely used [Speicher and Carter, 2005]. 
Numerous procedures have been reported for producing banding patterns on 
metaphase spreads. A band is a part of a chromosome that is clearly distinguishable 
from its adjacent segments by appearing darker or lighter with one banding technique 
[Shaffer et al., 2009]. Chromosome banding methods are based on staining methods 
with a dye. The banding techniques fall into two principle groups: (1) those resulting in 
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bands distributed along the length of the whole chromosome, such as G-, Q- and R-
bands, including techniques that demonstrate patterns of DNA replication; (2) those 
that stain specific chromosome structures and give rise to a restricted number of 
bands, including C- and NOR-banding. Bands that show staining are referred to as 
positive bands; weakly staining bands are negative bands. However the staining 
patterns are not always black and white, different bands stains to different intensities 
[Francke, 1994; Bickmore, 2001]. 
Nearly all methods of chromosome banding rely on harvesting chromosomes in 
mitosis. This is usually achieved by treating cells with tubulin inhibitors, such as 
colcichine or colcemide, which depolymerise the mitotic spindle and arrest the cell at 
this stage [Bickmore, 2001]. In 1976, Yunis published a method for obtaining high-
resolution chromosomes, visualizing human chromosomes in mid-prophase, instead of 
metaphase [Yunis, 1976] (Fig. 1.2.). 
 
 
Figure 1.2. A partial karyotype of G-banded chromosome 7 from cells at successive stages of mitosis, 
illustrating the coalescing of sub-bands into larger, less defined, and less informative landmark bands. 
Cells captured in late prophase may show 850 to 1000 bands per haploid karyotype, i.e., high resolution. 
By mid-metaphase, fine band detail is lost as chromosomes condense and bands fuse, and only 400 or 
fewer bands per haploid karyotype may be observed [from Bangs
 
 and Donlon, 2005]. 
 
After staining to induce banding patterns, chromosome preparations are examined 
under a light microscope (1000x magnification). Images are captured and stored, 
nowadays with computerized image capture. They are then analysed by identifying 
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each chromosome pair, to form what is called a karyotype or karyogram1 (Fig. 1.3.). 
Chromosomes are identified by their size, position of the centromere and the patterns 
of bands along their arms. The chromosomes are counted in several metaphase plates 
and looked for abnormalities in banding patterns. This is a non-automated and labour-
intensive procedure [Warburton, 1995].  
 
G-Banding and R-Banding 
Techniques that use Giemsa dye mixture as the staining agent are termed G-staining 
methods and the resulting bands G-bands (Fig. 1.3.). Chromosomes are treated with 
trypsin and then with Giemsa stain to produce dark heterochromatic regions and light 
euchromatic regions [Seabright, 1971]. Giemsa is specific for the phosphate groups of 
DNA and attaches itself to regions of DNA where there are high amounts of adenine-
thymine (AT) bonding.  
 
 
Figure 1.3. – High resolution karyogram with G-banding showing a female with an extra X chromosome 
(47,XXX) [photo from Laboratório de Citogenética da Faculdade de Medicina da Universidade de 
Coimbra]. 
                                                 
1
 - According to Shaffer et al. (2009) – ISCN 2009, the term karyogram should be applied to a 
systematized array of chromosomes prepared either by drawing, digitized imaging, or by photography, 
typifying the chromosomes of an individual or a species. The term karyotype should be used to describe 
the normal or abnormal, constitutional or acquired, chromosomal complement of an individual, tissue 
or cell line. The term ideogram is reserved for the diagrammatic representation of a karyotype. 
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R-banding includes a pre-denaturation of chromosomes with hot acidic saline followed 
by Giemsa staining. The AT-rich DNA is preferentially denatured, being stained under-
denatured GC-rich regions. This way the banding patterns are opposite in staining 
intensity to those obtained by the G-staining method [Dutrillaux et al., 1973; Shaffer et 
al., 2009]. 
 
Q-Banding 
Q-banding (Fig. 1.4.) involves staining with quinacrine, which reacts specifically with 
certain bases. Quinacrine intercalates into chromosomal DNA irrespective of sequence, 
but fluoresces brighter in regions of AT-rich DNA [Caspersson et al., 1970]. In addition to 
quinacrine, other fluorescent dyes, like DAPI, Hoechst 33258, are specific for AT-rich 
DNA. The fluorescence of DAPI and Hoeschst is not quenched by guanine, like 
quinacrine is, and the banding patterns are less distinct than those produced by 
quinacrine [Bickmore, 2001]. 
 
Figure 1.4. - Quinacrine stained karyotypes showing a 45,XX,-21 chromosome constitution [from 
Dutrillaux et al., 1973]. 
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C-Banding 
Centromeric DNA and pericentromeric heterochromatin, composed of alpha-repetitive 
DNA and various families of repetitive satellite DNA are detected by C-banding (Fig. 
1.5.). The patterns obtained with C-banding, revealing constitutive heterochromatin, 
do not allow the identification of every chromosome in somatic cell complement, 
being used only to identify specific chromosomes [Eiberg, 1973]. The C-bands on 
chromosome 1, 9, 16 and Y are morphologically variable. The short-arms of the 
acrocentric chromosomes also demonstrate variations in size and staining intensity, 
not only with C-banding, but also with the other banding techniques [Shaffer et al., 
2009]. 
 
Figure 1.5. - C-banding of metaphase chromosomes of a patient with Roberts syndrome. Arrows show 
selected chromosomes with premature centromere separation. Open arrows show selected 
chromosomes with normal C-banded regions [from Vega et al., 2005]. 
 
NOR-banding 
NOR-banding, with silver staining, detects the 18S and 28S ribosomal RNA genes that 
are clustered together in large areas containing about 40 copies of each gene, located 
at the acrocentric short arms, at the nucleolar organizer regions (NORs) (Fig. 1.6.) 
[Tantravahi et al., 1977; Shaffer et al., 2009]. 
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Figure 1.6. - Ag-NOR staining of human chromosomes for detection of NOR regions. The short arms of 
acrocentric chromosomes have a positive staining [photo from Laboratório de Citogenética da 
Faculdade de Medicina da Universidade de Coimbra]. 
 
Replication Banding 
Replication banding is a function-based banding method and is based on the fact that 
different bands replicate their DNA at different times during S phase of the cell cycle. 
This relationship between timing of replication and chromosome banding is usually 
studied by incorporating pulses of 5-bromo-2’-deoxyuridine (BrdU) into cells during 
defined stages of S phase and then examining chromosomes in the subsequent 
metaphase [Latt, 1973; Bickmore, 2001]. 
 
Chromosome Band Nomenclature 
Each chromosome in the human somatic cell complement is considered to consist of a 
continuous series of bands, with no unbanded areas. A band is a part of a chromosome 
clearly distinguishable from adjacent parts, having lighter or darker staining intensity. 
The bands are allocated to various regions along the chromosome arms, and the 
regions are delimited by specific landmarks, including the centromeres, the telomeres 
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and certain bands characteristic of different chromosomes [Shaffer et al., 2009]. The 
designation of the regions, bands and sub-bands for each chromosome are described 
in the International System for Human Cytogenetic Nomenclature [ISCN(2009) - Shaffer 
et al., 2009]. Briefly, regions and bands are numbered consecutively from the 
centromere outward along each chromosome arm. The symbols p (petit) and q are 
used to designate, respectively, the short and long arms of each chromosome (Fig. 
1.7.). The centromere (cen) itself is designated 10; the part facing the short arm is p10, 
the part facing the long arm is q10. The two regions adjacent to the centromere are 
labelled as 1 in each arm, the next more distal regions as 2, and so on [Shaffer et al., 
2009].  
 
Figure 1.7. – G-band ideograms of human chromosome 10 at 400- (left) and 850- (right) band resolution 
[adapted from ISCN 2009].  
 
For the designation of a particular band four items are required: 
a) the chromosome number; 
b) the arm symbol; 
c) the region number; 
d) the band number. 
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These items are given in order without spacing or punctuation. The bands can be 
subdivided in sub-bands, being numbered consecutively from the centromere 
outward. For example 18q22.1, is the band located at the long arm of chromosome 18, 
region 2, band 2, sub-band 1. The visualization of these sub-bands depends on the 
resolution of the karyotype (Fig. 1.2.). 
It is important to emphasize that on routine banding of chromosomes, still used in 
most laboratories to this day (specially G-banding), only rearrangements and genomic 
imbalances (deletions and duplications) greater than 5 megabase (5 Mb) in size, and 
often 10 Mb, are detected. 
 
1.1.3. Molecular Cytogenetics and Cytogenomics 
The first application of molecular techniques to chromosome cytology was based on 
the observation that complementary nucleotide sequences could anneal or hybridize 
to each other to form more stable complexes. The first in situ hybridization analysis 
was reported in 1969 by Joe Gall and Mary Lou Pardue, who used DNA–RNA 
radioactive hybridization [Gall and Pardue, 1969]. The first successful multicolour FISH 
experiments were done in 1989 by Nederlof and co-workers by visualizing three 
differently labelled nucleic acid sequences, simultaneously, in blue (amino methyl 
coumarin acetic acid – AMCA), red (tetramethylrhodamine isothiocyanate – TRITC) and 
green (fluorescein isothiocyanate – FITC) [Nederlof et al., 1989; Liehr et al., 2009]. Over 
the past years molecular cytogenetic techniques of increasingly higher resolution have 
been developed. The cytogenetic use of these new technologies is designed to provide 
a description of chromosome structure at a resolution that exceeds that of microscopic 
analysis. Therefore, these technologies bridge the gap between cytogenetic and 
molecular approaches. The molecular cytogenetics techniques include: Fluorescence in 
situ hybridization (FISH); Comparative Genomic Hybridization (CGH) and Array - 
Comparative Genomic Hybridization (array CGH). Beside these cytogenetic techniques, 
there are also molecular biology techniques that have been used to study chromosome 
imbalances, such as Multiplex Ligand Probe Amplification (MLPA) and Quantitative 
Fluorescence Polymerase Chain Reaction (QF-PCR).  
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1.1.3.1. FISH – Fluorescence in situ Hybridization 
Molecular cytogenetics is usually based on fluorescence in situ hybridization (FISH). In 
this technique a labelled DNA probe is hybridized to cytological targets such as 
metaphase chromosomes, interphase nuclei or even extended chromatin fibres.  
 
 
Figure 1.8. – Principal steps of a FISH experience. A) A fluorescently-labeled segment of DNA 
complementary to a chromosomal region of interest is used; B) Hybridization between the probe and 
the complementary chromosomal DNA occur; C) The slides can be visualized in a fluorescent 
microscope. If the DNA complementar to the probe is present a signal with the color of the emission 
wavelength of the fluorochrome of the probe is seen [A and B - adapted from Medical Genetics 
Information Resource database; C - photos from Laboratório de Citogenética da Faculdade de Medicina 
da Universidade de Coimbra]. 
 
FISH is a technique used to identify the presence of specific chromosomes or 
chromosomal regions through hybridization of fluorescently-labelled DNA probes to 
denatured chromosomal DNA. Every FISH experience has 3 fundamental steps: 
1) Preparation of the probe – A probe is a fluorescently-labeled segment of DNA 
complementary to a chromosomal region of interest (Fig 1.8. A); 
A 
B 
C 
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2) Hybridization – Denatured chromosomes fixed on a microscope slide are 
exposed to the fluorescently-labeled probe. Hybridization occurs between the 
probe and complementary chromosomal DNA (Fig 1.8.B); 
3) Visualization – Following hybridization, the slide is examined under a 
microscope using filtered light (depending on the fluorochrome used). 
Fluorescent signals indicate the presence of the complementary chromosomal 
DNA for that probe (Fig 1.8.C). 
All types of human DNA sequences have been used as probes for molecular 
cytogenetic studies. These include unique sequences, repetitive sequences such as α-
satellite and telomere DNA, locus specific DNA obtained by PCR amplification, large 
genomic DNA sequences cloned into cosmids, bacterial artificial chromosomes (BACs), 
P1-derived artificial chromosomes (PACs), yeast artificial chromosomes (YACs), 
chromosomes band or arm specific sequences generated by microdissection and DNA 
libraries established by chromosome flow sorting. Following the sequencing of the 
human genome with the Human Genome Project, large-insert clones that have been 
mapped and sequenced can be used as probes and are now readily available for 
almost all genomic regions. Probes can be selected using internet-browsers such as 
Ensembl Cytoview or the UCSC genome browser [Speicher and Carter, 2005]. To make 
the probes, DNA sequences are labeled directly with fluorescent dyes or indirectly with 
biotin or digoxigenin, which are then detected with immunofluorescent staining [Fan, 
2002].  
Many FISH techniques have been developed, including FISH with unique sequences; 
FISH with multiple subtelomeric probes; multiplex or multicolour FISH (M-FISH), 
Combined Binary Ratio Labelling (COBRA) FISH [Tanke et al., 1999] and spectral 
karyotyping (SKY); color banding; primed in situ labeling (PRINS), fiber FISH, reverse 
FISH and comparative genomic hybridization (CGH) [Fan, 2002; Liehr et al., 2009]. With 
these techniques, deletions or rearrangements of a single gene can be detected, 
cryptic chromosome translocations can be visualized (except with CGH), copy number 
can be assessed and very complex rearrangements can be characterized. FISH can be 
used in metaphase spreads, but also in interphase nuclei. The later allows the study of 
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all types of human tissues at any stage of cell division, without the need of cell culture 
and chromosome preparation. 
 
FISH with unique sequences 
FISH with unique DNA sequences is the most basic molecular cytogenetic technique 
[Lichter and Ward, 1990]. The probe used could be specific of a single gene, a particular 
chromosomal region or locus, being the technique used, for example, for the 
confirmation of microdeletion syndromes (Fig. 1.9.). 
 
 
Figure 1.9. – Partial metaphase hybrydized with locus-specific probes for Smith Magenis Syndrome 
(17p11.2) (green) and Miller Dicker Syndrome (17p13.3) (red) [photo from Laboratório de Citogenética 
da Faculdade de Medicina da Universidade de Coimbra]. 
 
FISH for multiple subtelomeric regions 
This technique uses 41 subtelomeric probes for all 24 different chromosomes (not 
including the short arms of acrocentrics) [Knight et al., 1997). Each of these probes is 
composed of unique sequences in the subtelomeric regions (~300 kb from the 
chromosome end). The probes for the short arms and the long arms are dual labelled 
with a green and a red fluorochrome respectively (Fig. 1.10.) [Fan, 2002].  This technique 
is particularly important in the detection of chromosomal imbalances in these regions, 
especially deletions that are associated with mental retardation. 
 
 
Figure 1.10. – Hybridization with subtelomeric probes for 5p and 5q showing a deletion of 5q 
subtelomeric region [photo from Laboratório de Citogenética da Faculdade de Medicina da Universidade 
de Coimbra]. 
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Chromosome Painting 
Chromosome painting allows the labeling of an entire chromosome using probes 
generated from specific chromosome libraries or chromosome microdissection (wcp, 
whole chromosome painting) [Cremer et al., 1988; Guan et al., 1994]. Partial chromosome 
painting (pcp) identifies the short or the long arm of a specific chromosome (Fig. 1.11.). 
This technique is extremely useful for the characterization of several chromosomal 
imbalances, like insertions and translocations. 
 
A B
 
Figure 1.11. – A) Whole chromosome painting for chromosomes 2 (green) and 3 (red); B) Partial 
chromosome painting of chromosome 2, being the short arm red and long arm green. [photo from 
Molekulare Zytogenetik Labor in Jena]. 
 
 
SKY, COBRA and M-FISH 
Combinatorial labelling uses the calculation of a spectral signature for each probe — 
each probe is identified by its unique combination of absences and presences of each 
fluorochrome. The required 24 colour combinations (for the 22 human autosomes plus 
the 2 sex chromosomes) can also be achieved using ratio labelling. In ratio labelling, 
different probes can be labelled with the same fluorochrome combinations, but are 
distinguished by the different proportions of the fluorochromes used. Using this 
approach, only four fluorochomes are necessary to achieve 96 possible colour 
combinations or pseudocolours. These labelling strategies allow the simultaneous 
visualization of all 24 human chromosomes, each in a different colour, in a single 
hybridization (Fig. 1.12.). The principle of combinatorial labelling is applied in almost 
cases. Specific technologies that use these approaches include Multicolour-FISH (M-
FISH), Spectral Karyotyping (SKY-FISH) and Combined Binary Ratio Labelling (COBRA) 
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[Schröck et al., 1996; Speicher et al., 1996; Tanke et al., 1999; Speicher and Carter, 2005; Liehr 
et al., 2009].  
 
 
Figure 1.12. Human male karyogram after hybridization of a seven-fluorochrome M-FISH mix [adapted 
from Geigl et al., 2006]. 
 
Multicolour-FISH (M-FISH) is defined as the simultaneous use of at least three different 
ligands or fluorochromes for the specific labelling of DNA (excluding the counterstain). 
Camera-based image acquisition and computer-based image analysis are required for 
the analysis of SKY, COBRA and M-FISH experiments. Indeed, in combinatorial labeling, 
at least one of the fluorochromes used has its emission wavelength in a spectral region 
that is invisible to the human eye and in ratio labeling the computer is essential to 
detect slight colour differences [Liehr et al., 2009]. Using these multicolour approaches 
the detection sensitivity for small interchromosomal rearrangements (involving <3 Mb 
of sequence) is poor [Speicher and Carter, 2005]. 
Subcentromeric FISH (subcenFISH) is a M-FISH technique that allows the 
characterization of the pericentromeric regions of all human chromosomes. 
SubcenFISH includes the most proximally available single-copy probes, 
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microdissection-derived partial chromosome probes specific for the long and the short 
arm, and a centromere specific probe. For the acrocentric chromosomes, no proximal 
single copy probes and no chromosome specific pcp probes of the short arms are 
available. For all the acrocentric chromosomes set, a probe that stains all p-arms of the 
acrocentric chromosomes (midi54) is used (Fig.1.13.) [Starke et al., 2003]. 
 
 
Figure 1.13. – Human male karyogram with subcentromeric FISH [adapted from Starke et al., 2003]. 
 
Multicolour Banding (MCB) 
Multicolour Banding (MCB) is performed using overlapping microdissection libraries 
that are differentially labelled, producing reproducible and unique patterns of 
fluorescence ratios along chromosomes. These fluorescence ratios can be transformed 
into pseudocolour banding using specific software (Fig. 1.14.) [Chudoba et al., 1999]. MCB 
allows the differentiation of chromosome region specific areas at the band and sub-
band level and provides the possibility to analyse chromosomes irrespective of their 
condensation grades [Liehr et al., 2009]. 
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Figure 1.14. – Human Karyotype with different regions of chromosomes differentially labelled using 
probes obtained by microdissection – MCB [from Liehr et al., 2009]. 
 
Reverse FISH 
A whole chromosome or a specific band is microdissected from a metaphase spread, 
amplified by PCR and labelled with a fluorochrome. The hybridization of this probe in a 
metaphase spread will reveal the chromosome or region microdissected (Fig.1.15.) [Su 
et al., 1994].  
 
Figure 1.15. – Metaphase plate showing the presence of a marker chromosome by reverse FISH [from 
Melo et al., 2009]. 
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Fiber-FISH 
Fiber FISH is a powerful tool for mapping DNA sequences onto specific regions of the 
genome, because it allows accurate sizing of gaps and overlaps between probes (Fig. 
1.16.). Overlaps between two differentially labelled probes are sized by measuring the 
‘length’ of the signal on the DNA fibers that show mixed fluorescence (fluorescence 
from both probes). Gaps are sized by measuring the length of non-hybridized regions 
between two hybridization signals. Fiber FISH has been particularly useful for 
measuring the size of regions of the human genome that have been impossible to 
sequence [Florijn et al., 1995; Speicher and Carter, 2005]. 
 
 
Figure 1.16. – Fiber-FISH image showing the overlaps and gaps between probes [adapted from Iafrate et 
al., 2004]. 
 
1.1.3.2. Comparative Genomic Hybridization 
In Comparative Genomic Hybridization (CGH) the DNA is extracted from a test sample 
and a normal reference sample [Kallioniemi et al., 1992]. The two DNA samples are 
differentially labelled — for example, with the test labelled in green and the reference 
in red. The combined probes are then applied to target metaphase chromosomes and 
compete for complementary hybridization sites. Therefore, if a region is amplified in 
the test sample the corresponding region on the metaphase chromosome becomes 
predominantly green. Conversely, if a region is deleted in the test sample the 
corresponding region becomes red [Speicher and Carter, 2005]. By measuring the ratio of 
green to red colour, gains or losses of chromosomes can be detected (Fig. 1.17.). The 
size of DNA segments that CGH can detect is >~5-10 Mb, because it is dependable on 
the resolution of the metaphase spread used as a template [Kirchhoff et al., 2001]. By 
using dynamic standard reference intervals in high-resolution CGH, the resolution can 
be improved to ~3 Mb [Kirchhoff et al., 2004]. Although CGH can be applied to 
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constitutional cytogenetics, its main application is in tumour samples. Using DNA, and 
not metaphase spreads of the patient, CGH can be used for the study of cells in the 
different stages of cell cycle. For rearrangements that do not involve genomic 
imbalances, such as balanced chromosome translocations and inversions, the use of 
CGH is useless. In addition, whole-genome copy number changes (ploidy changes) 
cannot be detected. Furthermore, CGH provides no information about the structural 
arrangements of chromosome segments that are involved in gains and losses [Speicher 
and Carter, 2005]. For example, when a gain is observed it is not possible to ascertain 
whether it is a duplication or a marker chromosome. 
 
 
Figure 1.17. – Schematic representation of a CGH experiment. Patient DNA is labelled in green and a 
reference DNA is labelled in red. After mixture, the probes are hybridized in a metaphase plate. By 
measuring the ratio of green to red colour, gains or losses of chromosomes can be detected  
[downloaded from http://commons.wikimedia.org]. 
 
1.1.3.3. Array Comparative Genomic Hybridization – Array CGH 
Array Comparative Genomic Hybridization (array CGH) was developed on the same 
principle as CGH on chromosomes.  In array CGH, DNA probes are arrayed on a chip 
and CGH is used to test for increased or decreased dosage of chromosomal regions of 
interest. This technology allows the screening in one experiment of a great number of 
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DNA genomic sequences. Solinas-Toldo and co-workers were the first to report that it 
was possible to substitute the chromosome target by a glass where an ordered set of 
defined nucleic acid sequences are spotted [Solinas-Toldo et al., 1997; Sanlaville et al., 
2005]. 
Genomic DNA of the patient is extracted from peripheral blood lymphocytes, skin 
fibroblasts or other available tissue and labelled with one fluorescent dye (usually Cy3-
labelled dCTPs). The labelled patient DNA, together with an equal amount of control 
DNA labelled with another fluorescent dye (usually Cy5-labelled dCTPs), are co-
hybridised to a selected set of pre-spotted genomic fragments. The spot intensities are 
measured at 532 nm (Cy3) and 635 nm (Cy5). If the amount of Cy3 and Cy5 fluorescent 
intensities are equal in one spot, this region of the patient DNA is interpreted as being 
normal/balanced; if a threshold of increased ratio of Cy3 to Cy5 is detected, a 
duplication of the patient DNA is suspected, and inversely if a deletion is present (Fig 
1.18.) [de Ravel et al., 2007]. 
 
Control
DNA
Test
DNA
Cot-1
microarray
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Cy5 labelling
- duplication
- deletion
- equilibrium
 
Figure 1.18. - Principle of array CGH. Test DNA and control DNA are differentially labelled with Cy3 and 
Cy5 respectively. The two labelled products are combined and hybridized onto the spotted slide. Images 
from hybridized slides are obtained by scanning in two channels and Signal intensity ratios from 
individual spots can be displayed as a simple plot. In the presence of a deletion the correspondent spot 
will appear red and in the presence of a duplication green. 
 
With a single test, array CGH can detect genomic errors for disorders that are usually 
identified by cytogenetic analysis and multiple FISH tests. The detection limits of copy-
number differences by array CGH depend on the probe density and the resolution of 
the platform used. The DNA probes commonly used range from genomic clones, most 
often BAC clones (80–200 kb), to oligonucleotides (25–85 bp) (Fig. 1.19.) [Emanuel and 
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Saitta, 2007]. A special type of oligonucleotide array can distinguish Single Nucleotide 
Polymorphisms (SNPs), allowing recognition of the parental origin of each DNA copy 
and enabling the detection of uniparental disomy. 
 
 
Figure 1.19.  - Diagram showing the differences in resolution between conventional karyotyping and 
different array CGH platforms. Conventional karyotype allows a resolution of no more than 5 Mb. The 
resolution with array CGH depends on the platform used. 
 
The advantage of array analysis is that it simultaneously assays discrete loci in a high-
throughput manner at a resolution never before possible with conventional 
cytogenetic techniques. The high-resolution analysis afforded by microarrays can 
identify several pathogenic abnormalities. The recent use of microarray-based 
comparative array CGH has accelerated the identification of novel cytogenetic 
abnormalities. However, microarray analysis can also uncover gains and losses in 
regions of the genome that have unclear clinical significance. Some of these are 
apparently benign copy number variants (CNVs), but others may have clinical 
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relevance that remains unknown [Shaffer et al., 2007]. Like CGH, array CGH does not 
identify balanced chromosome rearrangements and complete ploidy. 
Selecting the correct molecular cytogenetics strategy for the study of a particular 
disease or chromosomal imbalance is a main issue. Indeed, different chromosomal 
abnormalities require different cytogenetic methods for their identification. As 
summarized in figure 1.20., depending on the chromosomal abnormality the different 
cytogenetic techniques can have different sensibilities. For instance, array-CGH is not a 
suitable technique for the detection of polyploidy and balanced translocations, 
inversions or insertions. On the other hand, it has a high resolution for detecting 
submicroscopic deletions and duplications/amplifications. 
 
# # #
 
Fig. 1.20. - Comparison of cytogenetic techniques for identifying chromosomal abnormalities. Various 
chromosomal aberrations that might be present in clinical samples are shown, with the ability of 
different cytogenetic techniques to detect them. A ‘+’ indicates that an approach is suited for identifying 
the chromosomal rearrangement, a ‘–’ indicates that the aberration would be missed. M-FISH, multiplex 
fluorescence in situ hybridization; SKY, spectral karyotyping; LOH, loss of heterozigoty. *Indicates that 
several experiments are needed [adapted from Speicher and Carter, 2005]. 
#
rearrangements > 5Mb. 
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1.2. SMALL SUPERNUMERARY MARKER CHROMOSOMES (sSMCs) 
1.2.1. Definition and Nomenclature of sSMCs 
According to the ISCN published in 2009, a marker chromosome (mar) is a structurally 
abnormal chromosome that cannot be unambiguously identified or characterized by 
conventional banding cytogenetics [Shaffer et al., 2009]. A marker chromosome 
comprises a mixed collection of structurally rearranged chromosome regions. 
Numerous terms have been used in the literature to described markers, including 
supernumerary marker chromosomes (SMC), extra structurally abnormal chromosomes 
(ESAC), supernumerary ring chromosomes (SRC), accessory chromosomes (AC/ACH), 
small accessory chromosome (SAC), extra or additional marker chromosome, 
supernumerary or extra microchromosome, additional or metacentric chromosome 
fragment or small bisatelited additional chromosome [revised by Liehr et al., 2004]. 
Certain markers chromosomes are large enough to be identified by G banding and 
have a well-established phenotype. Examples include iso(12p), associated with 
Pallister-Killian syndrome (PKS) [Shinzel, 1991]; iso(18p), associated with mild-moderate 
mental retardation and a characteristic facial appearance [Callen et al., 1990]; or iso(9p)-
syndrome, associated with mental retardation and craniofacial dysmorphisms. The 
other markers, smaller, are usually identified only by molecular cytogenetics. Some of 
these smaller supernumerary markers are also associated with well established 
syndromes, like cat-eye syndrome and the presence of an extra small marker derived 
from chromosome 22. 
Crolla proposed a definition of small supernumerary marker chromosomes (sSMCs) as 
“small structurally abnormal chromosomes that occur in addition to the 46 
chromosomes” [Crolla et al., 1997]. Liehr suggested a “more cytogenetic” definition, 
defining sSMCs “as structurally abnormal chromosomes that cannot be identified or 
characterized unambiguously by conventional banding cytogenetics alone, and are (in 
general) equal in size or smaller than a chromosome 20 of the same metaphase 
spread” [Liehr et al., 2004]. In contrast, a supernumerary marker chromosome larger 
than chromosome 20 usually can be identifiable based on chromosome banding. The 
 
Introduction 
 
41 
 
definition of small sSMC versus larger sSMC is not functional, but cytogenetic, because 
sSMC and larger sSMC can have the same karyotypic evolution [Liehr et al., 2004]. 
sSMC can either be present in addition to [Liehr et al., 2009]: 
1) an otherwise normal karyotype (e.g.: 47,XX,+mar); 
2) a numerically abnormal karyotype (e.g. Down syndrome – 48,XY,+21,+mar); 
3) a structurally abnormal but balanced karyotype (e.g. 46,XX,del(mar-
region),+mar). 
sSMCs are a morphologically heterogeneous group of structural abnormal 
chromosomes that can appear in different shapes: inverted duplicated chromosomes 
(inv dup), centric minute chromosomes (min) and ring chromosomes (r) (Fig. 1.21.). The 
subgroup of inv dup is composed of different types of sSMC, including dicentric 
chromosomes.  
 
Figure 1.21.– Different shapes of sSMC. Small supernumerary marker chromosomes (sSMC) are defined 
as structurally abnormal chromosomes that cannot be identified or characterized unambiguously by 
conventional banding cytogenetics alone, and are (in general) equal in size or smaller than a 
chromosome 20 of the same metaphase spread. Different forms of sSMC can appear: inverted 
duplication chromosomes (inv dup), centric minute chromosomes (min) or ring chromosomes (r) [from 
Liehr et al., 2004].  
 
Taking into account the morphology variety, the term “markers” seems to be more 
comprehensive, even after their identification by molecular cytogenetics [Liehr, 2009]. 
One problem not resolved in the new ISCN 2009 [Shaffer et al., 2009] is the difficulty 
encountered when a definition of subpopulation of small supernumerary marker 
chromosomes (sSMCs) is to be formulated. Additionally, no uniform regulations are 
available concerning the order of sSMC cell lines in the karyotype formula and the 
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description of the sSMCs main shapes (centric minute, inverted duplication and ring). 
When the “marker” chromosome becomes a well-characterized sSMC its shape should 
be indicated. However, according to the ISCN the only possibility of doing that 
correctly is using the abbreviation “der”, for derivative. Liehr pinpointed this 
nomenclature problem in a recent letter to editor of the Journal of Histochemistry and 
Cytochemistry [Liehr, 2009]. According to the definition of derivative chromosomes 
(der) proposed in the 2009 ISCN, a “der” is a structurally rearranged chromosome 
generated either by a rearrangement involving two or more chromosomes or by 
multiple aberrations within a single chromosome. On the other hand, sSMCs are very 
specific and clearly definable according to their shapes. The only possibility according 
to the ISCN 2009 is to designate ring chromosomes as “r”, being the term “der” used 
for the other shapes of sSMCs. The term “inv dup” is considered outdated and the 
replacement of this designation is suggested - for example inv dup(15)(q11.2) replaced 
by idic(15;15)(q11.2;q11.2). However, this replacement could be confusing; in the way 
that “inv dup” is a widely accepted term.   
Taking into account these considerations, Liehr proposed that the abbreviations “min” 
for centric minute-shaped sSMCs, “inv dup” for inverted duplicated sSMCs and “r” for 
ring-shaped sSMCs should continue to be applied and the use of “der” should be 
avoided in the subgroup of centric minute-shaped sSMCs. In table I, a comparison of 
the nomenclature proposed by ISCN 2009 and Liehr, in different sSMC cases, is 
described, showing that the system proposed by this author is more simple and 
informative [Liehr, 2009] (Table 1.I.). Furthermore and taking into account the order of 
the different cell lines in an sSMC mosaic case, this author purposes to sort the clones 
first by their modal chromosome number, second according to the number of cells 
containing the marker, and finally by the size of the imbalance they cause. Therefore, 
the normal cell line (46,XX or 46,XY) would be always referred at last2.  
                                                 
2
 Considering the following example of a mosaic case with 4 different cell lines: 1) a normal complement 
in 4 analysed cells; 2) a cell line with a supernumerary  marker chromosome (mar1) present in  5 
analysed cells; 3) a cell line with a different, bigger, supernumerary  marker chromosome (mar2) present 
in 4 analysed cells;  4) a cell line with a different supernumerary  marker chromosome (mar3), smaller 
than mar2, present in 4 analysed cells; the order of the different cell lines should be: 
47,XX,+mar1[5]/47,XX,+mar2[4]/47,XX,+mar3[4]/46,XX[4]. 
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Table 1.I. - Comparison of ISCN 2009 nomenclature with the one suggested by Liehr for sSMCs shaped in 
centric minute, inverted duplication, or ring structure [from Liehr, 2009]. 
 
 
1.2.2. Relevance and risk of sSMCs  
The first cases in the literature describing the presence of an sSMC appeared in the 
60’s. Indeed, in 1961, Ilberry and collaborators described a boy with epicanthic fold 
and protuberant tongue who had a karyotype 47,XY,+mar[53]/46,XY[16] de novo 
[Ilberry et al., 1961]. Ellis and colleagues published, in 1962, a case with an aberrant 
small acrocentric chromosome and Froland et al., in 1963, described a boy with several 
congenital defects with a karyotype 47,XY,+mar [Ellis et al., 1962; Froland et al., 1963]. 
Only several years latter, a correlation between several sSMCs cases and their possible 
phenotypic effects was described, when Buckton and collaborators showed that the 
ascertainment of sSMCs among individuals in psychiatric institutions was 3.27/1000 
compared to their frequency of only 0.24/1000 among consecutive newborns [Buckton 
et al., 1985; Crolla et al., 2005].  
Several attempts have been made to correlate specific marker chromosomes with a 
clinical picture, resulting in the description of few new syndromes like i(18p)-
syndrome, the Pallister-Killian syndrome i(12p) (OMIM 601803) and the der(22) and 
cat-eye syndromes (CES) (OMIM 115470) [Crolla, 1998].  
The risk for phenotypic abnormalities associated with an sSMC depends on several 
factors, including inheritance, mode of ascertainment, chromosomal origin, and the 
morphology, content, and structure of the marker [Graf et al., 2006].  Phenotypes 
associated with an sSMC are variable, from normal to severely affected. It has been 
shown that, depending on the chromosomal region of an sSMC, differences can be 
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observed and expected in clinical outcome. Indeed, this observation is confirmed by 
different reports of small trisomies in connection with the presence of an sSMC and 
specific clinical features [Crolla, 1998; Stankiewicz et al., 2000; D'Amato Sizonenko et al., 
2002; Starke et al., 2003; Sarri et al., 2006; Baldwin et al., 2008]. However, the majority of 
markers published in the literature have not been fully characterized and in order to 
correlate an sSMC with a clinical outcome is essential to know it chromosomal origin 
and content. 
sSMCs can be detected postnatally or prenatally, the last being a major problem for 
cytogenetic investigation and genetic counselling, due to time availability and, 
essentially, due to the difficulty in the majority of cases in establishing a robust 
genotype/phenotype correlation. Occasionally, sSMCs lead to spontaneous abortions. 
The majority of sSMCs do not grossly interfere with fetal development, because they 
contain little or no euchromatin.  
Some markers are inherited directly from a phenotypically normal parent. In such 
cases, there are often no phenotypic consequences for individuals who inherit the 
marker, conferring the presence of a familial sSMC a low risk. However, there are 
exceptions to this, such as when there are imprinting effects from uniparental disomy 
(UPD), or low level, tissue specific mosaicism for the marker chromosome in a parent 
without phenotypic manifestations [Graf et al., 2006].   
The risk of an abnormal phenotype in de novo prenatal cases with an sSMC is given as 
approximetly 13% [Warburton, 1991]. However, and taking in consideration the origin of 
the sSMC, the risk of an abnormal phenotype associated with a de novo acrocentric 
sSMC (excluding those derived from chromosome 15) is 7% (if sSMC is from 13, 14, 21 
or 22) and 28% (for non-acrocentric autosomes) [Crolla, 1998]. Graf and colleagues 
estimated a 26% (28/108) risk for phenotypic abnormality for any non-sex 
chromosome de novo supernumerary marker chromosome [Graf et al., 2006]. It was 
suggested that if high resolution ultrasound studies are normal, this risk reduces to 
18% [Graf et al., 2006]. As a result of the high risks and many uncertainties regarding the 
clinical outcome, many pregnancies with de novo sSMC are terminated.  
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Furthermore, the detection of mosaicism or uniparental disomy (UPD) of the parental 
chromosomes homologous to the sSMC confers more complexity to the case 
management. 
 
1.2.3. Mechanisms of sSMCs formation 
Different mechanisms of sSMC formation including trisomic rescue, monosomic 
rescue, post fertilization errors and gamete complementation have been proposed 
[Bartels et al., 2003; Liehr et al., 2004]. Another mechanism, that could explain the 
existence of multiple sSMCs of different origin, is the formation of sSMC from 
transfection of chromosomes into the zygote derived from one or more superfluous 
haploid pronuclei that would normally be degraded by deoxyribonucleases or other 
means [Daniel and Malafiej, 2003].  
sSMCs can assume different shapes: inverted duplication (inv dup) chromosomes; 
centric minute chromosomes (min); neocentric chromosomes; ring chromosomes 
(SRC), and complex rearranged sSMCs. The mechanism of formation of the sSMC could 
be different according to the shape of the marker. 
 
Inv dup supernumerary chromosomes 
The most frequent mechanism proposed for the formation of inv dup sSMCs derived 
from acrocentric chromosomes is a U-type exchange resulting from crossover mistakes 
of chromatids of two homologous chromosomes during meiosis (Fig. 1.22.) [Schreck et 
al., 1977; Liehr et al., 2004]. A U-type exchange is also proposed for the formation of iso-
chromosomes of non-acrocentric chromosomes, with a break within the centromeric 
DNA [Liehr, 2010 – sSMC homepage]. Besides U-type exchange, other theories have arise 
concerning the formation of dicentric iso-chromosomes including: a non-sister 
chromatid exchange followed by a second-division non-disjunction; errors in 
replication, caused by parental inversion heterozygosity; translocation exchange; and 
mitotic errors originating from ligation error in a replication fork during S-phase, 
followed by a new replication [Murmann et al., 2009]. 
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Figure 1.22. –Frequent mechanism proposed for the formation of inverted duplication sSMCs.  A U-
type exchange derived from crossover mistakes of the two homologous during the pachytene of 
prophase I [adapted from Liehr et al., 2004]. 
 
Small neocentric supernumerary chromosomes  
Neocentric chromosomes do not contain detectable alpha-satellite DNA. They are 
called analphoid markers, carrying newly derived-centromeres (neocentromeres) that 
are formed within interstitial chromosomal sites that have not previously been known 
to express centromeres [Choo, 1997]. 
The development of the majority of neocentric sSMCs is based on a U-type exchange, 
between two chromatid of two different chromosomes (inter-chromosomal), and most 
of the neocentric sSMC are small iso-chromosomes (Fig. 1.23.). The acentric fragment 
created during a U-type exchange in these cases is included into a gamete, a neo-
centromere is activated and the new “chromosome” is distributed throughout further 
cell cycles. This theory is supported by the fact that the frequency of inv dup(15) 
chromosomes is similar to that observed in neocentric chromosomes 15 among other 
acrocentric derived chromosomes of the corresponding group [Liehr et al., 2006]. 
However, Murmann et al. (2009) have proven that in contrary to the model shown in 
Fig. 1.23., in most neocentric inv dup-chromosomes the U-type exchange appears not 
intra- but inter-chromosomal, between two chromatids of the same chromosome (Fig. 
1.24).  
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Figure 1.23. – Formation of a neocentromere supernumerary chromosome. An acentric inverted 
duplication chromosome is formed following a U-type exchange in meiosis I that forms a 
neocentromere, preventing it lost in subsequent cell divisions [adapted from Liehr et al., 2004]. 
 
 
Figure 1.24. – U-type exchange could also occur between two chromatids of the same chromosome 
(intra-chromosomal). During meiosis crossing over leads to the formation of one acentric inv dup marker 
with two arms and one dicentric derivative. After meiosis I and the meiosis II division, respectively, the 
intra-chromosomal dicentrics break when both their centromeres are pulled apart resulting in a deleted 
derivative and an inv dup del derivative [adapted from Murmann et al., 2009]. 
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There are some cases reported in the literature of sSMCs with a ring chromosome 
conformation and associated with the presence of a neocentrome [Slater et al., 1999; 
Spiegel et al., 2003, Mascarenhas et al., 2008]. The mechanism of formation in these cases 
should follow the one described for ring chromosomes (see below) with a part of one 
chromosome, without containing the centromere, is excised and a neocentromere is 
formed. 
 
Small supernumerary ring chromosomes  
In cases which the morphology of the sSMC can be determined, almost 50% appear to 
be ring chromosomes [Liehr et al., 2006]. Several explanations for formation of non-
neocentric small supernumerary ring chromosomes (sSRC) are available in the 
literature. Two major models are proposed: 
I) a sSRC can be formed after a break within the centromere (“centromere 
misdivision”), along with a break either in p arm or in q arm. This is the case 
where ring formation is in connection with an inverted duplication due to an 
U-shape reunion between broken sister chromatids [Michalski et al., 1993] (Fig. 
1.25.A) or when a SRC is associated with a deletion of a part of the 
chromosome.  In contrast to neocentric sSMC, parts of the centromere are 
included, leaving two centric chromosome fragments, one of which forms a 
small ring (Fig. 1.25.C); 
II) a sSRC formation requires the occurrence of one break in the p arm and a 
second break in the q arm, and the two broken ends of a centric fragment 
fusing together to form a ring. The resulting SRC contains DNA from both p and 
q arms. sSRC formation can start with a centric minute chromosome (Fig. 
1.25.B) or the formation of a sSRC could be associated with complex 
chromosomal rearrangements [Stankiewicz et al., 2001; Stavropoulou et al., 1998]. 
A dicentric iso-chromosome could be formed primarily, followed by an 
excision of one centromere, with the excised fragment subsequently forming a 
ring chromosome (Fig. 1.25.D). 
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Figure 1.25. – Formation of sSRC. A) Formation of a sSRC after a U-shape reunion; B) Formation of a 
sSRC after a centric minute chromosome ; C) Formation of a sSRC in connection  with a deletion; D) 
Formation of a sSRC associated with complex rearrangements, with a primary dicentric iso-chromosome 
formation, being one of the centromeres excised [adapted from Liehr, 2010 – sSMC homepage]. 
 
Recently, Baldwin and co-workers proposed that small-ring formation with a 
“centromere misdivision”, might be a predominant mechanism of origin [Baldwin et al., 
2008]. These authors supported this theory by the existence of several deletion cases 
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reported in the literature associated with a complementary sSRC and of a cryptic 
deletion case reported in their paper, associated with a complementary sSRC. This 
mechanism of breakage within the centromere creating a pericentromeric deletion 
and a complementary ring chromosome was first described by Barbara McClintock, in 
1938, using maize [McClintock, 1939].  
Taking this into account, when in the presence of a familial SRC in a child with an 
abnormal phenotype and with a phenotypically normal parent (carrier of a SRC), this 
mechanism should be considered, given the possibility of cryptic pericentromeric 
deletions and a balanced deletion and ring state in a normal parent and other relatives 
[Baldwin et al. , 2008]. 
It is postulated that sSRC do not have telomeres [Ning et al., 1999]. However, the 
presence of telomeric and subtelomeric sequences at the fusion points of ring 
chromosomes was demonstrated for larger ring chromosomes [Pezzolo et al., 1993].  
 
Complex rearranged supernumerary marker chromosomes 
There are some cases reported in the literature of sSMCs with no consecutive 
chromosomal material, having complex intrachromosomal rearrangements [Trifonov et 
al., 2008]. There are also cases reported in the literature with more than one sSMC 
derived from 2 different chromosomes [Liehr et al., 2006], from 3 chromosomes [Huang 
et al., 2006], from 4 chromosomes [Tsuchiya et al., 2008]; from 5 chromosomes 
[Beverstock et al., 2003]; from 6 chromosomes [Vermeesch et al., 1999] and from 7 
different chromosomes [Chen et al., 2006]. 
The formation of these complex rearranged sSMC could arise from a superfluous 
haploid pronucleus in which there is incomplete digestion of some chromosomes, and 
transfection of these leftover pieces into the zygote [Daniel and Malafiej, 2003]. 
 
1.2.4. Frequency and distribution of sSMCs  
An important issue when studying the impact of an sSMC case is the frequency of 
sSMC in prenatal and in postnatal cases in different human sub-populations. Liehr and 
Weise addressed this question, reviewing 132 datasets derived from the literature and 
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from own data [Liehr and Weise, 2007] (Table I.2). The range of frequency of sSMC 
carriers in the different datasets analysed varied between 0.028% and 0.15%. These 
variations were mainly caused by the size of the analysed population and the bias 
caused by single studies. In this study 1 288 693 cytogenetically studied cases 
detecting 980 sSMCs were assembled, being the i(18p), der(22), i(2p) and inv dup(22) 
also counted as sSMC. According to this study, 70% of the reported sSMC are de novo, 
being the other 30% familial cases. 
The frequency of sSMC in newborn cases is 0.044%, taking into account several reports 
of consecutive newborn children, without further selection criteria [Liehr and Weise, 
2007]. In prenatal cases this rate is higher, being 0.075% in 688 030 cases provided by 
>240 laboratories. This detection rate was independent if chorion villi samples (CVS) or 
amniotic fluid cells were studied. Liehr and Weise evidenced a strong positive 
correlation (0.204 %) of sSMC presence and ultrasound abnormalities, but Pallister-
Killian-, cat-eye-, der(22)- and iso(18p)-syndrome chromosomes were included and are 
usually correlated with malformations. 
 
Table 1.II. – Frequency of sSMCs in human subpopulations.  
Subpopulation sSMCs Frequency 
Prenatal cases 0.075% 
Newborn cases 0.044% 
Mentally retarded patients 0.288% 
Sub fertile people 0.125% [0.165% in male; 0.022% female] 
[adapted from Liehr and Weise, 2007] 
 
The higher rate of cases with sSMC in prenatal compared to newborn could be 
explained by the bias caused by the maternal age effect in prenatal studies. 
Additionally, prenatal diagnostics is often performed when a suspicion of foetal 
pathology exists, increasing this bias, and foetus with sSMC may result in miscarriage 
and will not be accounted in newborn cases [Blennow et al., 1994]. Warburton reported 
a frequency of 0.043% of de novo sSMCs in prenatal studies [Warburton, 1991]. The 
discrepancy of this value could be attributed to the fact that only de novo cases were 
reported (the familial ones were excluded) and that the sSMCs accounted did not 
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include extra chromosomes like iso(18p), iso(9p), Pallister-Killian-, cat-eye- and 
der(22)-syndrome chromosomes. 
The sSMC frequency rate in mentally retarded patients is 0.288% taking into account 
26 studies with 2000 sSMCs carriers in 69 332 patients. The sSMC rate is ~7 times 
higher in developmentally retarded patients than in the normal population [Liehr and 
Weise, 2007]. 
In patients with fertility problems, and considering 41 studies with 30 510 patients, the 
overall rate is 0.125%, but with a higher frequency in male (0.165%) comparing with 
female (0.022%). Patients with fertility problems have a 2.9 times enhanced risk for an 
sSMC compared to the general population [Liehr and Weise, 2007]. It has been shown 
that the frequency of chromosome abnormalities in infertile male is approximately five 
times higher than that found among the normal male population [Chandley et al., 1975]. 
The majority of chromosome abnormalities appeared to be exerting their effect on 
male fertility through disturbance of spermatogenesis. Chromosomopathies account 
for approximately 2% of all men who attend infertility clinics, rising to 15% among 
those with azoospermia [Chandley, 1998].   
An interesting estimation could be done – taking into account the estimated world 
population of 6 823 000 000 people and a 0.044% rate of sSMC in newborns, that will 
be at present ~3.0x106 living sSMC carriers [U.S. Census Bureau, 2010; Liehr and Weise, 
2007]. 
 
1.2.5. Mosaicism and sSMCs 
Mosaicism refers to the presence of genetically different cells in a multicellular 
organism that have been derived from a single fertilized egg. Many different 
mechanisms and types of genetic changes can lead to mosaicism, such as differences in 
the number and configuration of chromosomes (loss, gain, translocation, deletion), 
and various types of mutations of a single gene [Hall, 2005].  
Chromosome instability is a hallmark of tumorigenesis but recently it was shown that 
is also common during early embryogenesis [Vanneste et al., 2009]. It is characterized by 
an elevated rate of gains or losses of complete chromosomes or segments of 
 
Introduction 
 
53 
 
chromosomes per cell cycle, resulting in cell-to-cell variability [Geigl et al., 2008]. 
Vanneste and collaborators revealed a high frequency of chromosome instability in 
cleavage-sate embryos involving complex patterns of segmental chromosomal 
imbalances and mosaicism for whole chromosomes and uniparental isodisomies 
[Vanneste et al., 2009].  
The clinical impact of genetic mosaicism may be negligible, minor or dramatic. It has 
been known for a long time that chromosomal mosaicism can be seen in some of the 
more common chromosomal disorders, like Down syndrome or Turner syndrome. In 
general, it has been observed that the more normal cells that are present, the milder 
the effect on the phenotype could be. However, this is not a straightforward 
observation. The impact of the type of cell lines (normal or abnormal) present in 
different tissues is also very important to evaluate the severity of phenotypes, 
associated with mosaicism. 
Mosaicism associated with sSMCs is a well-known fact. As previously discussed (section 
1.2.3.) the different mechanisms proposed for sSMC formation, inluding trisomic 
rescue or monosomic rescue and post fertilization errors, would frequently lead to 
mosaicism. Additionally, sSMCs may tend to rearrange and/or reduce size during 
karyotype evolution. These phenomena could lead to the formation of different cell 
lines, for example: 
a) in ring chromosomes, due to the characteristic instability of a ring structure at 
mitosis after sister chromatid exchange events, double or even more sSRC 
could be found [Starke et al., 2003; Carreira et al., 2007] 
b) the decrease of cells with sSMC during lifetime [Hoo et al., 1974]  or even the 
disappearance of the sSMC in the most frequent studied tissues during lifetime 
could occur (e.g. peripheral blood) [Fitzgerald and Mercer, 1980]; 
c) the formation of different variants and a highly complex mosaic arising from 
centric minute or ring chromosomes that are degraded differently in different 
cells/tissues [Liehr et al, 2004]. 
Fickelscher and collaborators characterized the levels of mosaicism of a prenatally 
ascertained case with a de novo sSMC derived from, chromosome 1. A molecular 
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cytogenetic study of eleven tissues of this foetus was performed showing that the 
presence of the sSMC varied between 13 and 62% within the different tissues. This 
finding is something common in sSMC carriers and could explain why up to the present 
no clinical correlations for sSMC mosaicism and clinical outcome in the corresponding 
carriers could be established [Fickelscher et al., 2007].  
The retrospective study made by Warburton of 377,357 reported amniocenteses in a 
10 years-period revealed that, of the 123 cases with sSMC, 53% were in mosaic and 
that mosaicism in phenotypically normal sSMC carriers was ~52.3% and in 
phenotypically abnormal sSMC carriers was ~56.3% [Warburton, 1991]. These numbers 
are approximate to the results of Daniel and Malafiej report – 61.9% mosaicism in 
phenotypically normal carriers and 56.6% in abnormal carriers, when reviewing 
supernumerary small ring marker in the literature [Daniel and Malafiej, 2003].  
There are also cases showing that similar grades of mosaicism in two generations are 
associated with differences in clinical outcome [Tan-Sindhunata et al., 2000] or showing 
major differences in mosaicism percentage without phenotypic consequences [Anderlid 
et al., 2001]. In conclusion, the risk associated with the presence of an sSMC is difficult 
to ascertain in the presence of mosaicism. 
With the use of molecular cytogenetic approaches and array techniques, it has been 
reported the presence of previously undetectable cryptic mosaicism associated with 
sSMC cases [Starke et al., 2003; Liehr et al., 2004; Tsuchiya et al., 2008; Liehr, 2009].  
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1.2.6. Uniparental Disomy and sSMCs  
Uniparental disomy (UPD) is the inheritance of both homologues of one chromosome 
from only one parent, either the father or the mother (instead of inheriting one from 
the father and other from the mother) [Schinzel and Baumer, 2005]. If the parent passes 
on two copies of the same chromosome (non-disjunction in meiosis II) it is considered 
an isodisomy. But if the parent passes on one copy of each homolog (non-disjunction 
in meiosis I) it is called a heterodisomy (Fig. 1.26.). Additionally, UPD can occur for an 
entire chromosome or only in a chromosomal segment (interstitial or telomeric) 
together with biparental inheritance of the rest of the pair of chromosomes and a 
normal karyotype, in this case being called “segmental UPD”. 
 
Heterodisomy Isodisomy
P1 p1 P2 P1 p1 P1 P1 P1
 
Figure 1.26. – Schematic representation showing the formation of an uniparental heterodisomy, usually 
after a trisomic “rescue” event and of an uniparental isodisomy, that can occur after pos-fertilization 
errors or by the fecundation of a nulissomic gamete followed by a postzygotic reduplication for 
aneuploidy “rescue”. P1 and p1 represent both homologs of progenitor 1 and P2 one of the homolog 
from progenitor 2. 
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Figure 1.27.- Mechanisms of formation of UPD associated with an sSMC. (A) Functional trisomy rescue; 
(B) Postzygotic reduplication by fertilisation of a normal gamete by a gamete carrying a sSMC followed 
by somatic reduplication of the normal homologue; (C) Post-fertilisation errors by either mitotic non-
disjunction followed by reduction of the single homologue or vice versa; (D) Complementation by 
fertilisation of a disomic gamete by a gamete carrying an sSMC. 
 
There are several mechanisms proposed for the formation of UPD, but the bases are 
always two events, either two meiotic, or one meiotic and one mitotic, or two mitotic.  
Indeed, the coexistence of UPD with an sSMC could be explained by four different 
mechanisms (fig 1.27.) [Kotzot, 2002]: 
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A) Functional trisomy rescue: The zygote is trisomic (caused by an error in meiosis 
I or in meiosis II) and, either at random or by an active mechanism, parts of the 
single parental homologue are lost through one or two breakage events in an 
early embryonic cell division (fig 1.27.A). The sSMC is formed following two 
breakage events that can originate a sSMC with heterochromatic material (just 
near the centromere) or with also euchromatic regions (breakage more or less 
distal to the centromere).  
B)  Postzygotic reduplication when a normal gamete is fertilised with a gamete 
carrying a sSMC (a meiotic fragment or an inherited sSMC) (fig. 1.27.B). UPD will 
appear because a duplication of the normal homologue in a zygote which has 
inherited a sSMC in place of the normal corresponding chromosome occurs, 
“rescuing” an aneuploidy (fig 1.27.B). This mechanism seems to be less 
frequent. 
C) Post-fertilization errors by either nondisjunction in an early mitosis and 
subsequent reduction of the monosomic homologue or by an inverse sequence 
(fig. 1.27.C). This subclass is the most complex and hard to demonstrate. 
D) Fertilisation of a disomic gamete by a gamete with a sSMC formed before or 
during meiosis (“complementation”) (fig. 1.27.D).  
 
The major problems associated with UPD are trisomy mosaicism on the placenta or the 
foetus, genomic imprinting, homozygosity of autosomal recessive mutations or the 
combination of all these [Kotzot, 1999]. After identification of the origin of the sSMC, its 
normal sister chromosomes should be tested for their parental origin to exclude a 
possible uniparental disomy (UPD), particularly in chromosomes for which genomic 
imprinting is known.  UPD is an example of the plasticity of the human genome, which 
for most chromosomes can tolerate the lack of biparental inheritance. In contrast a 
minority of genes expressed irregularly as a result of UPD will lead to severely harmful 
phenotypes [Kotzot, 2008]. Predicting the phenotypic effects of UPD is, therefore, 
complex. UPD phenomena in chromosomes 6, 7, 11, 14, 15 and 20 has shown in some 
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cases abnormalities in affected individuals [Chudoba et al., 1999; Shaffer et al., 2001; 
Kotzot, 2002]. 
The proportion of maternal versus paternal, meiotic versus mitotic nondisjunction in 
UPD parallels that of trisomy: predominance of maternal origin and increased mean 
maternal age. Thus, the vast majority of maternal UPD is heterodisomy, mostly 
stemming from maternal meiosis I nondisjunction. Mean maternal age in maternal 
UPD equals that usually found in maternal trisomy, i.e. an elevation of about 6 years 
over euploid controls. Paternal UPD, in contrast to maternal, is almost always 
isodisomy [Schinzel and Baumer, 2005]. 
UPD can be tested by molecular approaches, such as microsatellite analysis or 
methylation-specific polymerase chain reaction, or more recently with SNPs array 
analysis [Salafsky et al., 2001; Nietzel et al., 2003; Starke et al., 2003; Conlin et al., 2010]. 
Although UPD is often considered an event to be characterized exclusively by 
molecular genetic or epigenetic approaches, it seems that at least one third of UPD 
cases emerge in connection with or due to a chromosomal rearrangement [Liehr, 2010]. 
Thus, additional cytogenetic characterization of UPD cases is essential.  
 
1.2.7. Parental age and sSMCs 
Hook and Cross reported a significant maternal age effect associated with de novo 
sSMCs in a study with 75000 prenatal cases assessed by conventional cytogenetics 
[Hook and Cross, 1987]. In 2005, using FISH for ascertain chromosomal origin of 131 
cases of  sSMCs, Crolla and collaborators notice no overall maternal age effect 
associated with sSMCs [Crolla et al., 2005]. However, in this study, de novo sSMCs 
derived from chromosome 15 were associated with a significantly increased maternal 
age. Previous studies demonstrated the existence of an exponential increase with 
maternal age associated with maternal meiosis I nondisjunction involving chromosome 
15 and with uniparental disomy for chromosome 15 [Robinson et al., 1996; Robinson et 
al., 1997]. The maternal age effect associated with de novo sSMC(15) in humans would 
suggest a common origin for both trisomy 15 following nondisjuction at meiosis I with 
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subsequent complete trisomy rescue leading to UPD(15) or incomplete trisomy rescue 
resulting in the formation of an sSMC(15) [Crolla et al., 2005]. 
Bartsch and collaborators reported a higher frequency of cat eye syndrome (CES) 
chromosomes in a prenatal retrospective study, that could be indicative of a maternal 
age effect in sSMC(22). In this study a CES chromosome was found in de novo cases 
(5/43 273 prenatal cases) in pregnant women referred because of advance maternal 
age [Bartsch et al., 2005]. Indeed, inverted duplications of chromosomes 15 and 22 
share similar origins because they both may arise in female meiosis from errors of 
recombination at sites of low copy repeats (LCRs). 
Apart from sSMCs derived from chromosome 15 and 22, the lack of comparable data 
concerning sSMCs from the other acrocentric and non acrocentric chromosomes does 
not allow taking a conclusion about the maternal age effect of de novo sSMCs. 
However, it seems that familial sSMCs are predominantly inherited via the maternal 
line [Liehr, 2006]. 
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1.3. Aim of the work 
Taking into account the following considerations: 
1 - sSMCs can be detected postnatally or prenatally, the last being a major problem for 
cytogenetic investigation and genetic counselling, due to time availability and, 
essentially, due to the difficulty in the majority of cases in establishing a robust 
genotype/phenotype correlation; 
2 - More precise knowledge of the size of the partial trisomy segment(s) and the gene 
content of the SMC would greatly improve the ability to predict phenotype and 
prognosis; 
3 - The great majority of sSMCs reported in the literature lack of detailed 
characterization; 
4 – The presence of a sSMC is often accompanied by mosaicism; 
 
the main goal of this work was the ascertainment of the genetic content of a set of 
cases with sSMCs derived from different chromosomes, comparing them with similar 
cases reported in the literature with trisomies involving the same regions, in order to 
establish a genotype/phenotype correlation. A more precise knowledge of the size of 
the partial trisomy segment and the gene content of an sSMC would greatly improve 
the ability to predict phenotype, contributing to a more informed prenatal counseling 
or prognosis. 
 
For this main achievement we aimed to: 
a) Characterize the shape of the sSMCs by conventional banding and multicolour FISH, 
namely recurring to subcentromeric FISH or multicolour banding, in order to evaluate 
the sSMC structure and the presence of pericentromeric genes in the different marker 
chromosomes; 
b) Evaluate the array CGH technique, with previous microdissection and amplification 
of the SMCs, for the ascertainment of the genetic content of the marker. If validated, 
this technique could have great value when the levels of mosaicism are low. 
c) Evaluate, whenever possible, the presence of uniparental disomy (UPD); 
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d) Establish EBV-transformed linfoblastoid cell lines for all the sSMCs cases. 
 
The final aim of this study is to propose guidelines for the management of sSMCs in a 
diagnostic cytogenetic laboratory, taking into consideration several issues like, for 
example: technical availability and presence/absence of mosaicism. 
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2.1. Cell culture and harvesting 
A good visualization of human chromosomes in somatic cells requires that dividing 
cells are studied during prometaphase. Large numbers of prometaphase cells can be 
obtained by growing cells in culture and by adding agents that inactivate spindle fiber 
formation, such as colcemid, to cell cultures during periods of active growth5. While 
the number of cells found in metaphase will increase as the length of exposure to 
colcemid increases, chromosome condensation also progresses with time. The optimal 
length of exposure to colcemid will be determined by the rate of cell division and the 
degree of condensation that is desired. Many cell types undergo growth and division 
spontaneously, but some cell types, such as peripheral lymphocytes, need to be 
stimulated into mitotic activity by the addition of a mitogen, like phytohemaglutinin, at 
the time cell cultures are initiated. 
Cytogenetic procedures are optimized when all of the cells in culture are synchronized 
in their mitotic cycle. This is achieved by adding chemical agents, like thymidine, that 
block progression into S phase to an actively growing culture. The harvesting 
procedure, after culture, involves centrifugation of cell suspensions into a cell pellet, 
treatment with a hypotonic salt solution, fixation of the suspended cell pellet, and 
dropping of the cells onto glass slides [Moore and Best, 2001]. Cell cultures for this study 
were obtained from peripheral blood and amniocytes. 
 
2.1.1. Peripheral blood cell culture 
Peripheral blood culture was performed according to standard protocols, by 
inoculating sodium heparin collected whole blood in PB-MAX (Gibco), containing L-
glutamin and phytohemaglutinin (PHA). PHA stimulates T lymphocytes to blast-like 
cells. After 48 to 72 h methotrexate (MTX)6 was added (final concentration of 5 μM) in 
                                                 
5
Colcemid and Colchicine are antimitotic drugs that bind to free tubulin and inhibit microtubule 
assembly [Fitzgerald, 1976]. These drugs bind to β-tubulin near the intradimer interface where they 
stabilize a “curved” tubulin conformation that inhibits microtubule elongation and destabilizes the 
polymer [Yin et al., 2007]. 
 
6Methotrexate is a folate antagonist that prevents thymidine syntesis. Depletion of thymidine pool 
prevents the cells from completing replication, and cells accumulate in the S-phase of the cell cycle. 
Subsequent addition of thymidine releases a synchronized wave of cells to complete replication and 
proceed through G2 and into mitosis [Bangs
 
 and Donlon, 2005]. 
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order to block DNA replication. After 17h incubation at 37ºC, thymidine was added 
(final concentration of 0.05 μM) to synchronize cells. After 5 h cultures were subjected 
to colcemid treatment for 20 minutes (final concentration of 0.1 μg/ml), and the cells 
were then ressuspended in 0.4% KCl with buffered hypotonic solution (JL006A, GGS, 
Genial Genetic Solutions). The KCL hypotonic buffer was incubated for 25 minutes at 
37ºC. A volume of 5 ml of methanol:acetic acid fixative solution (3:1) was added to the 
cell pellet under agitation and 3 more fixative washes were subsequently performed. 
Cell pellet(s) were stored at -20ºC in fixative solution. The best cell suspension, with 
high metaphase index and of very good quality, was chosen for subsequent studies 
[Haines et al., 1995; Bangs  and Donlon, 2005].  
 
2.2.1. Amniocytes cell culture 
Amniocytes cell culture was performed using standard procedures [Haines et al., 1995; 
Meron, 2001] with modifications]. Briefly amniotic fluid was cultured with 5 ml of 
complete medium (Ham’s F 10 medium supplemented with 2mM L-Glutamine, 10% 
Fetal Bovine Serum (FBS) and Penicillin/Streptomycin) and 3 ml of Amniomax 
(GIBCOTM) or AmnioMed (EuroCloneTM). After 5-7 days in culture the proliferation of 
the culture was assessed in a daily basis. When a sufficient growth was detected cells 
were prepared for manipulation. Following a 3 hour treatment with colcemid (1 µg of 
KaryoMAX, GIBCOTM) at 37ºC, cells were washed and tripsinized (0.05% trypsin with 
EDTA, without Ca or Mg). Hypotonic shock was done for 20 minutes with 0.4% KCl 
solution. Cells were fixed consecutively with 3 solutions: methanol/acetic acid solution 
(6:1); methanol/acetic acid solution (3:1) and methanol/acetic acid solution (1:1).  
 
2.2. Chromosomes spreading  
Cell suspensions in fixative were used to prepare metaphases for G-banding, C-
banding, NOR-banding or FISH. When preparing slides with chromosome spreads one 
should be aware that it is not an exact science, although careful attention to a number 
of variables certainly increases the chance of successful results.  
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Cells in fixative solution were diluted at the appropriate density to produce a 
reasonable number of well-spread metaphases in each microscopic field. About 12-14 
μl of cell suspension were distributed on several spots on a slide (pre-wet slide, when 
needed). A drop of new fixative solution was added to each area of spreading when 
needed.  The slide was placed face up into a hot metal plate (37ºC) for evaporation of 
the fixative solution. The degree of spreading could be adjusted using different 
temperatures on the heated plate, with higher temperatures increasing chromosome 
spreading. For difficult-to-spread cells, after the surface became grainy, the slide was 
passed briefly through water vapours, and then some droplets of fixative were placed 
on the slide [Haines et al., 1995; Bangs  and Donlon, 2005]. The rate at which the fixative 
evaporates is critical to the final dispersion of the chromosomes on the slide. Thus, 
humidity and temperature over the surface of the drying slide can be manipulated to 
produce optimal chromosome preparations. The ideal metaphase spread has all 46 
chromosomes dispersed in the same optical field under the microscope (1000x 
magnification), with minimal overlapping chromosomes. 
Aging of the slides was done at room temperature during 2-3 days or at 65ºC 
overnight. After dehydration of the slides, with ethanol (70%, 2min; 95%, 2min; 100%, 
2 min) FISH was performed. 
For multicolour FISH procedures, after aging, the slides were subjected to pepsin pre-
treatment using 0.005% pepsin in 0.1 N HCl. This was followed by rinsing in PBS and a 
10 min post-fix treatment with 4% formaldehyde for 5 min at room temperature. The 
post-fix solution was rinsed with water and the slides were dehydrated with ethanol 
series (70%, 95%, 100%).  
 
2.3. Banding Techniques 
2.3.1. G-Banding technique 
Giemsa banding (G-Banding) produces a series of light and dark bands along the 
lengths of the chromosomes, allowing the identification of chromosomes and 
chromosomes regions. Bands that are dark with G-Banding generally correspond to 
late-replicating regions of the genome. Giemsa is specific for the phosphate groups of 
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DNA and attaches itself to regions of DNA where there are high amounts of adenine-
thymine. These bands tend to contain relatively few active genes (Fig. 2.1.). G-Banding 
is produced by pre-treatment of chromosomes with trypsin before staining with 
Giemsa.  
Briefly, aged slides of prometaphase chromosomes were incubated with trypsin 
(0.06g/100ml to 0.12g100 ml) for about 8 to 20 s, to obtain a partial digestion of the 
chromosomes. The concentration and time of trypsinization depend of the slides 
quality and cell types. Slides were washed with 5% FCS in phosphate buffer (pH 6.8) 
and incubated with 4% -10% Giemsa staining solution in phosphate buffer (pH 6.8) for 
4 minutes. After a short wash (2x) with phosphate buffer, slides were ready to be 
observed at bright-field microscope [Schreck and Distèche, 2001]. Karyotypes were 
mounted and analysed using 1000x amplification and a Cytovision software. 
 
 
Figure 2.1. – Karyogram obtain after G-banding showing a small supernumerary marker chromosome – 
47,XX,+mar. [photo from Laboratório de Citogenética da Faculdade de Medicina da Universidade de 
Coimbra]. 
 
2.3.2. C-Banding technique 
Noncoding constitutive heterochromatin, such as the repetitive DNA surrounding the 
centromeres of all of the chromosomes, replicates later in the cell cycle than other 
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chromatin and exhibits special characteristics of stability under extreme conditions of 
heat and chemical exposure. This property of tightly condensed heterochromatin can 
be exploited to produce a unique banding pattern (C-Banding) in which the 
constitutive heterochromatin stains darkly and all other chromatin remains pale. C-
Banding is produced by treatment of chromatin with acidic and then basic solutions 
followed by staining with Giemsa [Moore and Best, 2001]. 
After a treatment with HCl 1N for 10 min, at room temperature the slides were rinsed 
with water and let dry (air dry). Slides were immersed in a Coplin jar containing freshly 
prepared 5% Ba(OH)2 solution (in SSC) at 50
oC . They were incubated during 30 s to 1 
min at room temperature. After washing thoroughly with water, the slides were 
immersed in a SSC solution during 45 to 60 min, in a 60oC water bath. The staining was 
done incubating the slides with 2% Giemsa Solution during 30 to 40 min. C-banded 
chromosomes were visualized with a bright-field microscope [Schreck and Distèche, 2001]. 
 
2.3.3. NOR-Banding technique 
This staining technique uses silver nitrate that stains the active ribosomal DNA-
containing Nucleolar Organizer Regions (NOR) located near the ends of the short arms 
of human acrocentric chromosomes 13, 14, 15, 21, and 22. 
Slides (not-aged) were incubated with a 50% silver nitrate solution (in bi-distilled 
water) in a wet-chamber and incubated overnight at 37ºC (the slides are removed 
from heat when appear golden brown). The slides were rinse in water and air-dried. 
NOR-banded chromosomes were observed with a bright-field microscope [Schreck and 
Distèche, 2001]. 
 
2.4. Extraction of Bacterial Artificial Chromosomes (BAC) 
The used Bacterial artificial (BAC) DNA was isolated from Escherichia coli cultures, 
Bacterial cultures were grown overnight, at 37oC and 120 rpm, with the appropriate 
antibiotic in LB medium (Bacto Yeast extract 5g, Bacto trypton 10g, NaCl 10g, H20 up to 
1 liter). For isolation of the plasmid DNA, a QIAprep Miniprep (Quiagen®) kit was used, 
following manufacter’s instructions.  
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2.5. Labelling of DNA 
The DNA can be labelled for a direct detection, using dUTPs directly coupled to 
fluorochromes, or for an indirect detection. In this case, the probe is labelled with a 
hapten that itself is not fluorescent. The most common haptens used are biotin (that 
reacts with streptavidin that is bind to a fluorochrome) or digoxigenin (that can be 
detected by an antibody coupled with a fluorochrome). Whereas Fluoresecence in situ 
hybrydization (FISH) is faster with directly labelled probes, indirect labelling offers the 
advantage of signal amplification by using several layers of antibodies, and might 
therefore produce a signal that is brighter compared with background levels. For 
labelling DNA, hapten- or fluorescent labelled dUTPs are generally incorporated into 
the probe by either nick-translation or DOP-PCR (Fig. 2.2.) [Speicher and Carter, 2005].  
 
Figure 2.2. - Before hybridization (a), the DNA probe is labelled by various means such as nick 
translation or DOP-PCR. Two labelling strategies (b) are commonly used — indirect labelling (left panel) 
and direct labelling (right panel). For indirect labelling, probes are labelled with modified nucleotides 
that contain an hapten, whereas direct labelling uses the incorporation of nucleotides that have been 
directly modified to contain a fluorophore. The labelled probe and the target DNA are denatured to 
yield single stranded DNA (c) and then they are combined (d), which allows the annealing of 
complementary DNA sequences. If the probe has been labelled indirectly, an extra step is required for 
visualization of the non-fluorescent hapten that uses an enzymatic or immunological detection system 
(e) [adapted from Speicher and Carter, 2005].  
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During nick-translation the double stranded probe is "nicked" by DNAse and partially 
digested. At the same time, the strand is filled up by a polymerase that incorporates 
dNTPs and also labelled dUTP offered in the labelling reaction. Nick-translation is 
usually used for labelling of cloned DNA. However, PCR can also be used to label these 
probes with degenerated primers (DOP-PCR). Usually DOP-PCR is used to generate and 
label complex probes such as paints from flow sorted chromosomes or 
microdissection. DOP-PCR has the advantage that the entire probe is also being 
amplified.  
BAC probes were amplified by degenerated oligonucleotide polymerase chain 
reaction7 (DOP-PCR; 50 μl; 30 cycles). Each probe was labelled separately by using 
secondary DOP-PCR (20 μl volume; 20 cycles) either with Spectrum Green or TexasRed. 
Finally, the probe was dissolved in 30 µl hybridization solution [Senger et al., 1998; 
Nietzel et al., 2001; Starke et al., 2003]. The probes were derived from CHORI BACPAC 
Resources (Oakland, USA), Dr M Rocchi (Universita degli Studi di Bari, Italy) or Dr. Nigel 
Carter (Sanger Centre, Cambridge, UK).  
 
2.6. Microdissection and Reverse Painting 
Eight copies of the marker chromosome were dissected on a slide with a metaphase 
chromosome spread, using glass micro-needles controlled by a micro-manipulator 
under an inverted microscope. The dissected material was amplified with DOP-PCR and 
PCR products were labeled by nick-translation with biotin-14-dATP. Subsequently, this 
probe was used for reverse painting on patient metaphases (Fig. 2.3.) [Trifonov et al., 
2003].  
                                                 
7
 The DOP Primer used was: 5’CCG ACT CGA GNN NNN NAT GTG G3’ 
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Figure 2.3. – Identification of the origin of a supernumerary marker chromosome derived from 
chromosome 16 using a reverse FISH approach. After microdissection and amplification of the marker, a 
probe was done. The hybridization of this probe with a metaphase plate of the same patient identified 
the normal 16 chromosomes and the marker. 
 
2.7. Fluorescence In situ Hybridization (FISH) 
FISH was performed using several probes including single probes (centromeric; 
subtelomeric, locus specific; BAC; and all-telomere); painting probes (whole 
chromosome painting – wcp, and partial chromosome painting – pcp) or multicolor 
probes (subcentromere specific probes - subcenM-FISH; multicolour banding probes – 
MCB) for different chromosomes, depending on the sSMCs cases. FISH was also done 
after marker chromosome microdissection, with reverse FISH (see section 2.5). For all 
FISH experiments standard procedures were used, depending on the probe. 
Centromeric- , locus-specific-, subtelomeric-, all-telomere-, and painting- probes were 
commercial probes and were hybridized according to manufacter’s instructions. When 
using subcenM-FISH, MCB, or BAC probes, hybridization, post-washing, signal 
detection, and image acquisition were performed as previously reported [Chudoba et al. 
1999; Liehr et al. 2002].  
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Hybridization 
In general the hybridization step was done using dehydrated pre-treated slides (with a 
15 min treatment in 2xSSC solution at 37ºC). When using commercial probes, slides 
and probes were denaturated together at 74ºC to 80ºC, during 2 to 3 min (depending 
on the probes used). The hybridization was done overnight in a wet-chamber at 37ºC.  
For subcenM-FISH, MCB, and BAC, probes were denaturated using a thermocycler with 
the following condition: 75ºC (5 min), 4ºC (2 min) and 37ºC (30 min). The slide (pepsin 
pretreated slide) was denaturated with 70% formamide (in 2SSC) at 72ºC for 3 min, 
followed by immersion in 70% ice-cold ethanol, 95% ethanol and 100% ethanol at 
room temperature (3 min each). Hybridization was done in a wet-chamber at 37ºC 
over-night. 
 
Post hybridization wash 
When using commercial probes, with direct labelled probes, slides were washed in 
washing buffer at 70ºC, during 30 to 60 s (depending on the probe). After rinsing with 
PBS, slides were mounted using antifade solution, to prevent rapid fading of the 
fluorescence signal, with DAPI. 
For subcenM-FISH, MCB, and BAC-FISH8, slides were washed 3 times with a solution of 
50% formamide at 42ºC during 5 min and 3 times with 2xSCC at 42ºC during 5 min. A 
final wash, with 4xSSCT at room temperature for 2 min was done. A blocking buffer 
(powder milk) was then used for 15 min at 37ºC. Each hybridization area of the slide 
was incubated with 100 µl antibody solution for 40 min at 37ºC (e.g., 5 µg/ml 
streptavidin-Cy5 in blocking buffer). The slides were washed with 4xSSCT (5 min) at 
room temperature and, after rinsing with water, were dehydrated with a series of 
ethanol (75%, 90%, 100 - 3 min each). The slides were mounted using antifade solution 
and using DAPI as a counter stain. 
 
 
                                                 
8
 In these FISH approaches, besides having direct labelled probes with fluorochromes, probes 
conjugated with biotin or digoxin are also used. An additional step is needed with binding of streptavidin 
or anti-digoxin (immunobinding), respectively, conjugated with a fluorochrome. 
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Visualization 
For multicolor FISH approaches, like subcenM-FISH and MCB, the analysis was done 
using a Zeiss Axioplan fluorescence microscope with MetaSystems (Isis) software. For 
the other FISH experiences a Nikon fluorescence microscope coupled with Cytovision 
software was used. 
 
SubcenM-FISH 
Figure 2.4. – A) SubcenM-FISH pseudo-color pattern for all 24 human chromosomes. Only one 
chromosome at a time can be stained; the chromosome figures were assembled from 24 different 
experiments B) Labelling scheme of the subcentromere specific multicolour FISH (subcenM-FISH) probe 
set. In the non-acrocentric chromosomes de p-arm is labelled with cyanine 5 (Cy5) and the q-arm with 
diethylaminocoumarin (DEAC). The centromere-near probe in the long arm is labelled with 
SpectrumGreen and in the short arm with Texas Red. In the acrocentric chromosomes, the long arm is 
stained with Cy5, the short arm with DEAC, and the centromere-near probe in the long arm with Texas 
Red. The centromeres are labelled with Spectrum Orange [adapted from Starke et al., 2003]. 
 
The proximal probes included in the subcenM-FISH set are chosen under the 
prerequisite that they were the most proximal probes presently mapped in the 
ENSEMBL database. Bacterial artificial (BAC) probes were amplified by DOP-PCR. For 
each chromosome a subcenM-Fish probe set is prepared. The set consists of the most 
proximally available single-copy probes, microdissection-derived partial chromosome 
(pcp) probes specific for the long and the short arm, and a centromere specific probe. 
For the acrocentric chromosomes, no proximal single copy probes and no chromosome 
specific pcp probes of the short arms are available. For all the acrocentric 
A B 
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chromosomes set, a probe that stains all p-arms of the acrocentric chromosomes 
(midi54) is used (Fig 2.4.) [Starke et al., 2003].  
 
MCB-FISH 
 
Figure 2.5. – Multicolor banding (MCB) pseudocolor pattern for all 24 human chromosomes on ~366 
band level. Only one up to three chromosomes can be simultaneously stained by MCB. The chromosome 
figures were assembled from different experiments. 
 
Between 3 and 12 microdissection libraries were combined per chromosome (Fig 2.5.; 
Fig. 2.6.). Three to five different fluorochromes were used to label the partial 
chromosome painting (pcp) probes: SpectrumOrange, SpectrumGreen, TexasRed, Cy5 
(Cy5 coupled to streptavidin; detection of biotinylated probes), and 
diethylaminocoumarin (DEAC). The probe Midi 54 for the acrocentric chromosomes 
was added specifically to cover the corresponding short arms of these acrocentric 
chromosomes [Mrasek et al., 2001; Weise et al., 2008].  
Recently, Weise and colleagues characterized the library of MCB probes with an array 
CGH approach. The possibilities of the MCB technique to characterize chromosomal 
breakpoints in one FISH experiment are now complemented by the feature of being 
anchored within the human DNA sequence at the BAC level (Fig. 2.7.) [Weise et al., 2008]. 
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Figure 2.6. - Label scheme for chromosome 1 in MCB: From left to right: ideogram, inverted DAPI, 
pseudocolors, fluorochrome profiles where arrows indicate boundaries of the three new libraries of 
MCB 1 [adapted from Weise et al., 2008]. 
 
 
 
Figure 2.7. - Graphical overview and labelling scheme for all 169 array-mapped MCB libraries. Double 
labeling of a single MCB library is indicated with two vertical color lines connected by a horizontal black 
line. The fluorochrome color key is at the bottom of the legend [adapted from Weise et al., 2008]. 
 
2.8. Microsatellite analysis for Uniparental Disomy analysis 
For uniparental disomy (UPD) analysis, genomic DNA was extracted from the 
peripheral blood lymphocytes of both parents, when possible, and the patient by using 
standard procedures. Twenty-five cycles of PCR were performed with labelled primers 
responsive to infrared (IRD800; MWG-Biotech, Germany). Denatured samples were 
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loaded onto a 6% denaturing polyacrylamide gel, separated electrophoretically on a 
Licor DNA 4000 sequencer (LI-COR, Nebraska), and detected with an infrared laser 
diode [Starke et al, 2003]. 
 
2.9. Array CGH – array painting 
DOP PCR-amplified microdissected DNA from the marker chromosome was labeled by 
a random prime labeling system (Bioprime DNA Labeling System, Invitrogen, Carlsbad, 
CA) using Cy5 labeled dCTP’s (Amersham Pharmacia Biotech, Piscataway, New Jersey) 
as described [Backx et al., 2008].  
 
 
Figure 2.8. – Schemetic representation of the methodology used for array-painting. After 
microdissection of the sSMCs, the DNA was amplified by DOP-PCR. The DNA was labelled and hybridized 
on a microarray slide. 
 
Except for some small modifications, probe preparation, and pre-blocking of the slide 
were performed as described [Fiegler et al., 2003]. To hybridize a spotting area of 24x24 
mm, the probe was dissolved in 20 l of hybridization solution. The hybridization was 
allowed to take place for 2 nights under a coverslip in a humid chamber saturated with 
20% formamide and 2x SSC. Post hybridization washes were performed [Vermeesch et 
al., 2005]. A full tiling BAC array was used, with a resolution of 100-150 Kb (VIB 
MicroArrays Facility - www.microarrays.be). The array was scanned at 635nm using a 
GenePix4000B scanner (Axon Instruments) and image analysis was done using GenePix 
Pro 6.0. Spot intensities were corrected for the local background [Melo et al., 2009].  
 
DOP-PCR 
Amplificated DNA 
from microdissected 
material 
DOP - Degenerate Oligonucleotide-primed 
PCR 
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Chapter III 
 
This chapter is subdivided in 10 sections (3.1 to 3.10), according to the chromosome 
derivative, as follows: 
3.1. – sSMC derived from chromosome 1 
3.2. – sSMCs derived from chromosome 2 
3.3. – sSMC derived from chromosome 5 
3.4. – sSMC derived from chromosome 11 
3.5. – sSMC derived from chromosome 13 
3.6. – sSMCs derived from chromosome 15 
3.7. – sSMCs derived from chromosome 16 
3.8. – sSMC derived from chromosome 17 
3.9. – sSMCs derived from chromosome 18 
3.10– sSMCs derived from chromosome 22 
 
For a better sistematization in each section the description of the cases, results 
obtained, review of the literature for each subtype of sSMCs are described and 
discussed.  
In section 3.2., 3.3., 3.4., 3.5., 3.7., 3.8., and 3.9., the text is extracted from the 
correspondent articles (published or submitted), as described in the list of publications 
included at the end of Chapter IV (page 212). In order to avoid repetition, material and 
methods subsection (included in the articles) was omitted, having Chapter II (Materials 
and Methods) the description of the materials and methods used. A general discussion 
of the results presented in this chapter is done in chapter IV followed by concluding 
remarks.  
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3.1. sSMC from chromosome 1 
A case of a small supernumerary ring chromosome derived from chromosome 1  
 
3.1.1. Introduction 
Genetic counselling of patients with small supernumerary ring chromosomes (sSRCs) 
can be difficult, especially in prenatal testing, due to the complexity in establishing a 
karyotype-phenotype correlation. In cases which the morphology of the sSMC can be 
determined, almost 50% appear to be ring chromosomes [Liehr et al., 2006]. Mosaicism 
is quite common, resulting either from postzygotic mutation or from mitotic instability 
resulting in loss of the ring during cell division [Chen et al., 1995]. Clinical outcome of 
sSRCs is highly variable depending on their origin, size, euchromatin content, co-
occurrence of uniparental disomy, and presence of mosaicism [Bernardini et al., 2007]. 
SRCs account for approximately 10% of the prenatal sSMC-positive cases and 60% of 
them are associated with abnormal phenotype [Blennow et al., 1994; Davidsson et al., 
2008]. sSRC derived from chromosome 1 are among the most common aneuploid small 
marker chromosomes, excluding the ones derived from chromosomes 15 and 22 [Liehr 
et al., 2004]. Over two-thirds of cases carrying a sSMC derived from chromosome 1 are 
associated with clinical abnormalities [Liehr et al., 2010].  
We report on a new case of mosaic small supernumerary ring derived from 
chromosome 1 in a female patient with a mild phenotype. The sSRC(1) was 
characterized by conventional cytogenetics, reverse FISH, subcenM-FISH and array 
CGH after microdissection. 
 
3.1.2. Results 
Case Report and Cytogenetic Studies 
A young girl was referred to genetic clinic with learning difficulties, microcephaly, 
microtia, tooth problems, scoliosis and vesico-uretral bilateral reflux with 
normochromic normocytic anemia. She had an inguinal right and left hernia corrected 
with surgery. Cytogenetic analysis, by G-Banding, revealed a de novo supernumerary 
marker chromosome in 8 of the 22 analysed cells (mos 47,XX,+mar[8]/46,XX[14]). At 
eleven years old she was clinically reassessed revealing a normal growth (height - P50; 
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weight - P50-75; cephalic perimeter - P10-P25) and adequate learning capacities. She 
presented vesico-uretral reflux with nephropathy. Scoliosis and anaemia were not 
confirmed. Blood was collected from the patient in order to perform additional 
cytogenetic studies. 
G-banding analysis revealed the presence of 3 different cell lines: one normal, other 
with a ring and the third with a double ring, being the karyotype mos 
47,XX,+r[6]/47,XX,dic r[2]/46,XX[24] (Fig. 3.1.1.). 
 
a) b) c)
 
Figure 3.1.1. - G-banding pattern of one normal chromosome 1 (a) and of the two rings found in two 
different cell lines (b, c). 
 
C-banding induced by barium hydroxide and Giemsa confirm the presence of the 3 cell 
lines, having the double ring  and the ring C-banding positive regions interpreted as 
centromeric (Fig. 3.1.2.). 
 
a) b)
 
Figure 3.1.2. - C-banding pattern of the two sSRCs found in two different cell lines, showing a double 
ring with two centromeres (a) and a ring with one centromere (b). 
 
Molecular Cytogenetics Analysis 
The markers chromosomes were microdissected, labelled, and hybridized in a 
metaphase plate of the patient for reverse FISH, showing to be derived from 
chromosome 1 (Fig. 3.1.3.). SubcenM-FISH specific for chromosome 1 was made, the 
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karyotype being: mos 47,XX,+mar.ish r(1)(::p12->q12::)[5]/47,XX,+mar.ish r(1;1)(::p12-
>q12::p12->q12::)[2]/46,XX[24]. 
The microdissected DNA of the sSMCs of the patient was hybridized, after labelling, in 
a full tiling BAC array specific for chromosome 1, with a resolution of 100-150 Kb (VIB 
MicroArrays Facility - www.microarrays.be), having material of approximately 36.24 
Mb (between 112.16 to 148.4 Mb), redefining the breakpoints between 
1p13.2 1q21.2 region.  
 
 
Figure 3.1.3. - Reverse FISH image showing the origin of the marker as derived from chromosome 1. The 
marker was microdissected, amplified, labelled and hybridized in a patient metaphase. 
 
3.1.3. Discussion 
We present a case of a female mosaic carrier of a small supernumerary ring derived 
from chromosome 1 in ~25% of her cells. The child presented a mild phenotype when 
clinically evaluated at 11 years old. The genetic content of the sSRC encompasses a ~36 
Mb pericentromeric region rich in genes, both in p arm and in q arm (1p13.2 1q21.2) 
(Fig. 3.1.4.). The region encompasses 136 genes, 17 of them in Online Mendelian 
Inheritance in Man (OMIM)-morbid map. Of these 17, 14 are located in the 1p-arm, 
and the other 3 in 1q-arm. One example of an OMIM morbid gene located in this 
region (located at 1p between 120.45-120.61 Mb) is NOTCH2, a very highly conserved 
and important gene for cell differentiation, that seems to be involved in tooth 
development [Mitsiadis et al., 2003]. In about 94% of patients with Alagille syndrome 
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(ALGS; OMIM 118450), an autosomal dominant multisystem disorder, a mutation in 
the gene encoding the NOTCH signalling pathway ligand Jagged-1 is present. ALGS was 
also associated with mutations in NOTCH2 in 2 different families, having all the 
affected individuals renal manifestations [McDaniell et al., 2006]. Our proband 
presented tooth problems and nephropaty. 
 
~36 Mb
 
Figure 3.1.4. – Schematic representation of chromosome 1 with the ~36 Mb region involved in the 
sSMC(1) (square) [adapted from Ensembl]. 
 
However, it is difficult to establish a genotype/phenotype correlation in a sSMC carrier. 
It is essential to have several cases reported and very well characterized, both clinically 
and molecularly. The majority of the cases described in the literature with a sSMC(1) 
lack detailed molecular characterization or clinical details. Liehr established a sSMC 
database to overcome this problem [Liehr T, 2010 - www.med.uni-
jena.de/fish/sSMC/00START.htm]. However, of the 46 cases with a sSMC(1) and clinical 
findings in his database, only 2 are nonmosaic, turning genotype/phenotype 
correlation more difficult.  
Taking into account the cases described in sSMC(1) collection, including our case, [Liehr 
T, 2010 - www.med.uni-jena.de/fish/sSMC/00START.htm] (Table 3.1.I) the most common 
clinical symptoms of centromere-near proximal imbalances are, for 1p proximal region, 
development delay, mental retardation, microcephaly, dysmorphic face, finger and toe 
malformation and hypotonia. The symptoms more associated with 1q pericentromeric 
imbalances are dysmorphic face, growth retardation, heart defect, and mental 
retardation. Kidney problems and microcephaly were described in 11% of the cases. 
However, more cases should be reported, especially with a good cytogenetic 
characterization, to strength these observations. Taking into account the data from 
table 3.1.I., our patient showed features associated with imbalances in both 1p 
proximal (microcephaly in early childhood) and 1q proximal (growth retardation and 
kidney problems). With increasing of age, the proband revealed a milder phenotype.  
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Table 3.1.I. - Clinical symptoms of centromere-near proximal imbalances in 1p and 1q-proximal region, 
according to the sSMC(1) collection database [www.med.uni-jena.de/fish/sSMC/00START.htm]. The 
frequency of symtoms is indicated, taking into account the 46 cases with a sSMC(1) associated with 
clinical findings, as described in the sSMC(1) database. 
Symptoms 1p - proximal 1q - proximal 
ataxia 8 % 0 % 
autism 25 % 0 % 
brain malformations 8 % 11 % 
developmental delay 83 % 33 % 
dysmorphic face 83 % 89 % 
finger or toe/foot malformations 42 % 22 % 
genital abnormalities 0 % 11 % 
growth retardation 17 % 55 % 
heart defect 17 % 44 % 
hypotonia 25 % 0 % 
joint problems 8 % 11 % 
kidney problems/ malformations 8 % 11 % 
mental retardation 58 % 33 % 
microcephaly 58 % 11 % 
overgrowth 17 % 11 % 
seizures 0 % 0 % 
vision impaired  8 % 0 % 
  [adapted from Liehr T, 2010 - www.med.uni-jena.de/fish/sSMC/00START.htm] 
 
Tönnies and co-workers, when reporting a child with a r(1) chromosome in about 14% 
of lymphocytes and 9% of buccal cells, stated that it would be important to verify the 
proportion of the mosaic cell line in different tissues to better understand the likely 
correlation between aneuploidy and clinical phenotype [Tönnies et al., 2003]. 
Fickelscher et al. verified the levels of mosaicism in different tissues in a prenatally 
ascertained sSMC(1). Post-mortem studies revealed that sSMC presence varied 
between 13 and 62% within different tissues [Fickelscher et al., 2007]. However, 
although analysis of different tissues can be important to better characterize mosaic 
patients, this kind of study does not seem to contribute significantly to the genetic 
counselling [Bernardini et al., 2007]. Indeed, the level of mosaicism in a patient with a 
SRC not always correlates with phenotypic features. For this purpose, it appears more 
appropriate the molecular characterisation of ring structures. It is also possible that 
the factors determining phenotypic severity in a mosaic carrier of a SRC are, rather 
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than the level of mosaicism, the cell lineage/type in which malsegregation occurs 
[Davidsson et al., 2008]. It is also important to re-evaluate the carriers of these sSMC at 
several ages, in order to establish the contribution of abnormal cell lines in their 
development. 
Using high resolution array-based applications, it may be possible to delineate well-
defined subgroups of patients with sSMC(1) and other sSMC in the future. This 
definition is essential for establishing a strong genotype/phenotype correlation, 
ultimately allowing a more informed genetic counselling, particularly in prenatal 
diagnosis. 
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3.2. sSMCs from chromosome 2 
Two new cases of de novo small supernumerary marker chromosomes (sSMC) 
detected at prenatal diagnosis [*] 
[*] The work presented in this section was published in: 
Jardim A, Melo JB, Matoso E, Pires LM, Ramos L, Carreira IM (2007) Prenatal Diagnosis 27: 380-381.  
 
3.2.1. Introduction 
Small supernumerary marker chromosomes (sSMC) can be defined as structurally 
abnormal chromosomes that cannot be identified or characterized unambiguously by 
conventional banding cytogenetics alone, and are (in general) equal in size or smaller 
than chromosome 20 of the same metaphase spread [Liehr et al., 2004]. sSMC are 
relatively uncommon in the general population. They have been detected with a 
frequency of 0.076% at prenatal diagnosis and at a much higher frequency of 0.426% 
in mentally retarded patients [Liehr et al., 2004]. 
The phenotypes associated with the presence of a de novo sSMC vary from normal to 
severely abnormal. In general, the risk associated with an abnormal phenotype in 
prenatally detected de novo cases with sSMC is 13% [Warburton, 1991], while for sSMC 
de novo derived from non-acrocentric chromosomes the risk is estimated to be 
approximately 28% [Crolla, 1998]. The phenotypic consequences of particular sSMC are 
difficult to predict because of differences in euchromatic DNA content, different 
degrees of mosaicism and/or uniparental disomy (UDP) of the parental chromosomes 
homologous to the sSMC [Starke et al., 2003]. 
The origin of sSMC is impossible to determine by routine cytogenetics alone but 
fluorescence in situ hybridization (FISH) enables the identification of its chromosomal 
origin. However, because of the several possibilities of different phenotypes 
attributable to the chromosomal origin of the sSMC, their characterization and also an 
adequate long-term follow-up are necessary [Starke et al., 2003; Liehr et al., 2006]. In 
cases with apparently normal phenotypes, the characterization of sSMC can provide 
important information about regions that are phenotypically silent in the presence of 
gene dosage imbalances [Sumption and Barber, 2001; Starke et al., 2003; Barber, 2005; Liehr 
et al., 2006]. In this report, we describe two new cases of de novo sSMC detected at 
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prenatal diagnosis derived from chromosome 2, with apparently normal phenotypes 
ascertained during the neonatal period and until the age of 2 years.  
 
3.2.2. Results 
Case A 
The first case is the prenatal diagnosis of a 39-year-old pregnant woman who 
underwent an amniocentesis at 17 weeks’ gestation due to advanced maternal age 
and also positive serum screening. Routine cytogenetics with GTG-banding (G-bands 
obtained by Trypsin and Giemsa) (Fig. 3.2.1.A) revealed the presence of sSMC in 15 of 
the 70 metaphases analysed. The sSMC were CBG positive (C-bands induced by barium 
hydroxide and Giemsa) (Fig 3.2.1.B) and NOR negative (silver staining of the nucleolus 
organizer regions). Chromosomal analysis of both parents’ lymphocytes revealed 
normal karyotypes. FISH with the I-Multiprobe System (Cytocell) (complete set of 
alphasatellite/satellite III probes for the 24 chromosomes) (Figure 3.2.1.C) enabled the 
identification of the chromosome 2 origin of the sSMC. The sSMC showed 
hybridization with the centromeric probe D2Z2 and the karyotype of the fetus was 
mos47,XX,+mar.ishder(2)(D2Z2+)[15]/46,XX[55]. Ultrasound analysis did not reveal any 
abnormalities in the fetus. After counselling, the parents decided to carry on with the 
pregnancy, and the presence of the sSMC was confirmed in lymphocytes after birth 
although with different frequencies of the two cell lines (50% of metaphases analysed 
had the sSMC). 
 
Case B 
In the second case, amniocentesis of a 38-year-old pregnant woman was performed at 
16 weeks’ gestation because of advanced maternal age. The GTG-banding (Fig. 3.2.1.D) 
study revealed the presence of sSMC in 14 of 30 metaphase spreads analysed. The 
sSMC were CBG positive (Fig. 3.2.1.E) and NOR negative. The parents’ karyotypes were 
normal. The origin of this sSMC was identified to be derived from chromosome 2 using 
the OctoChrome System (Cytocell) (includes whole chromosome painting probes for 
the 24 chromosomes) (Fig. 3.2.1.F). The sSMC hybridized with the wcp (whole 
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chromosome paint) for chromosome 2 and the karyotype of the fetus was 
mos47,XY,+mar.ishder(2)(wcp2+)[14]/46,XY[16]. Ecographic evaluation of the fetus 
was normal. After genetic counselling, the parents decided to continue the pregnancy, 
and postnatal chromosomal analysis confirmed the presence of the sSMC in 73% of the 
blood lymphocytes. 
 
 
Figure 3.2.1. - (A) GTG, (B) CBG and (C) FISH with centromeric probe D2Z2 for the sSMC (indicated by 
arrow) in case 1; (D) GTG, (E) CBG and (F) FISH with wcp for chromosome 2 for the sSMC (indicated by 
arrow) in case 2. 
 
 
3.2.3. Discussion 
Chromosome 2 is rarely involved in the formation of marker chromosomes [Crolla, 
1998; Ostroverkhova et al., 1999]. Only 11 other cases have been reported in the 
literature [Plattner et al., 1993; Daniel et al., 1994; Ostroverkhova et al., 1999; Villa et al., 
2001; Giardino et al., 2002; Lasan Trcic et al., 2003; Starke et al., 2003; Guanciali-Franchi et al., 
2004; Mrasek et al., 2005; Liehr et al., 2006] and of these only 2 at prenatal diagnosis [Villa 
et al., 2001; Mrasek et al., 2005; Liehr et al., 2006]. Only 8 of the 11 cases were 
characterized in detail for their chromosomal content, and analysis of the data seems 
to indicate a correlation between the centromere-near sequences of 2p11.2 and the 
presence of clinical abnormalities, and the absence of clinical symptoms with presence 
of proximal sequences of 2q11.2. [Starke et al., 2003; Mrasek et al., 2005; Liehr et al., 
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2006]. Small partial trisomies of material derived distally from 2q11.2 are associated 
with clinical abnormalities [Giardino et al., 2002; Mrasek et al., 2005; Liehr et al., 2006]. The 
normal phenotype and development of both children up to the age of 2 years leads us 
to suspect that both cases are probably proximal trisomies of 2q. Nevertheless, a 
thorough characterization of both sSMC reported is still necessary and will be pursued. 
As soon as the parents give their consent, we intend to determine the euchromatic 
content of the sSMC by using microdissection and also bacterial artificial chromosomes 
(BACs) of the pericentromeric region of chromosome 2. The complete characterization 
of both sSMC as well as the continued follow-up of the children will take us one step 
further towards a more comprehensive genotype–phenotype correlation and thus 
ensure a more informed genetic counselling in the future. 
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3.3. sSMC from chromosome 5 
Characterization of sSMC derived from chromosome 5: Towards a 
Genotype/Phenotype correlation [*] 
[*]The work presented in this section was partially published in: 
Melo JB, Santos HL, Backx L, Vermeesch JR, Kosyakova N, Weise A, Ewers E, Liehr T, Carreira IM (2011) Chromosome 5 derived 
small supernumerary marker chromosome: towards a genotype/phenotype correlation of proximal chromosome 5 imbalances. 
Journal of Applied Genetics (in press). 
 
3.3.1. Introduction 
Small supernumerary marker chromosomes (sSMC) are defined as structurally 
abnormal chromosomes that cannot be identified or characterized unambiguously by 
conventional banding cytogenetics alone and are generally equal in size or smaller 
than a chromosome 20 of the same metaphase spread [Liehr et al., 2004]. Clinical 
outcome of sSMC is highly variable depending on their origin, size, euchromatin 
content, eventual co-occurrence of uniparental disomy, and prevalence of aneuploidy 
in mosaic cases. 70% of non-acrocentric sSMC do not have phenotypic consequence, 
while the remaining 30% have different clinical manifestations [Liehr et al., 2006]. The 
heterogeneous group of sSMC presents serious genetic counseling problems, 
especially if they are de novo. It is very important to characterize the content and the 
structure of the sSMC, in order to establish an adequate genotype-phenotype 
correlation. Most sSMC are derived from short arms and pericentric regions of the 
acrocentic chromosomes, while the occurrence of an additional derivative 
chromosome 5 is very rare. 
In the present study we report features of a patient with a sSMC derived from 
chromosome 5 - sSMC(5), which was characterized by GTG-banding, fluorescence in-
situ hybridization (FISH) and full-tiling resolution array CGH after sSMC 
microdissection. We also retrospectively compare and review all cases with sSMC from 
chromosome 5 previously reported and cases with chromosomal imbalances involving 
a trisomy with a genetic content overlapping our case. The use of molecular 
cytogenetics, especially array CGH approaches, is crucial for an efficient 
genotype/phenotype correlation. 
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3.3.2. Results 
Case Report 
The patient is the third female child of healthy non-consanguineous 
parents, with two normal sisters. The delivery was uneventful, after a pregnancy with 
reduced fetal movements, with a birth weight of 2,750 g, no evidence for anoxia and 
she started crying soon after birth. Hypotonia was observed since birth. She revealed 
moderate psychomotor delay, started walking late and had speech difficulties, with the 
first sentence only at 4 years old. She presented mild facial dysmorphisms, namely 
mild hypertelorism, high and wide nasal bridge, a prominent and bulbous nose, thin 
upper lip, dental anomalies  and slight protrusion of the chin.  The patient revealed 
learning difficulties throughout her life but has succeeded finishing a professional 
course, although she can't be persistent in a job. She is now 35 years old and has a 
healthy son with a normal karyotype.  
 
Cytogenetics and Molecular Cytogenetics 
Lymphocyte culture was established from peripheral blood and GTG-banding analysis 
was performed revealing a female karyotype with an sSMC in 70% of the 20 analyzed 
metaphases. The marker chromosome was very small and appeared to have a ring 
shape (Fig 3.3.1A). Karyotypes of both parents were normal (data not showed).  
Centromeric-FISH, using the probe SE 1/5/19 (Poseidon Kreatech Diagnostics, The 
Netherlands) revealed that the sSMC was derived from chromosomes 1, 5 or 19 (data 
not showed). Reverse FISH confirmed the origin of the marker and suggested the 
involvement of the euchromatic region of 5q in the sSMC (Fig 3.3.1B). SubcenM-FISH 
specific for chromosome 5 confirmed the ring-shape of the marker and demonstrated 
that the sSMC possessed euchromatic material from 5q, the karyotype being mos 
47,XX,+r(5)(::p11.1 q11.2?::)[70%]/46,XX[30%] (Fig 3.3.1.C). With array CGH, after 
microdissection of the sSMC, the breakpoints of the marker were redefined. Thus, the 
sSMC led to a partial trisomy with approximately 15 Mb length, between 46.15~49.56 
MB (5p11.1) and 61.25~61.33Mb (5q12.1) on chromosome 5 (Fig 3.3.2).  
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UPD was excluded in this patient for chromosome 5, with the following markers being 
informative: D5S2505, GATA145D09, D5S1457, D5S1501, D5S1456, D5S211, D5S1453 
(data not shown). 
C Inv DAPI Sp Green Sp OrangeTexasRed Cyanine 5 DEAC
#5
mar
cep 5 bA19F12 bA160F8 pcp 5q wcp 5
mar#5 #5
A B
 
Figure 3.3.1. - G-banding and FISH results. The sSMC(5) is signed as mar. A. GTG banded images of both 
normal chromosomes 5 and of the sSMC(5). B. Reverse FISH image confirming the origin of the sSMC 
and the extent of the chromosome 5 involved in the marker. The sSMC was microdissected and the DNA 
was amplified, labeled and hybridized in a patient metaphase. C. FISH image applying the 
subcentromeric probes for chromosome 5, revealing that the centromere-near region in p-arm 
(bA19F12, in purple) is absent in the marker, the centromere-near region in q-arm (bA160F8, in red) is 
present in the marker, being the sSMC mainly derived from q-arm (in yellow). For space reasons only 
one of the two normal chromosomes 5 is shown.  
 
  
 
110 
 
0
500
1000
1500
2000
2500
3000
3500
4000
4500
0
C
y
5
 n
o
rm
a
li
z
e
d
fl
u
o
re
s
c
e
n
c
e
Mb
Chr. 5
46.15 61.33
A.
B.
RP11-753D19(+) RP11-72L18(+) 
RP11-52C13(-) RP11-714L04(-)
C
y
5
 n
o
rm
a
li
z
e
d
fl
u
o
re
s
c
e
n
c
e
C
y
5
 n
o
rm
a
li
z
e
d
fl
u
o
re
s
c
e
n
c
e
 
Figure 3.3.2 – A. Array CGH result after microdissection and amplification of the sSMC(5). A. The plot 
shows a gain for region 5q11 to 5q12.1, between 46.15~49.56 MB and 61.25~61.33 Mb, with the 
flanking BAC clones, RP11-52C13 (absent in the sSMC), RP11-753D19 (present in the sSMC), RP11-72L18 
(present in the sSMC), RP11-714L4 (absent in the sSMC). B. Ideogram of chromosome 5 showing the 
region involved in the sSMC, corresponding to the flanking BAC clones identified in 3A. 
 
Literature review 
To the best of our knowledge, there are 21 cases with a sSMC derived from 
chromosome 5 reported in the literature. Beside these reports, 14 additional cases are 
reported in sSMC homepage [Liehr 2010, sSMC homepage], i.e. 1.2% of the sSMC cases 
included in this data base. However not all are correlated with a clinical outcome. 
Taking into account the cases reported in the literature, in three of these cases clinical 
information is not available and/or the marker chromosomes were poorly 
characterized, being therefore excluded of a possible genotype/phenotype correlation 
[Masuno et al.,1999, Heng et al., 2003 – case 12; Karaman et al., 2006 – case18]. Four of the 
reported cases with a sSMC(5) do not present clinical findings [Starke et al., 2003 – case 
11; Leite et al., 2006; Baldwin et al., 2008 – case 10; Manvelyan et al., 2008 – case 9, Fig 3.3. – 
i) to iv)]. The other fourteen reported sSMC(5) cases present significant clinical findings 
(Fig 3.3.3 – v) to xvii)), including one with a neocentromere (Fig 3.3.3.v) [Schuffenhauer et 
al., 1996; Avansino et al., 1999; Stankiewicz et al., 2000 – case 1; Anderlid et al., 2001 - case G; 
Fritz et al., 2001; D'Amato Sizonenko et al., 2002 – case 1 and case 2; Brecevic et al., 2006 - 
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case 5; Huang et al., 2006- cases 53 and 54; Liehr et al., 2006a – case 5-6; Sarri et al., 2006; 
Baldwin et al., 2008 – case 9; Polityko et al., 2008,]. Additionally to these cases of sSMC(5), 
there is one with the presence of two sSMC with euchromatin from two different 
chromosomes (chromosomes 5 and 6) [Liehr et al., 2006b].  
 
r(::p13 q10::p13 q10::) Schuffenhauer et al., 1996
mar(::p13.1 q10::) Avansino et al., 1999
r(::p14 q11.2::) Stankiewickz et al., 2000 (case 1)
r(::p12 q10::) Anderlid et al., 2001 (case G)
r(::p13.3 q12.3::) D’Amato Sizonenko et al., 2002  (case 2 ) 
r(::p13.3 q10::) D’Amato Sizonenko et al., 2002  (case 1 ) 
invdup(:p12 q11.1::q11.1 p12:) Brecevic et al., 2006 (case 5)
invdup(pter q10::q10 pter) Huang et al., 2006 (case 54)
min(:p12~13.1 q10:) Liehr et al., 2006a (case 5-6)
min(:p13.3~p13.2 q11.2:) Sarri et al., 2006
r(::p11 q12.1::) Baldwin et al. 2008 (case 9)
min(pter q10) Polityko et al., 2008
r(::p11.1 q12.1::) present case
invdup(pter p14::p14 pter) Fritz et al., 2001
min(5)(:p12→q11.1:) Starke et al., 2003 (case 11)
der(5)(:p11.2→q11.1:)/der(5)(:p11.1→q11.2:) Baldwin et al., 2008 (case 10)
mar(5)(:p?15.3→q11?:) Leite et al., 2006 (case 1)
min(5)(:p12 → q11.1:) Manvelyan et al., 2008 (case 9)
(i)
(ii)
(iii)
(iv)
(v)
(vi)
(vii)
(viii)
(ix)
(x)
(xi)
(xii)
(xiii)
(xiv)
(xv)
(xvi)
(xvii)
(xviii)
dup(q11.2 q13.1) Yip et al. 1989
dup(q11.2 q14) Breslau-Siderius et al. 1993
dup(q11.1 q15) Rojas.Martinez et al. 1990
dup(q11 q12) Jalbert et al. 1975
(a)
(b)
(c)
(d)
 
Figure 3.3.3. – Representation of the approximate breakpoints/genetic content of the reported sSMC(5) 
cases with or without clinical symptoms and with a sufficient cytogenetic characterization and of the 
cases with a duplication or insertion involving trisomy of proximal 5q arm. The sSMC(5) cases are 
designated from i) to xviii) and the duplications/insertions cases are designated from a) to d). Green 
squares correspond to reported sSMC(5) without clinical symptoms and red squares to reported 
sSMC(5) or partial trisomy 5q associated with clinical findings. Breakpoints’ representation is 
approximated. 
 
Of the sSMC (5) so far reported, approximately 50% have a ring shape, the others 
being inverted duplications or minutes. The great majority of sSMC(5) described are 
mainly derived from 5p arm. The approximately breakpoints/genetic content of the 
sSMC(5) documented with or without clinical findings are shown in figure 3.3.3. The 
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characterization of the sSMC(5) summarized in figure 3.3.3 were mainly performed by 
FISH, using in some cases multicolor FISH approaches like subcenM-FISH and 
multicolor banding, or using other FISH probes specific for chromosome 5. The present 
case is the first reported sSMC(5) characterized by array CGH, allowing a more precise 
information about the genetic content of the marker. The features of the patients with 
a trissomic region, associated with the presence of a sSMC with a molecular 
cytogenetic content overlapping our case, are described in Table 3.3.I [Stankiewicz et al., 
2000 – case 1; D'Amato Sizonenko et al., 2002 –case 2; Sarri et al., 2006; Baldwin et al., 2008 – 
case 9]. 
Besides the cases with sSMC(5), there are reports in the literature describing probands 
with a proximal 5q trisomic region located close to the centromere and overlapping 
the region of our sSMC(5): 1) a boy with a de novo duplication involving 5q11.2 q14 
region [Breslau-Siderius et al., 1993]; 2) a case with a de novo duplication 5q11.1 q15 
[Rojas-Martinez et al., 1990]; 3) a boy with a trisomy 5q11.2 q13.1 as a result of a 
paternal balanced insertion in the long arm of chromosome 20 [Yip et al., 1989] and 4) a 
girl with a trisomy 5q11 q22 as a result of a maternal balanced insertion at 
chromosome 1 [Jalbert et al., 1975]. The features of these patients are also included in 
Table 3.3.I and represented in figure 3.3.3. (a) to d)), as the genetic content involved in 
the trisomy overlaps our case. 
 
3.3.3. Discussion 
We have reported a mosaic case with a sSMC derived from chromosome 5 with 
approximately 15 Mb length characterized by multicolor FISH and array CGH, after 
microdissection. The proband karyotype was initially established as mos 
47,XX,+r(5)(::p11.1 q11.2?::)[70%]/46,XX[30%]. With array CGH, after 
microdissection of the sSMC, the breakpoints of the marker were redefined, leading to 
a partial trisomy between 46.15~49.56 MB (5p11.1) and 61.25~61.335Mb (5q12.1) on 
chromosome 5. We reviewed all reported cases with a sSMC(5) and with a trisomy 
involving the region contained in the marker chromosome. 
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sSMC(5) involving regions just near the centromere, apparently without euchromatin 
involvement, do not present clinical manifestations (Fig 3.3.3, i) to iii)). The other 
reported sSMC(5), with involvement of euchromatic regions in p-arm and/or q-arm, 
are associated with clinical manifestations. The exception seems to be the case of Leite 
and collaborators [Leite et al., 2006], which reported a sSMC(5) involving a long 
extension of p-arm (p?15.3 q11?) but with no apparent pathological phenotype (Fig 
3.3.3, iv). This could be associated to the fact that the sSMC is present in mosaic (< 40% 
of cord cells with the marker). The characterization of this marker was done using a 
cross-species color banding FISH approach with gibbon whole chromosome painting 
probes, homologous to human chromosomes, leading to an unclear characterization of 
the sSMC. It would be interesting to evaluate this case using another molecular 
cytogenetic approach, in order to confirm the genetic content of the marker.  
The majority of the sSMC(5) reported involved partial trisomy of 5p arm, being the 
sSMC(5) with 5q material rarer (Fig 3.3.3.). A critical region has been proposed for 
chromosome 5 p-arm in 5p13, being trisomy including this region associated with 
psychomotor delay and a characteristic facies following a pregnancy complicated by 
polyhydramnios *Avansino et al., 1999; D’Amato-Sizonenko et al., 2002]. The dysmorphic 
features include macrocephaly, epicanthic folds with apparent hypertelorism, enlarged 
anterior fontanelle, midfacial hypoplasia with a small nose, micrortrognathia, short 
neck, low-set dysplastic ears with preauricular skin tag, arachnodactyly and talipes 
equinovarus. Psychomotor retardation may be accompanied by a seizural disorder 
*D’Amato-Sizonenko et al., 2002]. 
sSMC(5) involving euchromatin in q arm are rare and a genotype/phenotype 
correlation is difficult to ascertain due to heterogeneity of the size and content of the 
sSMC. Of the 4 reported cases with a sSMC(5) and with a molecular cytogenetic 
content overlapping our case (described in Table 3.3.I and represented in Fig 3.3.3. – xiv to 
xvii), 3 sSMC(5) cases (Fig 3.3.3. - xiv to xvi) involve 5p arm euchromatic content, namely 
the critical region proposed for 5p13, and euchromatic material from 5q arm 
[Stankiewicz et al., 2000 – case 1; D'Amato Sizonenko et al., 2002 –case 2; Sarri et al., 2006]. 
The dysmorphic features of these cases are concordant in some extent with the ones 
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described for trisomy involving 5p13 *Avansino et al., 1999; D’Amato-Sizonenko et al., 
2002]. Interestingly, the report of Stankiewicz and colleagues [Stankiewicz et al., 2000 – 
case 1] (Fig 3.3.3.- xiii) describe besides the dysmorphic features and mental 
development slightly delayed, speech difficulties, with beginning of an indistinctly 
speech at 4 years old (Table 3.3.I.). The observation of learning difficulties and speech 
delay was also seen in our proband. The case reported by Baldwin and co-workers 
[Baldwin et al., 2008 – case 9] (Fig 3.3.3.- xvii) revealed also development delay, but no 
speech difficulty was reported. However, this proband was clinically evaluated at 1 
year old and it would be interesting to reassess him later in life to confirm a possible 
speech difficulty. There are in the literature some cases with a duplication involving 
proximal 5q arm [reviewed by Douyard et al., 2006], 4 of them having a cytogenetic 
content overlapping our case (Figure 3.3.3 – a to d; Table 3.3.I) [Jalbert et al., 1975; Yip et 
al., 1989; Rojas-Martinez et al., 1990; Breslau-Siderius et al., 1993] and 3 of these cases 
reported speech difficulties, with speech delay [Yip et al., 1989] (Fig 3.3.3. – a) or even 
absence of speech [Jalbert et al., 1975; Rojas-Martinez et al., 1990] (Fig 3.3.3.- c and d). It 
was not possible to assess this characteristic in the other remaining case, due to the 
age of examination (8 months) (Breslau-Siderius et al., 1993] (Fig 3.3.3. – b). It seems that 
cases with trisomy involving 5q11.2 to 5q12.1 are associated with speech delay and 
cases with more distal duplications of 5q arm are related with absence of speech. 
Douyard and collaborators, when reviewing proximal 5q duplications cases, already 
noted this observation, and our report could reinforce this correlation [Douyard et al., 
2006]. This evidence could suggest a possible critical region associated with speech 
deficiency in proximal 5q arm. Nonetheless, in order to strengthen this association, it 
would be important to have more sSMC(5) or partial 5 trisomies documented, even if 
they are associated with normal phenotypes.  
Hypotonia and development delay are also a common feature of the cases reviewed 
involving a 5q proximal arm trisomy. The dysmorphic features observed in all cases are 
broad, but in most of the reported cases, including our patient, was described a 
prominent nose with a wide nasal bridge. 
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Mosaicism, a very common phenomenon in sSMC cases, is a very important factor 
regarding the heterogeneity of clinical manifestations. It would be expected that 
patients with a low-grade of mosaicism would display a milder phenotype, but this is 
not confirmed by the literature. Depending on the specific tissues with the sSMC, 
namely if cerebral tissue is involved, the impact of the marker size could be overcome. 
Imprinting phenomena could also influence the clinical impact of the sSMC, and it 
would be interesting to evaluate this in all sSMC cases.  
A genotype-phenotype correlation is very difficult to ascertain mainly due to 
breakpoint distribution heterogeneity and to different levels and distribution of 
mosaicism. A more precise knowledge of the size of the partial trisomy segment and 
the gene content of a sSMC would greatly improve the ability to predict phenotype, 
contributing to a more informed prenatal counseling and prognosis. Indeed, this kind 
of studies gives detailed information that would allow data sequence mining for 
disease-related genes, where dosage gene increase could have an important role. 
Multicolor FISH approaches, recurring to subcenFISH and/or multicolor banding allow a 
good characterization of the heterochromatic/euchromatic content of a sSMC. 
Currently, with the use of array CGH, it is possible to identify the specific gene content 
of sSMCs. However this technique could present some problems: 1) when the sSMC is 
present in a low percentage of cells, it could be difficult to have significant results; 2) 
depending on the coverage of the pericentromeric region on the array it could be 
difficult to assess the content just near the centromere. In such cases the use of array 
CGH after the microdissection and amplification of the sSMC coupled with an array 
with high resolution in pericentromeric regions, namely a BAC full-tilling array, could 
overcame these problems. In conclusion, it is very important to characterize 
thoroughly the genetic content of all sSMC and report them, in order to establish a 
more precise genotype-phenotype correlation. 
  
 
 
 
  
Ta
b
le
 3
.3
.I
 –
 C
lin
ic
al
 a
n
d
 c
yt
o
ge
n
et
ic
 f
ea
tu
re
s 
o
f 
ca
se
s 
w
it
h
 a
n
 s
SM
C
(5
) 
o
r 
w
it
h
 a
 d
u
p
lic
at
io
n
, i
n
vo
lv
in
g 
a 
tr
is
o
m
y 
in
 p
ro
xi
m
al
 5
q
 a
rm
. 
R
ep
o
rt
 
Fe
at
u
re
s 
 St
an
ki
e
w
ic
kz
 e
t 
a
l.
 
(c
as
e 
1
) 
 Fi
g 
3
.3
.3
.–
 x
iv
) 
K
ar
yo
ty
p
e 
Tr
is
o
m
ic
 r
e
gi
o
n
 
M
e
th
o
d
 
m
o
s4
7
,X
X
,+
r(
5
)[
5
7
%
]/
4
6,
X
X
[4
3%
] 
  
5
p
1
4
q
1
1
.2
 
FI
SH
: a
lp
h
o
id
 r
ep
ea
t,
 t
e
lo
m
er
ic
 p
ro
b
e
s,
 W
C
P
, l
o
cu
s 
sp
ec
if
ic
 p
ro
b
es
, r
ev
e
rs
e
 p
ai
n
ti
n
g 
C
lin
ic
al
 S
ym
p
to
m
s 
A
t 
b
ir
th
: B
o
rn
 a
ft
e
r 
u
n
co
m
p
lic
at
ed
 p
re
gn
an
cy
. 
A
t 
4
y:
 s
p
ee
ch
 in
d
is
ti
n
ct
ly
 w
it
h
 4
y;
 m
e
n
ta
l d
ev
el
o
p
m
en
t 
d
el
ay
ed
.  
A
t 
2
7
y:
 B
ak
er
's
 c
ys
ts
; 
b
ila
te
ra
l 
ta
lip
e
s 
va
lg
u
s 
an
d
 g
en
u
 v
al
gu
m
; 
sm
al
l 
fa
ci
al
 D
F 
- 
ep
ic
an
th
ic
 f
o
ld
s,
 h
ig
h
 a
rc
h
ed
 p
al
at
e,
 h
yp
er
te
lo
ri
sm
, 
le
ft
 s
tr
ab
is
m
u
s,
 u
p
w
ar
d
 s
la
n
ti
n
g 
p
al
p
eb
ra
l 
fi
ss
u
re
s,
 
sy
n
o
p
h
ry
s,
 p
ro
m
in
en
t 
n
o
se
 w
it
h
 w
id
e
 n
as
al
 b
ri
d
ge
, m
ic
ro
gn
at
h
ia
, l
o
w
 s
et
 p
o
st
er
io
rl
y 
ro
ta
te
d
 d
ys
p
la
st
ic
 e
ar
s,
 lo
w
 f
ro
n
ta
l a
n
d
 p
o
st
e
ri
o
r 
h
ai
rl
in
e.
 
A
t 
3
0
 y
: m
ild
ly
 m
en
ta
lly
 r
e
ta
rd
ed
. 
 D
’A
m
at
o
-S
iz
o
n
en
ko
 
et
 a
l.
 (
ca
se
 2
) 
 Fi
g 
3
.3
.3
.–
 x
v)
 
 
K
ar
yo
ty
p
e
  
Tr
is
o
m
ic
 r
e
gi
o
n
 
M
e
th
o
d
 
m
o
s4
7
,X
Y,
 +
r(
5
)[
8
1
%
]/
4
6,
X
Y[
19
%
] 
5
p
1
3
.3
q
12
.3
 
FI
SH
: C
EP
, W
C
P
, P
C
P
, Y
A
C
s 
p
ro
b
es
 
C
lin
ic
al
 S
ym
p
to
m
s 
P
re
gn
an
cy
: P
o
ly
h
yd
ra
m
n
io
n
s.
 
A
t 
b
ir
th
: 
B
ir
th
 w
ei
gh
t 
at
 7
5
th
 c
en
ti
le
; 
O
FC
 >
9
0
th
 c
en
ti
le
; 
le
n
gt
h
 a
t 
5
0
th
 c
en
ti
le
; 
A
p
ga
r 
sc
o
re
s 
6
/7
/-
; 
m
ac
ro
ce
p
h
al
y;
 l
ar
ge
 a
n
te
ri
o
r 
fo
n
ta
n
el
; 
u
p
sl
an
ti
n
g 
p
al
p
eb
ra
l 
fi
ss
u
re
s;
 w
id
e 
n
as
al
 b
ri
d
ge
; 
ab
n
o
rm
al
 e
ar
s;
 p
re
au
ri
cu
la
r 
p
it
s;
 b
ila
te
ra
l p
al
m
ar
 c
re
as
e;
 c
ar
d
ia
c 
m
u
rm
u
r;
 a
n
te
ri
o
r 
an
u
s;
 b
ila
te
ra
l t
al
ip
es
 e
q
u
in
o
va
ru
s;
 h
yp
o
to
n
ia
, V
SD
; h
yd
ro
ce
p
h
al
u
s;
 b
ila
te
ra
l i
n
gu
in
al
 h
er
n
ia
e.
  
A
t 
9
m
: 
fa
ci
al
 e
cz
em
a;
 d
o
lic
h
o
m
ac
ro
ce
p
h
al
y;
 e
p
ic
an
th
ic
 f
o
ld
s;
 u
p
sl
an
ti
n
g 
p
al
p
eb
ra
l f
is
su
re
s;
 h
yp
er
te
lo
ri
sm
; 
b
ro
ad
 b
ri
d
ge
 o
f 
n
o
se
; 
m
ic
ro
re
tr
o
gn
at
h
ia
, 
m
ild
ly
 lo
w
-s
et
 e
ar
s;
 b
el
l-
sh
ap
e 
th
o
ra
x;
 
n
o
rm
al
 r
en
al
 s
ca
n
; n
o
rm
al
 b
ra
in
 a
n
d
 s
p
in
e 
M
R
I;
 n
o
rm
al
 o
p
h
th
al
m
o
lo
gi
ca
l a
n
d
 h
ea
ri
n
g 
ex
am
in
at
io
n
. 
A
t 
1
y:
 w
ei
gh
t 
an
d
 l
en
gt
h
 <
 3
rd
 c
en
ti
le
; 
O
FC
 >
9
0
th
 c
en
ti
le
 w
it
h
 l
ar
ge
 a
n
te
ri
o
r 
fo
n
ta
n
el
; 
fe
ed
in
g 
p
ro
b
le
m
s;
 s
am
e 
D
F;
 r
es
p
ir
at
o
ry
 p
ro
b
le
m
s;
 u
n
ab
le
 t
o
 s
it
; 
d
ev
el
o
p
m
en
t 
p
ro
gr
es
s 
– 
al
er
t,
 
b
ab
b
lin
g,
 g
ra
b
b
in
g 
an
d
 t
ra
n
sf
er
ri
n
g 
o
b
je
ct
s,
 s
m
ili
n
g 
so
ci
al
ly
.  
 Sa
rr
i e
t 
a
l.
 
 Fi
g 
3
.3
.3
.–
 x
vi
) 
 
K
ar
yo
ty
p
e
  
Tr
is
o
m
ic
 r
e
gi
o
n
 
M
e
th
o
d
 
m
o
s4
7
,X
X
,+
m
ar
(5
)[
70
%
]/
4
6
,X
X
[3
0%
] 
5
p
1
3
.3
~p
1
3
.2
→
q
11
.2
 
M
-F
IS
H
: s
u
b
ce
n
M
-F
IS
H
, M
C
B
 
C
lin
ic
al
 S
ym
p
to
m
s 
K
ar
yo
ty
p
ed
 in
it
ia
lly
 b
ec
au
se
 o
f 
at
ri
al
 s
ep
ta
l d
ef
ec
t,
 v
en
tr
ic
u
la
r 
se
p
ta
l d
ef
ec
t 
an
d
 o
d
d
 f
ac
ie
s;
 w
al
ke
d
 a
t 
1
8
 m
; m
o
d
er
at
e 
le
ar
n
in
g 
d
if
fi
cu
lt
ie
s 
b
u
t 
at
te
n
d
s 
n
o
rm
al
 s
ch
o
o
l; 
m
o
th
er
 d
es
cr
ib
es
 h
e
r 
as
 "
sl
o
w
" 
an
d
 "
h
ea
vy
" 
w
h
en
 s
h
e 
h
as
 t
as
ks
 t
o
 p
er
fo
rm
; 
 
A
t 
9
y 
8m
: 
W
ei
gh
t 
> 
9
7
th
 c
en
ti
le
; 
le
n
gt
h
 9
2
th
  c
en
ti
le
; 
O
FC
 >
9
7
th
 c
en
ti
le
; 
ea
rs
 5
5
th
 c
en
ti
le
; 
m
ild
 d
o
lic
h
o
ce
p
h
al
y;
 t
o
n
gu
e 
w
it
h
 a
 v
er
ti
ca
l f
u
rr
o
w
; 
th
ic
k 
th
o
ra
x 
w
it
h
 8
5
 c
m
 c
ir
cu
m
fe
re
n
ce
 (
> 
9
7
th
 
ce
n
ti
le
),
 
im
d
 
1
8
.3
 
cm
 
(9
0
th
 
p
c)
; 
2
 
su
p
er
n
u
m
er
ar
y 
n
ip
p
le
s,
 
ta
p
er
in
g 
fi
n
ge
rs
; 
p
al
m
s 
8
5
th
 
ce
n
ti
le
; 
m
id
d
le
 
fi
n
ge
r 
> 
9
7
th
 
ce
n
ti
le
, 
th
u
m
b
 
d
is
ta
lly
 
p
la
ce
d
, 
fo
o
t 
le
n
gt
h
 
9
7
th
 
ce
n
ti
le
; 
cl
in
o
/c
am
p
to
d
ac
ty
ly
 o
f 
to
es
 IV
 a
n
d
 V
; 
D
F:
 lo
w
 s
et
 e
ar
s 
w
it
h
 p
re
au
ri
cu
la
r 
p
it
s,
 b
ro
ad
 e
ye
b
ro
w
s,
 h
yp
er
te
lo
ri
sm
, d
o
w
n
 s
la
n
te
d
 p
a
lp
eb
ra
l f
is
su
re
s,
 h
ea
vy
 e
p
ic
an
th
u
s;
, h
ig
h
 n
as
al
 b
ri
d
ge
. 
Sh
e 
b
eg
an
 t
o
 g
ai
n
 w
ei
gh
t 
fr
o
m
 ~
 7
 y
. O
p
h
th
al
m
o
lo
gi
c 
in
ve
st
ig
at
io
n
 w
as
 n
o
rm
al
. 
 
  
   B
al
d
w
in
 e
t 
a
l.
 (
ca
se
 
9
) 
 Fi
g 
3
.3
.3
.–
 x
vi
i)
 
  
K
ar
yo
ty
p
e
  
Tr
is
o
m
ic
 r
e
gi
o
n
 
M
e
th
o
d
 
4
7
,+
r(
5
)[
2
5
%
]/
46
[7
5
%
] 
p
1
1
→
q
1
2.
1 
su
b
ce
n
M
-F
IS
H
 w
it
h
 3
 B
A
C
s 
C
lin
ic
al
 S
ym
p
to
m
s 
P
re
gn
an
cy
: I
n
tr
au
te
ri
n
e 
gr
o
w
th
 r
et
ar
d
at
io
n
 a
n
d
 s
m
al
l f
o
r 
ge
st
at
io
n
al
 a
ge
. 
A
t 
5
5
d
 (
 n
eo
n
at
al
 in
te
n
si
ve
 c
ar
e 
u
n
it
):
 a
p
n
ea
; p
o
o
r 
fe
ed
er
; e
le
va
te
d
 t
ri
gl
yc
e
ri
d
es
; n
o
rm
al
 h
ea
d
 u
lt
ra
so
u
n
d
; m
ild
 D
F.
 
A
t 
1
y:
 d
ev
el
o
p
m
en
ta
l d
el
ay
; a
tr
ia
l s
e
p
ta
l d
ef
e
ct
; h
em
an
gi
o
m
a;
 m
ild
 D
F.
 
Y
ip
 e
t 
a
l.
 
 Fi
g 
3
.3
.3
.–
 a
 
K
ar
yo
ty
p
e
  
Tr
is
o
m
ic
 r
e
gi
o
n
 
M
e
th
o
d
 
4
6
,X
Y,
d
er
(2
0
)t
(2
0
;5
)(
q
1
1
.2
;q
11
.2
q
1
3.
1
) 
 
q
1
1
.2
→
q
1
3
.1
 
C
o
n
ve
n
ti
o
n
al
 c
yt
o
ge
n
et
ci
s 
C
lin
ic
al
 S
ym
p
to
m
s 
B
ir
th
 w
ei
gh
t 
2
8
0
0
g 
A
t 
2
y 
9
m
: 
gl
o
b
al
 d
ev
el
o
p
m
en
t 
d
el
ay
 w
it
h
 s
p
ee
ch
 d
el
ay
; 
sl
ig
h
t 
cl
in
o
d
ac
yl
y 
o
f 
th
e 
4
th
 a
n
d
 5
th
 d
ig
it
s;
 u
ri
n
ar
y 
tr
ac
t 
d
e
fe
ct
; 
D
F:
 p
ro
m
in
en
t 
fo
re
h
ea
d
, 
w
id
e-
fl
at
 n
o
se
, 
u
p
sl
at
in
g 
p
al
p
eb
ra
l 
fi
ss
u
re
s,
 u
p
p
e
r 
se
t 
ea
rs
 w
it
h
 lo
w
er
 h
e
lic
es
 p
ro
tr
u
d
in
g,
 h
yp
er
te
lo
ri
sm
.  
 B
re
sl
au
-S
id
e
ri
u
s 
et
 
a
l.
 
 Fi
g 
3
.3
.3
.–
 b
 
K
ar
yo
ty
p
e
  
Tr
is
o
m
ic
 r
e
gi
o
n
 
M
e
th
o
d
 
4
6
,X
Y,
d
u
p
(5
)(
q
1
1
.2
→
q
1
4
) 
 
q
1
1
.2
→
q
1
4 
FI
SH
 
C
lin
ic
al
 S
ym
p
to
m
s 
A
t 
8
m
: 
d
ev
el
o
p
m
en
t 
d
el
ay
; 
gr
o
w
th
 r
et
ar
d
at
io
n
; 
co
n
ge
n
it
al
 h
ea
rt
 d
ef
ec
ts
 –
 a
tr
ia
l 
se
p
ta
l 
d
ef
e
ct
 a
n
d
 v
al
vu
la
r 
p
u
lm
o
n
ic
 s
te
n
o
si
s;
 h
yp
o
to
n
ia
; 
cr
an
io
st
en
o
si
s;
 D
F:
 p
ro
m
in
en
t 
fo
re
h
ea
d
, 
la
rg
e 
n
o
se
 b
ri
d
ge
, e
p
ic
an
th
al
 f
o
ld
s,
 lo
w
 s
et
, p
o
st
er
io
rl
y 
ro
ta
te
d
 e
ar
s,
 e
ar
 t
ag
s.
  
 R
o
ja
s-
M
ar
ti
n
e
z 
et
 a
l.
 
 Fi
g 
3
.3
.3
.–
 c
 
K
ar
yo
ty
p
e
  
Tr
is
o
m
ic
 r
e
gi
o
n
 
M
e
th
o
d
 
4
6
,X
Y,
d
u
p
(5
)(
q
1
1
.2
→
q
1
4
) 
 
q
1
1
.1
→
q
1
5 
n
.a
. 
C
lin
ic
al
 S
ym
p
to
m
s 
A
t 
3
.5
y:
 d
ev
el
o
p
m
en
t 
d
el
ay
; a
b
se
n
ce
 o
f 
sp
ee
ch
; g
ro
w
th
 r
et
ar
d
at
io
n
; m
ild
 h
yp
er
to
n
ia
; 
m
ic
ro
ce
p
h
al
y;
 D
F:
 p
ro
m
in
en
t 
n
o
se
, d
o
w
n
sl
at
in
g 
p
al
p
eb
ra
l f
is
su
re
s,
 e
p
ic
h
an
ti
c 
fo
ld
s,
 lo
w
 s
e
t 
d
ys
p
la
st
ic
 
ea
rs
. 
      
  
 Ja
lb
e
rt
 e
t 
a
l.
 
 Fi
g 
3
.3
.3
.–
 d
 
K
ar
yo
ty
p
e
  
Tr
is
o
m
ic
 r
e
gi
o
n
 
M
e
th
o
d
 
4
6
,X
X
,r
ec
(1
;5
)i
n
s 
(1
;5
)(
q
3
2
;q
1
1
q
2
2
) 
 
q
1
1
→
q
2
2 
C
o
n
ve
n
ti
o
n
al
 c
yt
o
ge
n
et
ic
s 
C
lin
ic
al
 S
ym
p
to
m
s 
A
t 
3
y7
m
: 
d
ev
el
o
p
m
en
t 
d
el
ay
, n
o
 g
ro
w
th
 r
et
ar
d
at
io
n
; 
ab
se
n
t 
sp
ee
ch
; 
ve
n
tr
ic
u
la
r 
se
p
ta
l d
ef
ec
t;
 h
yp
o
to
n
ia
; 
m
ic
ro
ce
p
h
al
y;
 t
h
in
 h
an
d
s 
an
d
 t
ap
er
in
g 
fi
n
ge
rs
; 
ey
e 
si
gh
t 
an
d
 h
ea
ri
n
g 
n
o
rm
al
; 
D
F:
 
lo
w
 s
et
, p
ro
tr
u
d
in
g 
ea
rs
, e
p
ic
an
th
al
 f
o
ld
s,
 b
u
lb
o
u
s 
an
d
 p
ro
m
in
en
t 
n
o
se
, p
ro
m
in
en
t 
fo
re
h
ea
d
, t
h
ic
k 
u
p
p
er
 li
p
; t
e
et
h
 a
b
n
o
rm
al
ly
 s
e
t 
 P
re
se
n
t 
ca
se
 
 Fi
g 
3
.3
.3
. –
 x
vi
ii)
 
 
K
ar
yo
ty
p
e
  
Tr
is
o
m
ic
 r
e
gi
o
n
 
M
e
th
o
d
 
m
o
s4
7
,X
X
,+
r(
5
)[
7
0
%
]/
4
6,
X
X
[3
0%
] 
p
1
0
→
q
1
2.
1 
(4
6
,1
5
~4
9
.4
6
M
b
→
 
6
1
.2
5
~6
1
.3
3
 M
b
) 
FI
SH
: C
EP
, r
ev
er
se
 p
ai
n
ti
n
g 
 
M
-F
IS
H
: s
u
b
ce
n
M
-F
IS
H
 
A
rr
ay
 C
G
H
 
C
lin
ic
al
 S
ym
p
to
m
s 
A
t 
b
ir
th
: N
o
rm
al
 d
el
iv
er
y,
 w
ei
gh
t 
2
7
5
0
g.
 
C
h
ild
h
o
o
d
: 
H
yp
o
to
n
ic
; 
p
sy
ch
o
m
o
to
r 
d
el
ay
; 
sp
ee
ch
 d
el
ay
 (
fi
rs
t 
se
n
te
n
ce
 a
t 
4
y)
; 
le
ar
n
in
g 
d
if
fi
cu
lt
ie
s;
 D
F 
–h
yp
er
te
lo
ri
sm
, 
h
ig
h
 n
as
al
 b
ri
d
ge
 w
it
h
 a
 b
u
lb
o
u
s 
p
ro
m
in
en
t 
n
o
se
, 
th
in
 u
p
p
er
 l
ip
, 
d
en
ta
l a
n
o
m
al
ie
s,
 s
lig
h
t 
p
ro
tr
u
si
o
n
 o
f 
th
e 
ch
in
. 
 
A
d
u
lt
h
o
o
d
: N
o
rm
al
 h
ei
gh
t 
(1
6
0
 c
m
) 
an
d
 w
ei
gh
t 
(5
3
 K
g)
; O
FC
 5
4
 c
m
; M
ild
ly
 m
en
ta
lly
 r
et
ar
d
ed
; M
ai
n
ta
in
s 
D
F 
d
es
cr
ib
ed
 f
ea
tu
re
s;
 H
ea
lt
h
y 
so
n
 w
it
h
 n
o
rm
al
 k
ar
yo
ty
p
e.
 
A
d
ap
te
d
 f
ro
m
 h
tt
p
:/
/w
w
w
.m
ed
.u
n
i-
je
n
a.
d
e/
fi
sh
/s
SM
C
/0
5
.h
tm
 a
n
d
 D
o
u
ya
rd
 e
t 
a
l.,
 2
0
0
6
. 
n
.a
. 
– 
d
at
a 
n
o
t 
av
ai
la
b
le
; 
d
, 
d
ay
s;
 y
, 
ye
ar
s;
 m
, 
m
o
n
th
s;
 F
IS
H
, 
fl
u
o
re
sc
en
ce
 in
 
si
tu
 h
yb
ri
d
iz
at
io
n
; 
D
F,
 d
ys
m
o
rp
h
ic
 f
ea
tu
re
s;
 C
EP
, 
ce
n
tr
o
m
er
ic
 p
ro
b
e;
 W
C
P
, 
w
h
o
le
 c
h
ro
m
o
so
m
e 
p
ai
n
ti
n
g;
 P
C
P
, 
p
ar
ti
al
 c
h
ro
m
o
so
m
e 
p
ai
n
ti
n
g;
 Y
A
C
, 
ye
as
t 
ar
ti
fi
ci
al
 
ch
ro
m
o
so
m
e;
 O
FC
, h
ea
d
 c
ir
cu
m
fe
re
n
ce
; B
A
C
, b
ac
te
ri
al
 a
rt
if
ic
ia
l c
h
ro
m
o
so
m
e
; M
C
B
 –
 m
u
lt
ic
o
lo
u
r 
b
an
d
in
g;
 M
-F
IS
H
 –
 m
u
lt
ic
o
lo
r 
FI
SH
. 
 
 
  
   
Results and Discussion 
3.3. sSMC from chromosome 5 
 
121 
 
3.3.4. References 
 
Anderlid BM, Sahlén S, Schoumans J, Holmberg E, Ahsgren I, Mortier G, Speleman F, Blennow E (2001) 
Detailed characterization of 12 supernumerary ring chromosomes using micro-FISH and search for 
uniparental disomy. Am J Med Genet 99: 223-233. 
 
Avansino JR, Dennis TR, Spallone P, Stock AD, Levin ML (1999) Proximal 5p trisomy resulting from a 
marker chromosome implicates band 5p13 in 5p trisomy syndrome. Am J Med Genet 87(1): 6-11. 
 
Backx L, Van Esch H, Melotte C, Kosyakova N, Starke H, Frijns JP, Liehr T, Vermeesch JR (2007) Array 
painting using microdissected chromosomes to map chromosomal breakpoints. Cytogenet Genome Res 
116(3): 158-166. 
 
Baldwin EL, May LF, Justice AN, Martin CL, Ledbetter DH (2008) Mechanisms and consequences of small 
supernumerary marker chromosomes: from Barbara McClintock to modern genetic-counseling issues. 
Am J Hum Genet 82(2): 398-410. 
 
Brecevic L, Michel S, Starke H, Müller K, Kosyakova N, Mrasek K, Weise A, Liehr T (2006) Multicolor FISH 
used for the characterization of small supernumerary marker chromosomes (sSMC) in commercially 
available immortalized cell lines. Cytogenet Genome Res 114(3-4): 319-324. 
 
Breslau-Siderius EJ, Wijnen JT, Dauwerse JG, de Pater JM, Beemer FA, Khan PM (1993) Paternal 
duplication of chromosome 5q11.2-5q14 in a male born with craniostenosis, ear tags, kidney dysplasia 
and several other anomalies. Hum Genet 92(5): 481-485. 
 
D'Amato Sizonenko L, Ng D, Oei P, Winship I (2002) Supernumerary marker chromosomes 5: 
confirmation of a critical region and resultant phenotype. Am J Med Genet 111(1): 19-26.  
 
Douyard J, Hawley P, Shaham M, Kimonis V(2006) Duplication of 5q15-q23.2: case report and literature 
review. Birth Defects Res A Clin Mol Teratol 76(4): 272-276. 
 
Fiegler H, Carr P, Douglas EJ, Burford DC, Hunt S, Scott CE, Smith J, Vetrie D, Gorman P, Tomlinson IP, 
Carter NP (2003) DNA microarrays for comparative genomic hybridization based on DOP-PCR 
amplification of BAC and PAC clones. Genes Chromosomes Cancer 36(4): 361–374. 
 
Fritz B, Dietze I, Wandall A, Aslan M, Schmidt A, Kattner E, Schwerdtfeger R, Friedrich U (2001) A 
supernumerary marker chromosome with a neocentromere derived from 5p14 pter. J Med Genet 
38(8): 559-565. 
 
Heng HH, Ye CJ, Yang F, Ebrahim S, Liu G, Bremer SW, Thomas CM, Ye J, Chen TJ, Tuck-Muller C, Yu JW, 
Krawetz SA, Johnson A (2003) Analysis of marker or complex chromosomal rearrangements present in 
pre- and post-natal karyotypes utilizing a combination of G-banding, spectral karyotyping and 
fluorescence in situ hybridization. Clin Genet 63(5): 358-367. 
 
Huang B, Solomon S, Thangavelu M, Peters K, Bhatt S (2006) Supernumerary marker chromosomes 
detected in 100 000 prenatal diagnoses: molecular cytogenetic studies and clinical significance. Prenat 
Diagn 26(12): 1142-1150. 
 
Jalbert P, Jalbert H, Sele B, Mouriquand C, Malka J, Boucharlat J, Pison H (1975) Partial trisomy for the 
long arms of chromosome no. 5 due to insertion and further 'aneusomie de recombinaison'. Med Genet 
12(4): 418-423. 
 
  
 
122 
 
Karaman B, Aytan M, Yilmaz K, Toksoy G, Onal EP, Ghanbari A, Engur A, Kayserili H, Yuksel-Apak M, 
Basaran S (2006) The identification of small supernumerary marker chromosomes; the experiences of 
15,792 fetal karyotyping from Turkey. Eur J Med Genet 49(3): 207-314. 
 
Leite RP, Souto M, Carvalho B, Martins M, Chaves R, Morais A, Guedes-Pinto H, Wienberg J, Ribeiro E 
(2006) Identification, characterization and clinical implications of two markers detected at prenatal 
diagnosis. Prenat Diagn 26(10): 920-924. 
 
Liehr T, Claussen U, Starke H (2004) Small supernumerary marker chromosomes (sSMC) in humans. 
Cytogenet Genome Res 107(1-2): 55–67. 
 
Liehr T, Mrasek K, Weise A, Dufke A, Rodríguez L, Martínez Guardia N, Sanchís A, Vermeesch JR, Ramel 
C, Polityko A, Haas OA, Anderson J, Claussen U, von Eggeling F, Starke H (2006 a) Small supernumerary 
marker chromosomes – progress towards a genotype- phenotype correlation. Cytogenet Genome Res 
112(1-2): 23-34. 
 
Liehr T, Starke H, Senger G, Melotte C, Weise A, Vermeesch JR. (2006 b). Overrepresentation of small 
supernumerary marker chromosomes (sSMC) from chromosome 6 origin in cases with multiple sSMC. 
Am J Med Genet A 140(1): 46-51.         
    
Manvelyan M, Riegel M, Santos M, Fuster C, Pellestor F, Mazaurik ML, Schulze B, Polityko A, Tittelbach 
H, Reising-Ackermann G, Belitz B, Hehr U, Kelbova C, Volleth M, Gödde E, Anderson J, Küpferling P, 
Köhler S, Duba HC, Dufke A, Aktas D, Martin T, Schreyer I, Ewers E, Reich D, Mrasek K, Weise A, Liehr T 
(2008) Thirty-two new cases with small supernumerary marker chromosomes (sSMC) detected in 
connection with fertility problems - detailed molecular cytogenetic characterization and review of the 
literature. Int J Mol Med 21(6): 705-714.  
 
Masuno M, Imaizumi K, Ishii T, Kimura J, Kuroki Y (1999) Supernumerary ring chromosome 5 identified 
by FISH. Am J Med Genet 84(4): 381. 
 
Melo JB, Matoso E, Polityko A, Saraiva J, Backx L, Vermeesch JR, Kosyakova N, Ewers E, Liehr T, Carreira 
IM (2009) Molecular cytogenetic characterization of two cases with de novo small mosaic 
supernumerary marker chromosomes derived from chromosome 16: Towards a genotype/phenotype 
correlation. Cytogenet Genome Res 125(2): 109-14. 
 
Polityko AD, Lazjuk GI, Liehr T (2008) High resolution molecular cytogenetic approaches and study of 
marker chromosomes. Medica Genetics 7(3): 34-40. 
 
Rojas-Martinez A, Garcia-Cruz D, Medina C, Moller M, Restrepo CM, Rivera H (1990) Tandem duplication 
of proximal 5q. Ann Genet 33(4): 228-230. 
 
Rooney DE, Czepulkowski BH, editors. 1992. Human Cytogenetics: A Practical Approach, 2
nd
 edition. New 
York: Oxford University Press.  
 
Sarri C, Gyftodimou Y, Grigoriadou M, Pandelia E, Kalogirou S, Kokotas H, Mrasek K, Weise A, Petersen 
MB (2006) Supernumerary marker chromosome 5 diagnosed by M-FISH in a child with congenital heart 
defect and unusual face. Cytogenet Genome Res 114(3-4): 330-337. 
 
Schuffenhauer S,  Kobelt A, Daumer-Haas C, Löffler C, Müller G, Murken J, Meitinger T (1996) Interstitial 
deletion 5p accompanied by dicentric ring formation of the deleted segment resulting in trisomy 5p13-
cen. Am J Med Genet 65(1): 56-59. 
 
Results and Discussion 
3.3. sSMC from chromosome 5 
 
123 
 
Stankiewicz P, Bocian E, Jakubów-Durska K, Obersztyn E, Lato E, Starke H, Mroczek K, Mazurczak T 
(2000) Identification of supernumerary marker chromosomes derived from chromosomes 5, 6, 19, and 
20 using FISH. J Med Genet 37(2): 114-120.  
 
Starke H, Nietzel A, Weise A, Heller A, Mrasek K, Belitz B, Kelbova C, Volleth M, Albrecht B, Mitulla B, 
Trappe R, Bartels I, Adolph S, Dufke A, Singer S, Stumm M, Wegner RD, Seidel J, Schmidt A, Kuechler A, 
Schreyer I, Claussen U, von Eggeling F, Liehr T (2003) Small supernumerary marker chromosomes 
(SMCs): Genotype phenotype correlation and classification. Hum Genet 114(1): 51–67. 
 
Trifonov V, Seidel J, Starke H, Martina P, Beensen V, Ziegler M, Hartmann I, Heller A, Nietzel A, Claussen 
U, Liehr T (2003) Enlarged chromosome 13 p-arm hiding a cryptic partial trisomy 6p22.2-pter. Prenat 
Diagn 23(5): 427–430.  
 
Vermeesch JR, Melotte C, Froyen G, Van Vooren S, Dutta B, Maas N, Vermeulen S, Menten B, Speleman 
F, De Moor B, Van Hummelen P, Marynen P, Fryns JP, Devriendt K (2005) Array CGH quality criteria for 
constitutional genetic diagnosis. J Histochem Cytochem 53(3): 413–422. 
 
Yip MY, Kemp J, Hanson N, Wilson M, Purvis-Smith S, Lam-Po-Tang PR (1989) Duplication of 5q11.2----
q13.1 from a familial (5;20) balanced insertion. Am J Med Genet 33(2): 220-223. 
  
 
 
 
Results and Discussion 
3.4. sSMC from chromosome 11 
 
 
125 
 
3.4. sSMC from chromosome 11 
Unbalanced chromosome abnormality in the pericentromeric region 11q: mother 
and child with distinct phenotypes with a small supernumerary marker chromosome 
derived from chromosome 11 [*] 
[*] The work presented in this section is under submission: 
Melo JB, Jardim A, Soares G, Backx L, Vermeesch JR, Kosyakova N, Weise A, Liehr T, Carreira IM. Unbalanced chromosome 
abnormality in the pericentromeric region 11q: mother and child with distinct phenotypes with a small supernumerary marker 
chromosome derived from chromosome 11. Submitted to American Journal of Medical Genetics A. 
 
3.4.1. Introduction 
Unbalanced chromosomal abnormalities (UBCAs) usually involve several megabases of 
DNA, and the great majority are ascertained because of phenotypic or reproductive 
effects that bring patients to medical attention. The more severely affected an 
individual is, the more likely he will be investigated; creating an ascertainment bias 
that does not reflect the full range of phenotypes that may be associated with 
imbalance of a particular chromosomal segment [Barber, 2005]. Small supernumerary 
marker chromosomes (sSMC) are small structurally abnormal chromosomes that occur 
in addition to the 46 chromosomes and cannot be identified or characterized 
unambiguously by conventional banding cytogenetics alone and are generally equal in 
size or smaller than a chromosome 20 of the same metaphase spread (Liehr et al., 
2004). The risk for phenotypic abnormalities associated with an sSMC depends on 
several factors, including pattern of inheritance, levels of mosaicism, mode of 
ascertainment, chromosomal origin, uniparental disomy, and the morphology, 
content, and structure of the marker [Graf et al., 2006]. 
We report a case of mother and son with the identical sSMC derived from 
chromosome 11 (sSMC(11)) with distinct phenotypes. 
 
3.4.2. Results 
Case Report 
The 13 years old boy presents facial dysmorphisms, macrocephaly, strabism, ptosis, 
mild mental retardation / developmental delay (global IQ on WISC-III evaluation at the 
  
 
126 
 
age of 15 years: 56). The 36 years old mother, besides a congenital cardiopathy – atrial 
septum defect (corrected with surgery), is phenotypically normal. 
 
Cytogenetics and Molecular Cytogenetics 
The sSMC was characterized comprehensively for its genetic content by G-banding, 
molecular cytogenetics using reverse FISH and subcentromere-specific multicolor 
fluorescence in situ hybridization (subcenM-FISH) [Starke et al., 2003], and array 
Comparative Genomic Hybridization (Array CGH) after microdissection and 
amplification of the sSMC-specific DNA [Melo et al., 2009]. G-banding showed that the 
sSMC was present in 83% of the 30 analysed metaphase in the boy and in 70% in the 
mother (Fig 3.4.1). The origin of the marker was ascertained by reverse FISH, as derived 
from chromosome 11 (Fig 3.4.2). 
The karyotype, after characterization of the marker by G-banding and subcenM-FISH, 
was in the mother – 
47,XX,+min(11)(:p11.12~11.2->q12:)[7]/47,XX,+r(11)(::p11.12~11.2-
>q12::)[2]/46,XX[4];  
and in the son –  
47,XY,+r(11)(::p11.12~11.2->q12::)[6]/47,XY,+r(11;11)(::p11.12~11.2-
>q12::p11.12~11.2->q12::)[3]/47,XY,+min(11)(:p11.12~11.2->q12:)[4]/46,XY[3] 
 (Fig. 3.4.3.A). 
The microdissected DNA of the sSMCs of the son was hybridized in a full tiling BAC 
array specific for chromosome 11, with a resolution of 100-150 Kb (VIB MicroArrays 
Facility - www.microarrays.be), having material of approximately 14.55 Mb size 
extension from 11q (between 50.47 Mb to 65.02 Mb) (Fig. 3.4.3 B and C). 
 
Uniparental Disomy analysis 
Uniparental Disomy (UPD) for chromosome 11 was excluded in the boy, with the 
following markers being informative: D11S1984, D11S2362, D11S1999, D11S1981, 
D11S1392, D11S2000, D11S1986, D11S1998, D11S4464, D11S912, and D11S968. 
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Figure 3.4.1 – Karyogram of the child showing a 46,XY with a small supernumerary marker chromosome 
that was encountered in 25 of the 30 analyzed cells. 
 
 
Figure 3.4.2 – Reverse FISH after microdissection and amplification of the the sSMC. The amplificated 
material was labelled and hybridized in a nomal metaphase plate. FISH image shows that the origin of 
the marker is the pericentromeric region of chromosome 11. 
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Figure 3.4.3 – A. SubcenM-FISH for chromosome 11, revealing that the centromere-near region in p-arm 
(RP11- 722K13, in red) is absent and the centromere-near region in q-arm (bA77M7, in purple) is 
present in the marker, being the sSMC derived from q-arm. The p-arm is absent in the marker (in 
yellow). The centromeric probe – CEP11 is identified in green and whole chromosome painting of 11 in 
blue (for space reasons only one of the two normal chromosomes 11 is shown). B. Array CGH result after 
microdissection and amplification of the sSMC(11). The plot shows a gain for region 11p11.12 to 
11q13.1, between 50,47 Mb to 65,02Mb C. Ideogram of chromosome 11 showing the region (red 
square) involved in the sSMC, corresponding to the flanking BAC clones identified in 1.B. 
 
3.4.3. Discussion 
Some sSMCs are inherited directly from a phenotypically normal parent. In such 
cases, there are often no phenotypic consequences for individuals who inherit the 
marker. However, there are exceptions to this. Although the sSMC reported here is 
maternally derived, the mother has a normal phenotype and the son an abnormal one. 
The difference in the phenotypes of mother and child could be due to both the 
different degree and distribution of mosaicism and to the different forms of the sSMC 
encountered.  
The variability of phenotypes among relatives observed in transmitted UCBAs can also 
be due to other causes, like chromosomal non-penetrance, uniparental disomy or 
undetected differences at the molecular level, in this or other locci. The normal 
outcome for a cytogenetically visible UBCA, deletion or duplication, could be due to 
several reasons [Barber et al., 2005], like for example: 
1) Low gene content;  
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2) Absence of dosage sensitive loci: many genes are not dosage sensitive, and 
imbalances involving a limited number of genes may not include genes that are dosage 
sensitive. 
3) Functional redundancy: deletions or duplications of genes that have additional or 
related copies outside an imbalanced segment may have no detectable effect on the 
phenotype. Metabolic pathways can substitute for a pathway affected by mutation or 
functional complementation can arise from duplicate genes. It has also been suggested 
that deletions involving gene clusters may be better buffered because of the remaining 
cluster of related genes on the normal homologue. 
4) Allelic exclusion: specific alleles have allele-specific levels of expression – a high 
expressing allele could compensate for a deleted locus and a low expressing allele for a 
duplicated gene in a given individual, but unlikely that these would be coinherited over 
several generations of the same family. 
Barber reviewed 130 families with directly transmitted, cytogenetically visible 
unbalanced chromosome abnormalities (UBCAs), and noticed that in 30 families (23%), 
the affected proband had the same UBCA as other phenotypically normal family 
members. There are more female than male transmitting carriers of UBCAs, suggesting 
that unbalanced chromosome complements may have a more deleterious effect on 
male than female meiosis, as has previously been suggested for balanced translocation 
and ring chromosome carriers [Barber, 2005]. 
sSMCs derived from chromosome 11 (sSMC) are rare and, so far, it is not yet totally 
clear which regions of chromosome 11 are critical and have clinical consequences. In 
the literature there are 5 cases reported of sSMC(11) associated with an abnormal 
phenotype [Neill et al., 2010; Baldwin et al., 2008; Rauch et al., 1992; Daniel and Malafiej, 
2003; Sanz et al., 2005] and 3 cases without phenotypical consequences [Mannens et al., 
1991; Haaf et al., 1992; Bartsch et al., 2005]. In the majority of these cases the 
characterization of the genetic content of the markers is not exhaustive.  
There is a difficulty in establishing a genotype–phenotype correlation in a ring carrier. 
Rings often appear as mosaics because of sister chromatid exchange within a ring in 
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mitotic crossing-over events, which generates aneuploid cells with increased mortality 
[Carreira et al., 2007]. 
It is essential to report all cases of sSMC, associated or not with clinical findings, with a 
good molecular cytogenetic content characterization to have a robust 
genotype/phenotype correlation. This case highlights the problem of correlating 
familial sSMCs encountered in a phenotypic normal parent with the expected 
phenotypic outcome in a child with the same imbalance. This is a major problem, 
especially in prenatal diagnosis. 
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3.5. sSMC from chromosome 13 
First prenatally detected small supernumerary neocentromeric derivative 
chromosome 13 resulting in a non-mosaic partial tetrasomy 13q [*] 
[*] The work presented in this section was published in: 
Mascarenhas A, Matoso E, Tönnies H, Gerlach A, Julião MJ, Melo JB, Carreira IM (2008) Cytogenetic and Genome Research 121: 
293-7. 
 
3.5.1. Introduction 
Human centromeres are defined cytogenetically by a primary constriction of the 
chromosomes and are required for proper chromosome segregation in both meiosis 
and mitosis. They are characterized by tandemly repeated alpha satellite DNA and 
heterochromatin [Choo, 1997; Warburton, 2004]. A class of mitotically stable human 
derivative chromosomes containing fully functional centromeres, so called 
neocentromeres lacking alpha satellite DNA has been described. Despite the complete 
absence of normal centromeric alpha-satellite DNA, human neocentromeres are able 
to form a primary constriction and assemble a functional kinetochore, suggesting that 
centromere formation is not strictly dependent on primary DNA sequence [Karpen and 
Allshire, 1997; Amor and Choo, 2002]. An analysis of the distribution of neocentromeres 
suggests clustering in chromosomal hotspot regions 15q25, 3q, and 13q [Amor and 
Choo, 2002; Warburton, 2004]. Neocentromeres often result in partial tri- or tetrasomy, 
because their formation confers mitotic stability to acentric chromosome fragments 
that would normally be lost [Levy et al., 2000]. The most common class of 
neocentromeric chromosomes are supernumerary inverted duplications of the distal 
segments of a chromosome [Choo, 1997; Warburton et al., 2000]. Small supernumerary 
marker chromosomes (sSMC) are defined as structurally abnormal chromosomes that 
cannot be identified or characterized unambiguously by conventional banding 
cytogenetics alone, and are generally equal in size or smaller than a chromosome 20 of 
the same metaphase spread [Liehr et al., 2004]. 
We present a case of a sSMC without centromeric alpha satellite DNA, which is an 
inverted duplication of distal 13q31, found in a prenatal diagnosis with ultrasound 
malformations, of a 34 year-old pregnant woman. Fifteen supernumerary 
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neocentromeric marker chromosomes originating from the distal region of 
chromosome 13q have been reported, supporting the idea that this chromosome may 
have an increased propensity for neocentromere formation (For review: 
http://www.med.uni-jena.de/fish/sSMC). However, only ten of these cases are sSMC, 
according to the definition proposed by Liehr et al. (2004) (see Table3.5.I.). Prenatal 
diagnosis of tetrasomy for distal 13q, mosaic or nonmosaic, is very uncommon [Knegt 
et al., 2003]. To the best of our knowledge, this is the first case reported prenatally of a 
supernumerary neocentromeric chromosome from distal 13q. 
 
3.5.2. Results 
A 34 year old woman was referred to prenatal cytogenetic diagnosis due to foetal 
abnormalities identified on ultrasound at 23 weeks of pregnancy. There was 
oligohydramnios, a large cisterna magna, ventriculomegaly, enlarged and 
hyperechogenic kidneys and club left foot. 
13q3.1
A B
Chromosome 13
 
Figure 3.5.1. – A. GTG banded images of normal chromosomes 13 and the marker chromosome. B. CGH 
profile for chromosome 13. The gain of the chromosome region 13q31 qter is shown. 
 
Studies on both the culture amniotic fluid and foetal blood cells revealed a de novo 
small supernumerary marker chromosome, in all 50 analysed metaphases. This marker 
showed a symmetrical G-banding pattern (Fig 3.5.1.A). CBG-staining revealed no 
pericentromeric heterochromatin and Ag-NOR staining showed no NOR on the marker 
(data not shown). FISH studies, using whole chromosome painting, centromeric and 
subtelomeric probes, revealed this marker to be 13 in origin (Fig 3.5.2.A) and an 
inverted duplication of the distal portion of chromosome 13q (Fig 3.5.2.B), with no 
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detectable alpha satellite DNA (Fig 3.5.2.C-D). The neocentromeric constriction was 
apparently at band 13q31 (Fig 3.5.1.A). Comparative genomic hybridization confirmed 
the origin and the chromosomal region involved in the partial tetrasomy (Fig 3.5.1.B). 
The presence of a functional neocentromere at band 13q31 on this marker 
chromosome was confirmed by immunofluorescence with antibodies to CENP-C (Fig 
3.5.2.E).  
The karyotype of the foetus was 47,XX,+mar.ish inv dup(13) 
(qter→q31::q31→neo→qter)(wcp13+,D13Z1/D21Z1–,D13S327++), resulting in a 
tetrasomy of the distal portion of chromosome 13q. 
After genetic counselling, parents decided for pregnancy termination. After the 
induced abortion the foetal observation with post-mortem autopsy identified the 
presence of short nose and neck, hypothelorism (inner canthal distance 1 cm), short 
palpebral fissures, low set ears and thymic hypoplasia. It also confirmed the presence 
of club left foot and renal dysplasia. The central nervous system study was unable to 
confirm the presence of the large cisterna magna and ventriculomegaly. 
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A B
D
C
mar
E
mar
 
Figure 3.5.2. - FISH using different probes. The supernumerary marker chromosome is signed as mar. A) 
Whole chromosome painting 13 identifying the supernumerary marker having chromosome 13 origin. B) 
Subtelomeric 13q probe showing the inversion duplication of the derivative. C) CEP 13/21 probe 
showing the absence of a normal alphoid centromere in the derivative. D) All centromeric probe 
reinforcing the absence of any alphoid centromere in the supernumerary derivative chromosome 13. E. 
FISH with wcp13 (red) and immunofluorescence with antibodies to CENP-C (green) that marks all active 
centromeres, including the neocentromere in the derivative chromosome 13. 
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3.5.3. Discussion 
We report the first case of a prenatal diagnosis that showed a small supernumerary 
marker chromosome consisting of an inverted duplication of the distal portion of 
chromosome 13q, containing no detectable alpha satellite DNA. The neocentromeric 
constriction was located at band 13q31. The presence of a functional neocentromere 
was proved by immunofluorescence studies using antibodies against a centromere 
protein - CENP-C, that is known to be important for centromere function, namely for 
the assembly of the kinetochore and in the correct segregation of sister chromatids 
[Politi et al., 2002]. CENP-C is associated with active neocentromeres that apparently do 
not contain repetitive sequences typical of conventional centromeres [Amor et al., 
2004]. 
The high number of observed 13q neocentromeres cases may be related with the 
viability of chromosome 13 trisomies. However in other chromosomes, like 18, 21 and 
X, that are well tolerated in trisomy, neocentromerization is a rare event: there is one 
case reported for chromosome 21 [Barbi et al., 2000], one for chromosome X [Kaiser-
Rogers et al., 1995] and one reported neocentromere for chromosome 18 [Rauch et al., 
1992]. These facts suggest that 13q has a higher propensity for formation of 
neocentromeric derivatives, but the reason for it remains to be elucidated. At least 
four distinct regions in 13q have been shown to contain neocentromeres: 13q21 (five 
cases), 13q31 (three cases), 13q31/32 (one case) and 13q32 (seven cases) [For review: 
http://www.med.uni-jena.de/fish/sSMC], which could suggest that these bands are 
“hotspot” regions for neocentromere formation. A study by Alonso and coworkers has 
analysed the DNA sequence of three chromosome 13 neocentromeres at 13q32, using 
CENP-A chromatin immunoprecipitation and genomic microarray analysis. They 
showed that there is no evidence of any overlap between the three neocentromeres, 
indicating, therefore, that there is no DNA sequence defined as a neocentromere 
hotspot in this region [Alonso et al., 2003]. Interesting also is that the sequence analysis 
of the DNA isolated from several independent neocentromeres revealed no common 
sequence, with the exception of an increase AT richness, a shared characteristic with 
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alpha satellite DNA sequences of human centromeres [Lo et al., 2001; Satinover et al., 
2001; Li et al., 2002]. 
The most frequent features seen in patients with partial trisomy or tetrasomy of 
chromosome 13q are microphthalmia, ear abnormalities, hypotelorism, facial 
dysmorphisms, urogenital defects and severe learning difficulties [Schinzel, 2001]. The 
phenotype of the case in this report also showed hypotelorism, low set ears, facial 
dysmorphisms and renal dysplasia. Regarding the size of the partial tetrasomy only 
three cases are cytogenetically comparable to our case (case 2; 3 and 4 – Table 3.5.I). 
However, these cases which involve a tetrasomy of 13q31-qter, two with the 
neocentromere location like ours at 13q31 (case 3 and 4 – Table 3.5.I) and one with 
the neocentromere at 13q32 (case 2 – Table 3.5.I), are different from the present case 
not only because they were mosaic but they were also postnatally diagnosed. 
Therefore the clinical comparison with our case can only be extrapolated. There are 
some clinical features that can be correlated in all of these cases, namely the 
cranio/facial abnormalities and ear malformations. Since this is the first case reported 
prenatally, it is important to notice the relevance regarding the ultrasound 
malformations, specially the ones involving the head (large cisterna magna, 
ventriculomegalia and the hypotelorism). The severity of the foetus phenotype could 
be explained by the full tetrasomy in the two tissues studied, in contraposition to the 
mosaic status of the previous reported postnatal cases involving the same region.  
The complexity and variability of the phenotypes seen in patients with sSMC of 
chromosome 13 do not support a genotype/phenotype correlation [reviewed by Liehr et 
al., 2007]. Furthermore, the wide range of mosaicism and the chromosome imbalances 
seen in all these cases must account to some extent for the wide variability of the 
observed phenotypes. Moreover, the presence of the neocentromere could lead to 
chromatin changes, influencing gene expression over an extended chromosomal 
region [Levy et al., 2000].  
In conclusion, there are, to the best of our knowledge, only three more cases 
described with sSMC with the location of the neocentromere in band 13q31 (case 3, 4 
and 5 – Table 3.5.I), as in our case. However, this is the first one with a neocentromere 
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in 13q31 reported prenatally and that was not a mosaic. The origin and mechanisms 
involved in neocentromeric marker chromosomes are interesting subjects that deserve 
further investigation. Every sSMC should be characterized by cytogenetic and 
molecular methods, in order to define the euchromatic content and to prove the 
physical neocentromere position, providing further information for genetic counselling 
and future genotype/phenotype correlations. 
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3.6. - sSMCs from chromosome 15 
Refined molecular cytogenetic characterization of the breakpoints of small 
supernumerary marker chromosomes derived from chromosome 15 [*] 
[*] The work presented in this section is under submission: 
Melo JB, Jardim A, Matoso E, Backx L, Vermeesch JR, Kosyakova N, Liehr T, Carreira IM. Molecular breakpoints definition of six 
supernumerary marker chromosomes derived from chromosome 15 by array techniques after microdissection. Submitted to 
Journal Histochemistry and Cytochemistry. 
 
3.6.1. Introduction 
Many rearrangements may occur in the imprinted chromosome region 15q11->q14, 
which is known for its instability due to the presence of repeated DNA elements 
[Battaglia, 2008]. This region harbours six common sites that mediate chromosomal 
rearrangements. These duplicons or breakpoints (BPs) consist of large segments with 
low copy repeats referred to as BP1–BP5 located in 15q11->q13, whereas BP6 is within 
15q14 [Kleefstra et al., 2010] (Fig. 3.6.1.). The rearrangements include deletions 
associated either with Angelman syndrome (OMIM 105830) or with Prader-Willi 
syndrome (OMIM 176270), according to parental origin [Lalande, 1996], translocations, 
inversions and supernumerary marker chromosomes formed by the inverted 
duplication of proximal chromosome 15. Interstitial duplications, triplications and 
balanced reciprocal translocations are much less frequent [Battaglia, 2008].  
 
 
Figure 3.6.1. Schematic representation of chromosome 15, showing the five recurrent breakpoints (BP), 
and the ~4 Mb segment (15q11-q14) that encompasses the Prader-Willi/Angelman syndrome critical 
region (PWS/ASCR) [from Battaglia, 2008]. 
 
Supernumerary marker chromosomes (SMC) originating from chromosome 15 are the 
most common SMCs. They encompass clinically irrelevant SMC(15)s containing only 
heterochromatin and 15p material, and clinically relevant SMC(15)s that consist of 
both eu- and heterochromatic 15q material [Kleefstra et al., 2010]. The two most 
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proximal breakpoints (BP1 and BP2) are implicated in the origins of clinically 
insignificant SMCs [Huang et al., 1997]. The three distal breakpoints give rise to larger 
SMCs [Roberts et al., 2003; Makoff and Flomen, 2007]. So far, BP6 has not been reported 
to be involved in the formation of SMCs [Kleefstra et al., 2010]. The critical ~4 Mb region, 
responsible for PWS/AS and the duplication chromosome 15 syndromes, lies between 
BP2 and BP3. 
As with others SMCs, a SMC(15) can be monocentric or dicentric. The dicentric 
SMC(15)s are the most common and may have originated from recombination 
between two homologs or between the two chromatids of one chromosome 15. Such 
a dicentric SMC(15) consists of two centromeres, with one inactivated, two bisatellited 
telomeres, and two inverted copies of the proximal end of the q arm [Kleefstra et al., 
2010]. These dicentric SMC(15)s are also referred to as “pseudodicentric chromosome 
15” or “inv dup(15)” [Roberts et al., 2003]. Two cytogenetic types of inv dup (15) 
markers chromosomes have been identified, with different phenotypic consequences 
[Battaglia, 2008; Crolla et al., 1995; Huang et al., 1997; Roberts et al., 2003]: 
a) small SMC(15)s, which are metacentric or submetacentric chromosomes without 
euchromatic material, not containing the Prader-Willi/Angelman syndrome critical 
region (PWS/ASCR), and that can be familial or de novo. Most children with this 
aberration show a normal phenotype, although exceptions have been reported 
[Hou and Wang, 1998]. They have been associated with male infertility [Eggermann et 
al., 2002; Morel et al., 2004]; 
b) large SMC(15)s, with the PWS/ASCR, between BP2 and BP3, being associated 
with an abnormal phenotype - the idic(15) syndrome [Battaglia, 2008]. On the basis 
of size, these clinically relevant SMC(15)s can be subdivided into type A,‘‘large’’ 
asymmetric and type B, ‘‘small’’ symmetric SMC(15)s. Type B SMC(15)s contain the 
triplicated 15pter to BP3 (located at 26.5 Mb) region, while type A SMC(15)s 
consist of 15pter->BP4(28.5Mb)::BP5(30.5Mb)->15pter [Kleefstra et al., 2010]. 
 
The inv dup(15) or idic(15) (inverted duplication of proximal chromosome 15 or 
isodicentric 15 chromosome) syndrome is characterized by a distinct neurobehavioral 
phenotype including moderate to profound developmental delay/intellectual 
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disability, absent or very poor speech, hypotonia, epilepsy, and an autism spectrum 
disorder [Robinson et al., 1993; Crolla et al., 1995; Battaglia, 2008; Battaglia et al., 2010]. The 
combination of severe epilepsy and the particular behaviour disorder renders a more 
distinctive clinical picture that distinguishes idic(15) syndrome from other conditions 
involving severe neurodevelopmental disability [Battaglia et al., 2010]. Incidence at birth 
is estimated to be 1/30 000 with a sex ratio of almost 1 [Schinzel and Niedrist, 2001; 
Battaglia et al., 2010].  
Genotype/phenotype studies have not been able, to date, to show any correlation 
between type and size of the idic(15), and the degree of severity of the clinical 
spectrum. We describe 6 new cases with SMC(15)s that were characterized by 
molecular cytogenetics and array CGH techniques, for the evaluation of the exact 
genetic content.  
 
3.6.2. Results 
We report 6 new cases of patients with a SMC(15) (cases I, II, III, IV, V and VI) (Table 
3.6.I.). 
 
I II
IV V VI
III
15 sSMC 15 sSMC 15 sSMC
15 sSMC 15 sSMC 15 sSMC
 
Figure 3.6.2. GTG banding of normal chromosomes 15 and the marker chromosome in 6 cases (I to VI). 
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Case I  
The sSMC(15) was ascertained prenatally in a case referred for advanced maternal age 
and confirmed in lymphocytes after birth. A normal child was born (Table 3.9.I). After G-
Banding, the karyotype was mos 47,XX,+mar[27]/46,XX[3] (Fig. 3.6.2.). Karyotypes of 
both parents were normal. Centromeric FISH identified the origin of the marker as 
being derived from chromosome 15. SubcenM-FISH and Multicolour Banding (MCB) 
analysis revealed the sSMC as an inv dup(15)(q11.2). 
The microdissected DNA of the sSMC was hybridized in a full tiling BAC array specific 
for chromosome 15, with a resolution of 100-150 Kb (VIB MicroArrays Facility - 
www.microarrays.be), having material of approximately 2.49 Mb size extension from 
15q (between 18.47 Mb to 20.96 Mb). This region encompasses only one gene (BCL8) 
described in OMIM morbid map, which is associated with large - cell Lymphoma 
[Dyominet al., 1997]. 
Uniparental Disomy (UPD) for chromosome 15 was excluded, with the following 
markers being informative: D15S652, D15S816, and D15S642. 
 
Case II  
During the first years of life the patient presented hipotony, psychomotor 
development delay and strabismus. At 7 years old started having mioclonic crisis. The 
child was clinically reassessed at 14 years old, presenting severe psychomotor delay; 
daily convulsions; and frequent respiratory infections (Table 3.6.I). He is the second 
child of nonconsanguineos parents with no familiar history, being the older child 
normal.  
G-banding revealed the presence of a supernumerary marker chromosome in all the 
analyzed cells, the karyotype of the boy being 47,XY,+mar (Fig. 3.6.2.). Karyotypes of 
both parents were normal. After MCB and subcenM-FISH analysis the sSMC 
characterization revealed an inv dup(15)(q13~14) (Fig. 3.6.3.) (Table 3.6.I.). 
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15 sSMC
 
Figure 3.6.3. -  Multicolour Banding (MCB) specific for chromosome 15, in the two normal chromosomes 
and in the sSMC of case II, revealing an  inv dup(15)(q13~14). 
 
The microdissected DNA of the sSMC was hybridized in a full tiling BAC array specific 
for chromosome 15, with the same resolution, having material of approximately 8.35 
Mb size extension from 15q (between 18.47 Mb to 26.82 Mb). This region 
encompasses six genes described in OMIM morbid map [OMIM], like UBE3A and 
GABRB3, located in PW/ASCR [Kleefstra et al., 2010]. 
 
Case III  
The patient was clinically assessed at 8 years old presenting severe psychomotor 
development delay; speech problems, no control of the sphincters, growth delay, 
autism and hyper-reactivity, and frontal lobe epilepsy (Table 3.6.I). 
G-banding revealed the presence of a supernumerary marker chromosome in all the 
analyzed cells, the karyotype being 47,XY,+mar (Fig. 3.6.2.). The characterization of the 
sSMC by subcenM-FISH and MCB, revealed an inv dup(15)(q11.2). However, array CGH 
analysis identified the marker with material of approximately 8.35 Mb size extension 
from 15q (between 18.47 Mb to 26.82 Mb), larger than expected with MCB results and 
with the same genetic content as case II (Table 3.6.I.). 
Uniparental Disomy (UPD) for chromosome 15 was excluded, with the following 
markers being informative: D15S659, D15S818, D15S655, D15S652, D15S816, 
D15S642, and D15S153. 
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Case IV 
A female patient was clinically re-evaluated at 18 years old having psychomotor 
development delay; speech problems; behaviour alterations; aggressiveness; and 
agitation (Table 3.6.I.). The age of the mother at birth was 39 years old. 
The karyotype revealed a de novo marker chromosome in mosaic (mos 
47,XX,+mar[16]/46,XX[8]) (Fig. 3.6.2.). MCB and subcenM-FISH characterization defined 
the marker derived from chromosome 15, as an inv dup(15)(q13~14), with duplicated 
PW/ASCR. Array CGH analysis of the microdissected DNA of the marker revealed a 
marker with 10.47 Mb size extension, between 18.47 Mb and 28.94 Mb (Table 3.6.I.). 
This region encompasses more two genes described in OMIM morbid map [OMIM] 
comparing with cases II and III: OCA2 and HERC2, associated with skin/hair/eye 
pigmentation [Sturm, 2009]. 
Uniparental Disomy (UPD) for chromosome 15 was excluded, with the following 
markers being informative: D15S1507, D15S653, D15S642, and D15S153. 
 
Case V  
A female child with hypotonia; mental retardation; autism; and speech problems was 
assessed at 5 years old. The karyotype revealed a sSMC in all cells (47,XX,+mar), 
maternally derived. The origin of the marker was identified by centromeric FISH. The 
PW/AS critical region was identified by locus-specific FISH probes, the marker being an 
inv dup (with duplicated PW/AS critical region) (Fig. 3.6.4.).  
mara) b)
15
15
c)
mar
15
 
Figure 3.6.4. a) Centromeric FISH for chromosome 15 showing the origin of the sSMC in case 
V.; b) Locus-specific probes for chromosome 15 - SNRPN in red (PW/AS critical region) and 
D15Z1 in green; c) Locus-specific probes for chromosome 15 –D15S10 in red (PW/AS critical 
region) and D15Z1 in green. 
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Table 3.6.I. – Description of the sSMC(15)s cases characterized by molecular cytogenetics and 
array CGH, after microdissection of the marker. 
C Origin Pre 
or 
Pos 
UPD Karyotype/ 
sSMC characterization M-
FISH 
Array result OMIM* Clinical presentation 
I de 
novo 
PRE 
+ 
POS 
No 
UPD 
47,XX,+mar[27]/46,XX[3] 
 
sSMC characterization: 
ish. inv dup(15)(q11.2) 
 
sSMC size: 2.49 Mb 
18.47 20.96 Mb 
15q11.2 15q11.2 
 
1 
Normal child was born 
II de 
novo 
POS n.a. 47,XY,+mar 
 
sSMC characterization: 
ish. inv dup(15)(q13~14) 
 
sSMC size: 8.35 Mb 
18.47  26.82 Mb 
15q11.2 15q13.1 
 
6 
14 years: Severe 
psychomotor delay; 
Convulsions – daily; 
Frequent respiratory 
infections 
 
III 
 
de 
novo 
POS No 
UPD 
47,XY,+mar 
 
sSMC characterization: 
ish. inv dup(15)(q11.2) 
 
sSMC size: 8.35 Mb 
18.47  26.82 Mb 
15q11.2 15q13.1 
 
6 
8 years: Severe 
psychomotor development 
delay; speech problems, 
no control of sphincters 
Growth delay 
Autism and hyper-
reactivity 
Frontal lobe epilepsy 
IV de 
novo 
POS No 
UPD 
47,XX,+mar[16]/46,XX[8] 
 
sSMC characterization: 
ish. inv dup(15)(q13~14) 
 
sSMC size: 10.47 Mb 
18.47 28.94 Mb 
15q11.2 15q13.2 
 
8 
18 years: Psychomotor 
development delay; 
speech problems; 
behaviour alterations; 
aggressiveness; agitation 
V mat POS n.a. 47,XX,+mar 
 
sSMC characterization: 
ish.inv dup(15)(q13~14) 
sSMC size: 12.38 Mb 
18.47 30.85Mb 
15q11.2 15q13.3 
 
8 
5 years: Mental 
retardation; Autism; 
Hypotonia; Speech 
problems  
 
VI de 
novo 
POS n.a. 47,XX,+mar 
 
sSMC characterization: 
ish.inv dup(15)(q13~14) 
sSMC size: 12.38 Mb 
18.47 30.85Mb 
15q11.2 15q13.3 
 
8 
27 years: Low IQ; Learning 
disabilities  
(mother of V) 
Mat – maternal; Pre – prenatal; Pos – postnatal; M-FISH – Multicolor Fluorescence in situ hybridization; Mb – Megabases; n.a. – 
not available; UPD – uniparental disomy; *-number of genes in OMIM morbid map; C- case. 
 
SubcenM-FISH and MCB results identified the breakpoints of the inv dup, as inv 
dup(15)(q13~14) (Fig. 3.6.5.). Array CGH analysis, after microdissection of the marker, 
revealed a sSMC with 12.38 Mb extension, between 18.47Mb and 30.85Mb (Table 
3.6.I.). This region encompasses the same number of genes (8) described in OMIM 
morbid map [OMIM] comparing with case IV. 
 
Case VI 
Patient VI is the mother of case V. She has the same sSMC(15) as the daughter, as 
characterized by MCB and SubcenM-FISH. At 27 years old she presents low IQ and 
learning disabilities (Table 3.9.I). 
 
  
 
152 
 
 
Figure 3.6.5. SubcenM-FISH specific for chromosome 15 in case V, with the two normal chromosomes 
15 and the sSMC. The sSMC(15) is dicentric (centromere in green) with breakpoints between q13~q14. 
 
3.6.3. Discussion 
A wide range of structural rearrangements may occur in the 15q11->q13 region, 
including supernumerary marker chromosomes. In the present study, we characterized 
the molecular content of SMC(15), present in 6 different patients, correlating clinical 
features with SMC(15) sizes. One case is a small SMC(15)s, without PWS/ASCR (case I), 
and without clinical features and/or development delay. The other 5 cases are large 
SMC(15)s with PWS/ASCR (cases II, III, IV, V, and VI), all having clinical features 
associated. Of these large SMC(15)s described, two cases are from group B, having 
symmetrical pattern corresponding to BP3 (BP3:BP3) (case II and Case III). The other 3 
cases have large SMC(15)s from group A, showing an asymmetrical pattern with distal 
margins at the known breakpoint BP4 (Fig. 3.6.6). As described in previous studies, all 
large SMC(15)s in this study had distal margins at the known breakpoints: at BP3 
(BP3:BP3), or at BP4 and BP5 (BP4:BP5) [Wandstrat et al., 1998; Roberts et al., 2003; Wang 
et al., 2004; Sahoo et al., 2005; Makoff and Flomen, 2007, Kleefstra et al., 2010]. 
Large SMC(15)s have been associated with increased mean maternal age at 
conception, similar to other trisomies [Crolla et al., 1995; Dennis et al., 2006; Roberts et al., 
2003; Valente et al., 2006; Battaglia et al., 2010, Kleefstra et al., 2010]. Indeed, 
nondisjunction is likely to play a role in the formation of all SMC(15)s. The fact that the 
majority of SMC(15) are nonmosaics suggests a meiotic origin of these markers and 
this is supported by the observations that all de novo SMC(15)s characterized 
molecularly have been shown to be maternal in origin [Crolla et al., 2005]. No paternally 
derived large SMC(15)s have been reported. The reasons for this remain unresolved. 
During spermatogenesis, cells carrying a SMC can be selected against [Cotter et al., 
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2000; Eggermann et al., 2002]. Alternatively, large SMC(15)s could be lethal if paternally 
inherited, although paternally inherited interstitial triplications have been described 
[Ungaro et al., 2001] that have the same PWACR copy number as those in patients with 
large SMC(15). 
 
I
II
III
IV
V
VI
BP3
BP4
BP5
BP2
2.49 Mb
8.35 Mb
8.35 Mb
10.47 Mb
12.38 Mb
12.38 Mb
 
Figure 3.6.6. – Schematic representation of the 15q region involved in all the SMC(15)s described in this 
study. The extension of each marker is described.  
 
The presence of a large SMC(15)s in all cells, with the PWS/ASCR, has been associated 
with phenotypic effects [Battaglia, 2008]. Previous reports on SMC(15) have shown that 
on average 80%-85% of SMC(15)s are present as nonmosaics [Leana-Cox et al., 1994; 
Mignon et al., 1996; Roberts et al., 2003; Crolla et al., 2005]. Mosaicism with a normal cell 
line has been described in a small subset of individuals [Roberts et al., 2003; Crolla et al., 
2005; Loitzsch and Bartsch, 2006; Saitoh et al., 2007; Guanciali-Franchi et al., 2008]. In case IV 
of this study, the large SMC(15) is present in 66% of the analyzed cells (Table 3.6.I). It 
has been seen that the features of patients with mosaic large SMC(15) are in the 
phenotypic spectrum of large SMC(15)s, depending on the percentage and type of cell 
line which contain the SMC(15) [Dennis et al., 2006; Kleefstra et al., 2010]. To date, 
mosaicism for large SMC(15) (with PW/ASCR) with no phenotypic effects has been 
observed in very few cases [Roberts et al., 2003; Loitzsch and Bartsch, 2006; Guanciali-
Franchi et al., 2008]. 
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Numerous copies of region-specific repeats that lie within proximal 15q facilitate 
mispairing and unequal meiotic exchanges, which promote a relatively high frequency 
of rearrangements within this region. Gene expression in this critical region is 
regulated by an imprinting mechanism [Dittrich et al., 1996]. Only maternally inherited 
aberrations of chromosome 15q11-13 seem to be pathogenic, with the exception of 
one report [Mohandas et al., 1999]. Maternal genes, contained in this genomic region, 
could act in a dosage dependent manner their copy number being critical for normal 
brain development and function [Battaglia, 2008]. Indeed, several cases of partial 
hexasomy for chromosome 15q have been reported, that arose because of the 
presence of either two idic(15) chromosomes or a very large idic(15) chromosome, 
that have a clinical presentation more severe than typical cases of idic(15) [Huang and 
Bartley, 2003; Maggouta et al., 2003; Nietzel et al., 2003; Qumsiyeh et al., 2003; Mann et al., 
2004]. It seems that whereas the size of the duplication chromosome does not seem to 
be directly related to the phenotype of patients with idic(15), the severity of the 
presentation of these hexasomic patients indicates that increasing dosage of the 
region has a negative effect on outcome [Mann et al., 2004]. 
In our cohort, patients with large SMC(15)s presented common features of idic(15) 
syndrome, like mental retardation or psychomotor development delay, epilepsy, or 
autistic-like behaviour, that is associated with high prevalence of behavioural 
problems. As pinpointed by Kleefstra and co-workers, these features could be 
explained by a dosage effect of various genes located in the 15q11.2->q13 region like: 
GABRB5, GABRB3, APBA2, CHRFAM7A, and SGNE1 that encode proteins present in 
nervous tissue; and NIPA1, CHRNA7, and UBE3A that show a possible association with 
neurologic and neuropsychiatric disorders [Kleefstra et al., 2010]. We did not identify 
significant differences in phenotype between patients with type A and type B large 
SMC(15)s. This observation is in concordance with other studies that reported 
phenotypic data of types A and B SMC(15) separately [Dennis et al., 2006; Kleefstra et al., 
2010]. As expected, the patient with a small SMC(15), without PW/ASCR, presents a 
normal phenotype.  
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In one patient (case III) multicolour FISH analysis (with MCB and SubcenM-FISH) 
showed a different size of the SMC(15) compared to the assessment by array CGH 
analysis. Additionally, routine cytogenetic analysis was not an accurate method to 
determine the size of the SMC(15). A full characterization of SMC(15) by array CGH 
techniques is essential to establish with more precision breakpoints position and size 
of duplicated segments. Array CGH analysis, after microdissection of the marker, 
showed to be a powerful approach to detect the duplication and its extent. 
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3.7. sSMCs from chromosome 16 
Molecular cytogenetic characterization of two cases with de novo small mosaic 
supernumerary marker chromosomes derived from chromosome 16: Towards a 
genotype/phenotype correlation [*] 
[*] The work presented in this section was published in: 
Melo JB, Matoso E, Polityko A, Saraiva J, Backx L, Vermeesch JR, Kosyakova N, Ewers E, Liehr T, Carreira IM (2009) Cytogenetic and 
Genome Research 125:109-14. 
 
3.7.1. Introduction 
The chromosome 16 long arm (16q) is characterized by the presence of a block of 
heterochromatin in the pericentromeric region (16q11.1→q11.2). Cases with an sSMC 
consisting of only these centromeric and heterochromatin regions do not show clinical 
manifestations [Callen et al., 1990, 1991; Crolla, 1998; Paoloni-Giacobino et al., 1998; Sanz et 
al., 2000]. However, trisomy involving band 16q12 is usually associated with a clinical 
impact [Barber et al., 2006]. 
We present two cases with an sSMC derived from chromosome 16. These cases were 
characterized by molecular cytogenetics, namely with centromere specific FISH probes 
and subcenM-FISH. Case A was also characterized by reverse FISH and array painting, 
using a full-tiling BAC array specific for chromosome 16 (with resolution of 100--150 
kb). The characterization of these sSMC demonstrated the involvement of 16q12 
euchromatin in both markers. 
 
3.7.2. Results 
Case A: 
A prenatal diagnosis due to advanced maternal age with no ultrasound anomalies was 
performed in the 16th week of gestation. Autopsy was done at 23 weeks, revealing a 
female fetus in the 50th percentile with signals of maceration and signals of acute 
anoxia. The fetus had an extra suprarenal gland near the left ovary and only slight 
facial dysmorphisms, namely discrete hypertelorism, large philtrum and asymmetrical 
implantation of the ears.  
GTG-banded amniocytes were studied revealing a female karyotype with an sSMC in 
24% of the analyzed metaphases. The marker chromosome was very small and 
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appeared to have a ring shape (Fig. 3.7.1.A). Karyotypes of both parents, performed in 
cultured lymphocytes, were normal (data not shown). The de novo sSMC was positive 
with C-banding, suggesting that the marker chromosome contained heterochromatin 
(Fig. 3.7.1.B). 
Centromere FISH, using probe D16Z1 revealed that the sSMC was derived from 
chromosome 16 (data not shown). All-telomere probe was negative in the sSMC (Fig. 
3.7.2.A). Reverse FISH confirmed the origin of the marker and suggested the 
involvement of the euchromatic region of 16q12 in the sSMC (fig. 2B). SubcenM-FISH 
specific for chromosome 16 confirmed the ring-shape of the marker and demonstrated 
that the sSMC possessed euchromatic material from 16q, the karyotype being mos 
47,XX,+r(16)(::p11.1→q12.1~q12.2::)*25%+/46,XX*75%+ (Fig. 3.7.2.C). With array-CGH 
the breakpoints of the marker were redefined to 16p11.2 and 16q12.1. Thus, the sSMC 
led to a partial trisomy of 33.43 Mb to 47.02 Mb on chromosome 16 (Fig. 3.7.3.). 
 
 
Figure 3.7.1. - A. GTG banded images of both normal chromosomes 16 and of the marker chromosome 
of case A. B. CBG banded images showing the marker chromosome of case A. The supernumerary 
marker chromosome is designated as mar. 
 
Case B:  
A cytogenetic study of a boy presenting congenital malformations, born at term, with 
birth weight 3200 g and length 50 cm, was done. At 13 years of age the weight was 47 
kg, length 160.5 cm and head circumference 54 cm. He presented low-set dysplastic 
ears, hypoplastic testes and cryptorchidism. No further clinical details were available. 
GTG-banding in metaphase spreads from lymphocytes revealed a male karyotype with 
a ring shape sSMC in 50% of the analyzed cells. Karyotypes of both parents were 
normal (data not shown). Centromere FISH revealed that the sSMC derived from 
chromosome 16 and subcenM-FISH specific for chromosome 16 demonstrated a 
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karyotype mos 47,XY,+r(16)(::p11.1→q12::)*7+/46,XY*7+ (results not shown due to 
similarity of the figures).  
 
Figure 3.7.2. – FISH using different probes in cases A (subfigures A-C). The supernumerary marker 
chromosome is signed as mar(16). A. Image of a hybridization of an all telomeric probe, showing an 
absence of signs in the small supernumerary marker in case A. B. Reverse FISH image confirming the 
origin of the sSMC and the extent of the chromosome 16 involved in the marker of case A. The sSMC 
was microdissected and the DNA was amplified, labeled and hybridized in a patient metaphase. C. FISH 
image applying the subcentromeric probes for chromosome 16, revealing in case A that the centromere-
near region in p-arm (RP11-360L15; in red) is absent in the marker, the centromere-near region in q-arm 
(RP11-474-B12; in purple) is present in the marker, being the sSMC mainly derived from q-arm (in blue). 
For space reasons only one of the two normal chromosomes 16 is shown.  
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Fig. 3.7.3. – A. Array painting result of the marker chromosome in case A. A. The plot shows a gain for 
region 16p11.2 to 16q12.1 with breakpoints mapping at BAC clones RP11-258P17 and RP11-520B19. B. 
Ideogram of chromosome 16 showing the region involved in the sSMC, corresponding to the flanking 
BAC clones identified in 3A. C. Diagram from Ensembl (www.ensembl.org) showing the genes present in 
the region between 16q11.2 and 16q12.1, which is the euchromatic content of the sSMC from case A. 
 
3.7.3. Discussion 
If a structural chromosome rearrangement is diagnosed in a pregnancy it is crucial to 
determine the implications of this particular abnormality in order to counsel the 
parents in their decision for a suitable course of action [Gardner and Sutherland, 2004]. If 
neither a family history nor ultrasound fetal abnormalities exist and a chromosome 
aberration is detected, the prognosis for the fetus is largely deduced from the results 
of the cytogenetic analysis. Depending on the type of aberration, the risk for 
abnormalities and/or mental retardation ranges from almost nil in case of 
amplification of heterochromatic material to a high risk in the presence of genetically 
active euchromatin [Trimborn et al., 2006]. Indeed, heterochromatic C-band negative 
variants of 16q11.2 involving α-satellite DNA have been described in the literature 
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[Jalal et al., 1993]. The carriers show neither phenotypic abnormalities nor mental 
retardation. There are several reports describing the presence of an sSMC from 
chromosome 16 associated with no clinical manifestations [Callen et al., 1990, 1991; 
Crolla, 1998; Paoloni-Giacobino et al., 1998; Sanz et al., 2000; Hengstschlager et al., 2001; 
Bartsch et al., 2005, Pater et al., 2006, Karaman et al., 2006, Rodríguez et al., 2008]. In only a 
few of these cases the markers have been characterized extensively, however their 
content seems to be limited to the centromeric and heterochromatin regions. Trisomy 
involving band 16q12 is usually associated with clinical impact [reviewed by Barber et al., 
2006]. It seems that individuals with duplications of this proximal 16q do not have 
characteristic facies but frequently have short stature, developmental and speech 
delay, learning difficulties and behavioral problems which range from mild to severe 
[Barber et al., 2006]. However, a recent report showed that not all euchromatic 
trisomies of 16q12 have a clinical repercussion [Rodríguez et al., 2008]. Indeed, the 
authors showed the presence of a partial trisomy of the long arm of chromosome 16, 
involving the heterochromatin block and the proximal euchromatin region at 16q12 in 
a healthy patient. This discrepancy could be attributed to the fact that the sSMC 
reported in this case was present in a mosaic form (~65% of the analyzed cells). 
To the best of our knowledge there are 6 reported cases of sSMC derived from 
chromosome 16 with clinical findings as described in table 1 [Krauss et al., 1987; Liehr et 
al., 2006; Crolla et al., 1998; Aviv et al., 2005; Avela et al., 2007; Baldwin et al., 2008]. In only 3 
of these cases (case 1, 2 and 6) the sSMC is characterized sufficiently. Case 1 is a 
postnatal case with a minute shaped centric marker with material from 16p11.1 to 
16q11.2. Case 2 is a ring 16 with p10 to q13 material but associated with a deletion in 
chromosome 1. Case 6 is a postnatal case with an sSMC consisting of 16p11.2 to 
16q11.2 characterized by array-CGH, but with a diagnosis of Beckwith-Wiedemann 
syndrome, associated with alterations in the methylation pattern of the 11p15 region. 
Therefore, it is difficult to assess genotype/phenotype correlations in carriers of sSMCs 
derived from chromosome 16. However, taking into account these reports and the two 
cases reported here, the presence of the proximal euchromatic region of 16q12 
(between 45.5 and 47.02 Mb) in the sSMC seems to result in broad clinical 
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consequences (Table 3.6.I), although more cases of affected and unaffected individuals 
with sSMC from chromosome 16 should be reported in order to confirm this 
observation. In both cases reported here and in the sSMC described by Krauss and 
colleagues [Krauss et al., 1987] the patients have broad facial dysmorphism, and in 
common alterations related to ear implantation (Table 3.7.I). 
Some protein-coding genes have been located in band 16q12, the region present in the 
sSMC of case A reported here (Fig 3.7.3.C). These include the E3 ubiquitin protein ligase 
gene (SIAH1), the peroxisomal Lon protease homologue 2 gene (LONP2), two 
multidrug resistance-associated proteins genes (ABCC11 and ABCC12), the beta 
subunit gene of phosphorylase kinase gene (PHKB) which is an enzyme that activates 
glycogen phosphorylases in muscle, liver, and other tissues, the gene for a precursor a 
T-cell immunomodulatory protein (ITFG1), the gene for a brain specific 
transmembrane protein (NETO2), the gene for a protein important for cell cycle 
progression restoration (DNAJA2), the alanine aminotransferase-2 gene (GPT2), a gene 
of the family of myosin light chain kinases (MYLK3), a gene from ORC family (ORC6L), a 
gene related with vacuolar protein sorting-associated proteins (VPS35) and a gene of 
the family of SHC-SH2 domain binding proteins (SHCBP1) (www.ensembl.org). 
In conclusion, molecular cytogenetic techniques, namely subcen-FISH and especially 
array CGH-based techniques, allow a more accurate characterization of the 
heterochromatic/euchromatic content of an sSMC, which is important for the 
establishment of genotype-phenotype correlation and for the improvement of 
prenatal counseling and patient follow-up.  
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Table 3.7.I - Description of previously reported cases with a sSMC derived from chromosome 
16 with clinical findings and the two cases reported here. 
Case age 
de novo/ 
inherited 
Karyotype clinical symptoms Ref. 
1 2 years de novo 47,XY,+min(16)(:p11.1→q11.1 or 
q11.1→p11.1::p11.1→q11.2:) [6%] 
normal at birth, edema at hands at 
9m; little asymmetry of skull, no 
dysmorphic signs, slight penis 
anomaly 
Liehr et al., 
2006  
case 16-1 
2 23 
years 
n.a. 47,XX,del(16)(p10q13), 
+r(16)(::p10→q13::)*100%+ 
mild general hypotonia, Head 
circumference 51cm = very small; 
bow shaped mouth, abnormal 
posterior rotated ears; detected 
due to a malformed child without 
the mar but with the del(16) 
chromosome 
Krauss et al., 
1987 
3 30 
years 
de novo 47,XY,+mar(16).ish(DZ16Z2+; D16Z3+, 
wcp16-) [100%] 
mild mental handicap; psychosis; 
schizophrenia, normal appearance 
without abnormalities 
Crolla et al., 
1998 case 21 
4 Pre 
natal 
de novo 47,XX,+mar(16) [88%] amniocentesis due to posterior 
fossa cyst with extension of the 
region of cerebellar vermis with 
splaying of cerebellar hemispheres 
suggesting Dandy-Walker complex 
in week 20 of gestation; 
termination of pregnancy in week 
23; no autopsy, external 
examination showed normal 
female phenotype. 
Aviv et al., 
2005 
5 Pos 
natal 
de novo 47,XY,+mar(16).ish(DZ16Z2+; D16Z3+, 
wcp16-) [50%]  
Patient born at term after normal 
pregnancy and delivery: 3150g, 
51cm, Head circumference 35.5cm. 
facial dysmorphic; epicanthic folds, 
thin, distinct eyebrows, simian 
crease in both hands, short neck, 
ventricular septal defect and open 
foramen ovale, delayed 
development; up to 3y of age 
patient progressed at -2SD, weight 
+5% and Head circumference at -
2.5 SD curve. 
Avela et al., 
2007 
6 Pos 
natal 
de novo 47,XX,+mar(16)(:p11.2→q11.2:) [85%] 
 
size p 0.7MB (array CGH) 
macroglossia, dysmorphic features, 
height, weight and OFC ~90 
centile; mild gross motor delay, 
asymmetric lower extremities; 
clinical features suggestive of 
Beckwith-Wiedemann syndrome 
(BWS)- testing for LIT1 methylation 
confirmed a diagnosis of BWS. 
Baldwin et 
al., 2008 
7 Pre 
natal 
de novo 47,XX,+r(16)(::p11.2 q12.1::) [24%] TOP, extra supra-renal, slight facial 
alterations, like discrete 
hypertelorism, large philtrum and 
asymmetrical implantation of the 
ears 
Case A 
8 13 
years 
de novo 47,XY,+r(16)(::p11.1→q12::) [50%] congenital malformations, born at 
term, low-set dysplastic ears, 
hypoplastic testes, cryptorchidism 
Case B 
Adapted from http://www.med.uni-jena.de/fish/sSMC/00START.htm 
n.a. – not available; SD – standard deviation; TOP = termination of pregnancy 
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3.8. - sSMC from chromosome 17 
Prenatal diagnosis of a small supernumerary marker chromosome 17 with a normal 
phenotypic outcome [*] 
[*]The work presented in this section is under submission: 
Melo JB, Jardim A, Saraiva J, Backx L Vermeesch JR, von Eggeling F, Kosyakova N, Liehr T, Carreira IM. Prenatal diagnosis of a small 
supernumerary marker chromosome 17 with a normal phenotypic outcome. Submitted to Cytogenetic and Genome Research. 
 
3.8.1. Introduction 
Small supernumerary marker chromosomes (sSMCs) are structurally abnormal 
chromosomes that cannot be identified or characterized unambiguously by classic 
cytogenetics analysis alone, and are (in general) equal in size or smaller than a 
chromosome 20 of the same metaphase spread [Liehr et al., 2004]. Phenotypes 
associated with a sSMC are variable, from normal to severely affected. It has been 
shown that, depending on the chromosomal region of a sSMC, differences can be 
observed and expected in the clinical outcome. Also other factors like uniparental 
disomy, mosaicism and mode of inheritance have to be considered. When detected 
prenatally, de novo sSMCs constitute a major problem for cytogenetic investigation 
and genetic counselling, due to time availability and, essentially, due to the difficulty, 
in the majority of cases, in establishing a robust genotype/phenotype correlation.  
The finding of unbalanced chromosomal abnormalities (UBCAs) was reviewed and 
summarized from a total of 200 families [Barber, 2005; 
http://www.ngrl.org.uk/Wessex/collection/ubca_chart.htm]. UBCAs involve the addition 
(duplication) or removal (deletion) of one of the two copies of each chromosomal 
segment present in normal diploid individuals. UBCAs usually involve several 
megabases of DNA, and carriers are usually ascertained either through an abnormal 
phenotype or because of adverse reproductive effects. UBCAs have also been reported 
in families for “incidental” reasons such as prenatal diagnosis because of maternal age 
[Barber, 2005].  
UBCAs without phenotypic effect are frequently not well characterized and so they 
could be more common than is apparent from the literature. We report a possible new 
chromosomal region involved in a cytogenetic UBCA, in a case of a sSMC detected 
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through prenatal diagnosis. The sSMC was characterized by molecular cytogenetics, 
namely with subcenM-FISH, and by array painting, using a full-tiling BAC array specific 
for chromosome17. 
 
3.8.2. Results 
Case report 
A pregnant woman was referred for amniocentesis, at 20 weeks gestation, due to 
advance maternal age. The pregnancy was normal with no relevant familiar history. 
High resolution ultrasound did not show any abnormality in the female foetus.  
She was born at 38 weeks gestation by normal delivery, with a birth weight of 2,900 kg 
and an Apgar score of 9/10/10. The clinical evaluation at birth was normal. She was 
clinically reassessed at 2 years of age, being a healthy child, with normal growth and 
development, and with no malformations nor dysmorphisms. 
 
Cytogenetics and Molecular Cytogenetics 
Routine cytogenetics with GTG-banding documented the presence of a centric minute-
shaped sSMC (47,XX,+mar) in 83 % of the analysed metaphases. Whole chromosome 
painting (WCP) identified the origin of the marker as being from chromosome 17. The 
parents had normal karyotypes. The sSMC was later characterized comprehensively for 
their genetic content by molecular cytogenetics using subcentromere-specific 
multicolor fluorescence in situ hybridization (subcenM-FISH) [Starke et al., 2003], and by 
array Comparative Genomic Hybridization (Array CGH) after microdissection and 
amplification of the sSMC by degenerated oligonucleotide polymerase chain reaction 
[Melo et al., 2009]. SubcenM-FISH results confirmed the origin of the sSMC as being a 
der(17)(::p11.2->q11.1::) (Fig.3.8.A). The microdissected DNA of the marker was 
hybridized in a full tiling BAC array specific for chromosome 17, with a resolution of 
100-150 Kb (VIB MicroArrays Facility - www.microarrays.be), having material of 
approximately 3.27 Mb size extension from 17p (between 19.32~19.74 Mb to 
22.15~22.59 Mb) (Fig. 3.8.B and C).  
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Uniparental Disomy analysis 
Uniparental Disomy (UPD) was excluded in this patient for chromosome 17, with the 
following markers being informative: D17S130; D17S520; D17S1293; D17S1795; 
D17S1290; D17S1301. 
 
 
Figure 3.8. –A. SubcenM-FISH for chromosome 17, revealing that the centromere-near region in q-arm 
(RP11-229K15, in purple) is absent and the centromere-near region in p-arm (RP11-746M1, in red) is 
present in the marker, being the sSMC derived from p-arm (in blue). The centromeric probe – CEP17 is 
identified in green and partial chromosome painting of 17q in yellow (for space reasons only one of the 
two normal chromosomes 17 is shown). B. Array CGH result after microdissection and amplification of 
the sSMC(17). The plot shows a gain for region 17p11.2 to 17q11.1, between 19.32~19.74 Mb to 
22.15~22.59 Mb with the flanking BAC clones present in the sSMC, RP11-79O4 (17p11.2) and RP11-
423O14 (17q11.1). C. Ideogram of chromosome 17 showing the region (red square) involved in the 
sSMC, corresponding to the flanking BAC clones identified in 1.B. 
 
3.6.3. Discussion 
In the literature there are 15 cases reported of sSMC derived from chromosome 17, 3 
of them being associated with a normal phenotype [Friedman et al., 1992; Starke et al. 
2003 – case 25; Bartsch et al., 2005 – case 30] (Table 3.8.I) and the others associated with 
affected phenotypes [Shabtai et al., 1979; Brondum-Nielsen and Mikkelsen, 1995 – case 11; 
Morrison et al., 1997; Kozma et al., 1998; Kulharya et al., 1998; Stankiewicz et al., 2001; 
Dupont et al., 2003; Shaw et al., 2004 – patient 1934 and patient 2170; Yatsenko et al., 2005; 
Baldwin et al. 2008 – case 17; Lee et al., 2009; Manolakos et al., 2010]. 
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Table 3.8.I – Cases described in the literature with a sSMC derived from chromosome 17 and 
without clinical findings 
Case sSMC shape and content %Mosaicism* sSMC Characterization 
Bartsch et al., 2005  
(case 3) 
r(17)(::p1?1→q1?1::) 68% FISH: centromeric probes, wcp 17 
Friedman et al., 1992 min(17)(:p11.2→q10:)  89% n.a. 
Starke et al. 2003  
(case 25) 
min(17)(:p11.2→q11.1:)  66% SubcenM-FISH 
Present case min(17)(::p11.2->q11.1::) 
19.32~19.74-22.15~22.59 Mb 
83% SubcenM-FISH 
Array CGH 
*%of metaphases with a sSMC; n.a. – not available information 
 
Apart from the present report, in the literature there is only one comparable case with 
a similar imbalance in 17p and with a good molecular cytogenetic characterization 
[Starke et al., 2003]. Additional chromosomal material of proximal 17p11.2 apparently 
does not contribute to an abnormal phenotype. However, this observation should be 
confirmed with other cases, and the degree of mosaicism should be considered. 
Unbalanced chromosomal abnormalities without phenotypic effect are frequently not 
published and therefore more common than is apparent from the literature. The data 
published by Barber and colleagues [Barber et al., 2005] are consistent with the idea 
that microscopic and submicroscopic imbalances of multiple evolutionarily conserved 
loci can be compatible with a normal phenotype. However, it should be taken into 
account that few of the children who were reportedly normal at term in cases 
ascertained at prenatal diagnosis for maternal age, have been followed up over a 
period of years by a medical geneticist.  
In summary, the presence of a de novo sSMC in prenatal diagnosis presents a problem 
for genetic counselling. The time to investigate the genetic content of the marker is 
limited and the degree of mosaicism might influence the phenotype. It is important to 
report all cases of sSMC associated or not with clinical findings. A good molecular 
cytogenetic content characterization is essential for a robust genotype/phenotype 
correlation. A chromosomal imbalance of 17p11.2, involving a partial trisomy of 
19.32~19.74 Mb to 22.15~22.59 Mb region, does not seem to be correlated with 
phenotypic effects. It is important to quickly and clearly characterize prenatal sSMCs, 
with molecular cytogenetic techniques such as SubcenM-FISH or array CGH. The 
knowledge of the exact genetic content of the marker, the determination of the levels 
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of mosaicism, and the exclusion of UPD will definitely help genetic counselling when a 
sSMC is encountered at prenatal diagnosis. 
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3.9. sSMCs from chromosome 18 
Three unusual but cytogenetically similar cases with up to five different cell lines 
involving structural and numerical abnormalities of chromosome 18 [*] 
[*] The work presented in this section was published in: 
Carreira IM, Mascarenhas A, Matoso E, Couceiro AB, Ramos L, Dufke A, Mazauric M, Stressig R, Kosyakova N, Melo JB, Liehr T 
(2007) Journal of Histochemistry and Cytochemistry 55:1123-1128. 
 
3.9.1. Introduction 
The occurrence of structural abnormalities that involve chromosome 18 is relatively 
high [Baumer et al., 2002; Miller et al., 2003], being the most frequently ones deletions 
and ring formation. About 70 cases have been reported with ring chromosome 18 and 
most of them are female [Schinzel, 2001].The phenotypic variability observed in 
patients with r(18) depends primarily on the extension of the deleted chromosome 
segment [Stankiewicz et al., 2001]. In most cases patients that present r(18) show a 
phenotype like the 18q- which is highly variable, probably depending on the extent of 
the terminal or interstitial 18q deletions [Brkanac et al., 1998; Cody et al., 1999; Engelen et 
al., 2003]. Few cases share the phenotype like 18p- syndrome or, a combination of 
these two syndromes [Schinzel, 2001; Stankiewicz et al., 2001; Bird et al., 1997]. In general, 
it is thought that malformations in these patients result of terminal deletions of both 
arms of the chromosome [Vermeesch et al., 2002]. Rings often appear as mosaics and in 
some cases loss of the ring, double sized rings or multiple copies of the ring have been 
observed, as a consequence of structural instability of the ring during cell division 
[Miller et al., 2003; Baumer et al., 2002]. Mosaicism involving structural and numerical 
chromosome anomalies in a single individual is rare [Sutcliffe et al., 2001; Eiben et al., 
1992]. We present two prenatal and two postnatal cases (twins) showing mosaicism 
for; rings, marker and monosomy 18. In these cases the application of several high 
resolution molecular cytogenetics techniques such as, FISH using centromeric probes, 
MCB and locus specific probes for chromosome 18 were important to increase the 
precision of the definition of the rearrangement itself, as to define more accurately the 
level of mosaicism, attained by the evaluation of a larger number of cells. 
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3.9.2. Results 
Case Report 
Case A 
Prenatal diagnosis of a 34 year-old gravida was performed in the 14th week of 
gestation due to ultrasound malformations including holoprosencephaly (HPE) and 
hypotelorism (Figure 3.9.1.A). It was the first gestation of a non-consanguineous healthy 
couple. After cytogenetic evaluation of the amniocytes (results see below) the parents 
chose, after genetic counselling, to terminate the pregnancy in the 15th week of 
gestation. An autopsy was performed and the anatomopathologic study revealed a 
foetus with female-like gonads, holoprosencephaly (Figure 3.9.1.B), low set ears and 
without other internal or external malformations. 
Case B 
A prenatal diagnosis was performed in a 27 year-old pregnant woman in the 28th week 
of gestation due to abnormal ultrasound result of the heart, suggesting a vitium cordis, 
i.e. pulmonar stenosis with poststenotic dilatation and hypoplastic right ventricle. The 
pregnancy was terminated at the 34th gestational week. Autopsy revealed deep setting 
ears, large back of the head and flat arch of feet. Moreover, the presence of a valvulary 
pulmonar stenosis with poststenotic dilatation was confirmed and it was also detected 
a premature closure of ductus botalii, and an obstructive fetal uropathy with left sided 
ureterstenosis including dilatation of renal pelvis and urethra-dilatation plus fibrosis.  
Cases C1 and C2 
Monozygotic twins were born to healthy Caucasian, non-consanguineous parents. The 
mother, a 1st gravida, was 28 years old at delivery. After an uneventful pregnancy, the 
girls were delivered by caesarean section at 36 weeks of gestation. At birth, auxological 
data for the first twin were, weight 2.180g [<3rd centile], length 43cm [4th centile], 
head circumference [OFC] 31.5cm [20th centile], and for the second twin weight 
1.460g, length 40cm, OFC 29.5cm [all <3rd centile]; Apgar scores were 9/10/10, 
respectively.  
According to similar abnormal clinical features observed in both girls, like minimal 
dysmorphisms including a smooth philtrum, a thin upper lip, low set ears, wide spaced 
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nipples, and clinodactyly of the fifth finger, cytogenetic analysis from lymphocytes was 
done.  
Developmental delay was first observed at 6 months. Independent walking was 
achieved at the age of 20 months. At the age of 4 they spoke short sentences of 3 – 4 
words. At the age of 8 years they were able to read single words and it was expected 
that they will acquire adequate reading abilities. Both girls displayed growth 
retardation with all growth parameters developing below the 3rd centile. At the age of 
8 4/12 years, height was 107.8cm (- 4,7 SDS) for the first twin and 103.7cm (-5,5 SDS) 
for the second twin. Ossification was delayed according to an age of 5 9/12 years and 5 
years, respectively. Growth hormone and related factors (IGFI and IGFBP3) were 
measured in the lower normal range at several occasions. Ultrasound examination 
excluded major malformations of internal organs. MRI of the brain performed in the 
first twin at the age of 4 years showed an Arnold-Chiari-I malformation without 
hydrocephalus and delayed myelination. Seizures have not been observed. Major 
clinical problems were recurrent infections, bronchial hyper reactivity, dry and 
eczematic skin. 
 
Cytogenetic Results 
Case A 
Cytogenetic analysis of G-banded chromosomes after the first passage from different 
cultures lines of amniotic fluid cells, using flask technique, revealed a mosaicism 
involving two cell lines: mos 46,XY,r(18)[36]/45,XY,-18[7] . Fluorescence in situ 
hybridization (FISH) was performed in order to clarify the structural rearrangement 
and the distribution of the different cell lines. Chromosome 18 centromeric probe 
D18Z1 showed signals on both, the normal chromosome 18 and the ring 
chromosomes. With this probe was also possible to identify a metaphase with a 
duplicated ring and another with a double ring. Hybridization with subtelomeric 
probes D18S552 (18p) and D18S1390 (18q), showed normal signals on the normal 
chromosome and deletion of both terminal regions in the ring chromosomes (data not 
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shown). With these FISH studies it was possible to identify two extra cell lines, so that 
the karyotype was:  
mos 46,XY,r(18)[36]/45,XY,-18[7]/47,XY,+r(18)x2[1]/46,XY,dupr(18)[1] (Fig. 3.9.1.C) 
(Table 3.9.I). 
After termination of the pregnancy a cytogenetic analysis and FISH studies were 
performed in the fibroblasts of the expelled foetus after the third passage. A new cell 
line with a small marker chromosome was detected, as well as three of the cell lines 
observed in the amniocytes. The line with two rings, observed in the amniocytes, was 
not found in the fibroblasts. Thus, result of the cytogenetic analysis in this tissue was: 
mos 46,XY,r(18)[89]/45,XY,-18[22]/46,XY,dupr(18)[2]/ 46,XY,mar(18)[4]. FISH with a 
centromere 18 specific probe was also performed to determine the origin of the 
marker chromosome, which was found to contain material from the pericentromeric 
region of chromosome 18 (Fig. 3.9.1.E).  
Applying subtelomeric probes 18p and 18q (Figure 1D), subcenM-FISH (Figure 1E) and 
MCB (Fig. 3.9.1.F) analysis, only the most frequent variant of the derivative 
chromosome 18 could be detected. Thus, a final karyotype like the following can be 
suggested:  
mos 46,XY,r(18)(::p11.1 ::q22)/45,XY,-18/  
46,XY,dupr(18)(::p11.1 q22::)/46,XY,del(18)(:p11.1 q12:) (Table 3.9.I). 
Karyotypes of both parents were normal. 
Case B 
After G-banding the amniocytes, two cell lines were accounted for with the following 
karyotype: 46,XY,r(18)[90%]/45,XY,-18[10%].  
MCB analyses revealed a complex karyotype with five cell lines:  
r(18)(::p11.2?2 q21.?2::)[12]/r(18;18)(::p11.2?2 q21.?2::p11.2?2 q21.?2::)[4]/r(18
;18)(::p11.2?2 q21.?2::p11.2?2 q21.?2::)x2[1]/del(18)(:p11.21 q11.2:)[1]/ace(18)(
:q11.2 q12.?2:)[1] (Fig. 3.9.2, Table 3.9.I). Karyotypes of both parents were normal. 
Cases C1 and C2 
Structurally abnormal female karyotypes with ring chromosomes 18 [karyotype 
46,XX,r(18)(p11.32q22.3)de novo] were observed in both girls without evidence for 
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mosaicism. MCB, subcenM-FISH and application of subtelomeric probes in 
combination with centromeric probes were very useful because they allowed the 
identification of adicional cell lines and a variety of rearrangemnts revealing therefore 
differing complex karyotypes in each of the twins (see Table 3.8.I). 
Parental karyotypes were normal. Two younger sisters of the twins are healthy.  
 
Figure 3.9.1. - A) Sonography revealed in case A a holoprosencephaly.; B) Frontal view of the autopsy of 
the fetus at 17 weeks, showing the holoprosencephaly; C) Partial G-banded karyotype showing the 
normal chromosome 18, the single ring (r), double ring (dr), two rings and the marker (mar) in case A; D) 
Commercially available FISH subtelomeric probes (Abbott/Vysis) for chromosome 18p (st 18p) and18q 
(st 18q) demonstrated that both corresponding regions are deleted in the ring chromosome of this case; 
E) FISH applying subcentromeric probes revealed that the centromere-near region in 18p11.21 was 
absent and the centromere-near region in 18q11.21 was present on the ring.; F) Multicolor banding 
(MCB) confirmed the aforementioned findings.  
Figure 3.9.2 - MCB results obtained in case B, besides a normal chromosome 18 either a ring 
chromosome (r), a double ring (dr) a minute shaped chromosome (del) or an acentric fragment (ace) 
was present. 
 
3.8.3. Discussion 
We report here 4 cases, 2 prenatal and 2 postnatal, with complex karyotypic changes 
involving the formation of rings of chromosome 18. 
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Table 3.9.I - Karyotype after application of MCB, subtelomeric probes 18pter and 18qter in combination 
with the centromeric probe for chromosome 18 and subcenM-FISH in the four cases. As highly complex 
karyotypes were present in all cases slightly different results were obtained for the probe sets used, as 
listed here.  
 
 
There are reports of rings for all chromosomes, although the most frequent are those 
involving autosomes 13 and 18 [Mohamed et al., 2001]. It is suggested that chromosome 
18 might carry an elevated number of certain repeated sequences susceptible to 
interchromosomal and intrachromosomal rearrangements [Pater et al., 2003]. The most 
frequently structural rearrangements that involve chromosome 18 are the deletions 
and the ring chromosomes. 
One of the mechanisms of formation of a ring chromosome can be explained by 
breakage of the chromosome at both ends and the joining back of both extremities, 
with loss of terminal regions [Sigurdardottir et al., 1999]. Depending on the size of the 
deletion at each end of the chromosome, the phenotypic appearance ranges from 
normal fertile carriers in a minority of cases, to those with severe malformations. 
Incidences and types of congenital malformations are similar to those carrying the 
del(18)(q21-qter) [Schinzel, 2001].  
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There is a difficulty in establishing a genotype-phenotype correlation in a ring carrier. It 
is necessary to determinate primary deletions associated with ring chromosome 
formation and also secondary loss or gain of material that may occur due to instability 
of ring chromosomes. This can cause a dilemma in prenatal diagnosis [Tümer et al., 
2004]. Rings often appear as mosaics due to sister chromatid exchange within a ring in 
mitotic crossing-over events, which generates aneuploid cells with increased mortality 
[Sigurdardottir et al., 1999; Vermeesch et al., 2002]. 
Patients with ring chromosome 18 usually share clinical features of 18q- syndrome, 
such as, hypotonia, poor coordination, microcephaly, hearing abnormalities, 
malformation of genitalia [Schinzel, 2001; Cody et al., 1999; Brkanac et al., 1998]. Less 
frequently these patients show characteristics in common with 18p- syndrome, such 
as, mild to moderate growth deficiency, microcephaly, ptosis and more occasionally 
holoprosencephaly (HPE) [Schinzel, 2001]. Case A shares features with both syndromes. 
Cytogenetic analysis revealed a male foetus and the anatomopathologic study 
reported a foetus with female-like gonads. This discrepancy may be related to 
malformation of genitalia, a clinical feature of 18q- syndrome. Low set ears is also a 
hearing abnormality associated with deletion of the long arm of chromosome 18. 
Holoprosencephaly (also found in the autopsy) is probably due to deletion of 18p 
[Muenke, 1989; Bird et al., 1997]. The genetic causes of HPE can be cytogenetic 
anomalies or monogenic syndromes [Croen et al., 1996; Olsen et al., 1997; Cohen 1989; 
Muenke, 1989]. The association of HPE and deletion of chromosome 18p was first 
described in a child with HPE and monosomy 18p due to an unbalanced translocation 
[Johnson and Bachman, 1976]. The region 18p11.3 is defined as one of the critical regions 
for HPE [Overhauser et al., 1995]. Despite the fact that all the cases reported here 
showed deletions on 18p11.3, HPE was only found in case A. This could mean that the 
HPE critical region was most probably not disrupted in the other 3 cases, ie. the 
chromosome breaks were more distal, towards the telomere. According to Strenge 
and Froster (2004), HPE only occurs in 10-20% of the cases showing the terminal 
deletion [Strenge and Froster, 2004]. 
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The occurrence of a r(18) together with a duplication of a segment of chromosome 18 
or with a small marker chromosome is rare [Madan et al., 1981; Stankiewicz et al., 2001]. 
In all the 4 cases reported here, a marker was detected in a small percentage of the 
cells observed from different cultures suggesting that it is not a culture artefact (Table 
3.8.I). The most likely explanation for the mosaic occurrence of the small marker in 
such small proportion could be that its loss would not be associated with a decreased 
cell survival as it would be if a complete ring was lost [Sigurdardottir et al., 1999]. 
Cytogenetic analysis of case A revealed a mosaicism involving a total of five cell lines 
(four in the amniotic fluid and four in post mortem fibroblasts, with two lines that only 
appear each in one or the other tissue) showing the mitotic instability of the ring [Fig. 
3.9.1., Table 3.9.I]. Mosaicism of monosomy 18 was considered as a culture artefact, due 
to mitotic loss of the ring [Schinzel, 2001; Fischer et al., 2001]. However, there are 
reasons that make us think otherwise and to agree with Yardin et al. (2001), two 
different cultures of the amniotic fluid in case A gave approximately the same level of 
mosaicim and the monosomic cell line was also present in fibroblasts [Yardin et al., 
2001]. In both tissues the percentage of this cell line was similar (16% and 18% 
respectively). Also in all 4 cases, a cell line with -18 was observed [Table 3.9.I]. One 
could suggest that this cell line, may have started as a r(18) which, because of its 
mitotic instability and crossing-over events between the ring sister chromatids, led to 
its loss during cell division generating the monosomy. So, the monosomic cell line may 
be part of the biological mechanism associated with the propagation of the ring during 
cell division. These events are also responsible for loss or duplications of ring 
chromosomes.  
The growth retardation observed in both twins (Cases C1 and C2) could be associated 
with the occurrence of sister chromatid exchange within the rings that generate 
aneuploid cells with double rings and consequently serious genetic imbalance. This 
process may lead to increase cell death that can led to a decreased number of viable 
cells at any given interval of development and subsequently to growth deficiencies in 
the carriers. Generally severe growth failure is seen more often in patients with larger 
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rings than among patients with smaller ones, because of the probability of the higher 
frequency of sister chromatid exchanges in the first ones [Kosztolányi, 1987]. 
In all the cases presented here a de novo r(18) was established, showing mitotic 
instability that seems to be an important tool for the investigation of the dynamics of 
ring chromosome mosaicism, through multiple cell divisions. Mosaicism in all four 
reported cases can be explained by post-zygotic errors during mitosis. The variability of 
the cell lines observed and the variability in structure of the ring chromosomes found 
highlights the importance of analyzing a large number of cells and the importance of 
using various cytogenetic techniques. 
The use of molecular cytogenetics is also of great value in the establishment of the 
presence of either loss or gain of chromosomal material in the ring structure as it will 
help to elucidate the role played by that material in determining the phenotypes, 
facilitating the search for candidate genes on those regions. 
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3.10. sSMCs from chromosome 22 
Molecular cytogenetic characterization of two cases with a small supernumerary 
marker chromosome derived from chromosome 22  
 
3.10.1. Introduction 
Segmental duplications, or low-copy repeats (LCRs) of >95% sequence identity, cluster 
within different chromosome regions and constitute approximately 5% of the human 
genome [Bailey et al., 2002]. Low-copy repeats range in size from 10-250 kb [Stankiewicz 
and Lupski, 2002]. They are considered highly dynamic regions in the genome because 
they mediate meiotic unequal nonallelic homologous recombination events, resulting 
in altered gene dosage associated with human genomic disorders [Babcock et al., 2003]. 
The LCRs on chromosome 22q (LCR22) are a complex mosaic of genes and 
pseudogenes formed by duplication processes. The 22q11 region is involved in 
chromosomal rearrangements that lead to altered gene dosage, resulting in genomic 
disorders that are characterized by mental retardation and/or congenital 
malformations. Three of such disorders- cat-eye syndrome (CES, OMIM 115470), 
der(22) syndrome, and velocardiofacial syndrome/DiGeorge syndrome (VCFS/DGS, 
OMIM 192430/ MIM 601362) - are associated with four, three, and one dose, 
respectively, of parts of 22q11 (Fig. 3.10.1) [McDermid and Morrow, 2002]. The reason for 
such a multitude of rearrangements lies in the complicated inverted and direct 
orientation of sequences in the LCR22 [McDermid and Morrow, 2002]. 
 
Figure 3.10.1. - Rearrangements on 22q11. VCFS/DGS is associated with interstitial deletions; Der(22) 
syndrome occurs in offspring of unaffected carriers of the constitutional t(11;22) translocation; patients 
with der(22) syndrome have a partial trisomy for 22pter-q11 and 11q23-qter. Patients with CES harbour 
a bissatellite supernumerary chromosome 22 that results in a partial tetrasomy [from McDermid and 
Morrow, 2002]. 
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The phenotypes of partial trisomy 22q include the CES, the der(22) syndrome, the 
microduplication 22q11.2 syndrome, and the chromosome 22q duplication syndrome. 
Full trisomy 22 typically results in abortion, but partial 22q trisomy including 22q11.2 
and/or parts of 22q12–q13 was reported with phenotypes that were compatible with 
survival [Bartsch et al., 2005]. The der(22) syndrome is more severe than CES and 
includes numerous additional signs that can be attributed to partial trisomy of 11q 
[Emanuel, 2008]. 
A very large subset of SMCs is derived from the human chromosome 22 and usually 
confers tri- or tetrasomy for the cat eye syndrome chromosomal region (the proximal 
2Mb of chromosome 22q) and/or other segments of 22q [Emanuel, 2008]. Features of 
CES include ocular colobomata, anal atresia, congenital heart defects, renal 
malformations, craniofacial anomalies (e.g., preauricular skin tags and pits), male 
genital anomalies, skeletal defects, and borderline to moderate mental retardation 
[Schinzel et al., 1981].  
A number of different SMCs containing the CES critical region (CESCR) have been 
described, including the typical bisatellite small and larger cat eye syndrome 
chromosomes and small ring-like SMCs(22) [Liehr et al., 1992; Mears et al., 1995; Crolla et 
al., 1997; McTaggart et al., 1998; Bartsch et al., 2005]. Owing to their small size and 
complex rearrangements, SMCs(22) have remained a diagnostic challenge [Bartsch et 
al., 2005]. McTaggart and co-workers classified the CES chromosomes into two types 
based on the location of the two breakpoints required to generate them within LCR22 
region (Fig 3.10.2.) [McTaggart et al., 1998]: 
- Type I - small CES chromosomes, that are symmetrical, with both breakpoints 
located within the proximal interval; 
- Type II - Large CES chromosomes, which are either asymmetrical (type IIa), with 
one breakpoint located in each of the two intervals, or symmetrical (type IIb), 
with both breakpoints located in the distal interval. 
Bartsch and colleagues, when reporting a set of SMC(22) with CESCR, suggested a type 
III CES chromosome defined by at least one breakpoint outside the LCRs22, larger than 
type II (Fig 3.10.2.).  
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Figure 3.10.2. - Representation of the CES chromosomes: type I (frequent); symmetrical type IIa, rare; 
asymmetrical type IIb, rarer; and type III (exceptional), with association of trisomy (3x) and/or tetrasomy 
(4x) of the 22q11.1 region [adapted from Bélien et al., 2008]. 
 
We performed FISH studies on two patients with different sSMC(22). In one of the 
cases the marker was additionally studied by array CGH after microdissection. One of 
the patients presented the more frequent type of CES (Type I) and the other the 
exceptional type (Type III). 
 
3.10.2. Results 
 
Case I 
A 6 years old boy with cat-eye syndrome presented congenital cardiopathy, 
psychomotor development delay, anal atresia, poor ponderal progression, bilateral iris 
coloboma, palate groove, lateral ventricles asymmetry, and small kidneys with 
deficient cortico-medullar differentiation (Table 3.10.I). Conventional cytogenetics 
revealed a karyotype of 47,XX,+mar, de novo, in all the analyzed cells. The SMC showed 
two AgNOR and two CBG positive regions, corresponding two a bisatellite and dicentric 
SMC (Fig. 3.10.3). 
FISH using centromeric probes (D14Z1/D22Z1) revealed the origin of the marker as 
being derived from chromosome 14 or 22, and confirmed the presence of two 
centromeres. The SMC did not present a signal for D22S75, a probe located in the 
VCFS/DGS region (~17.5 Mb)(Fig. 3.10.4.). 
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G Band AgNOR C Band
mar  
Figure 3.10.3. – Karyogram of Case I obtained by GTG-banding showing a 47,XY,+mar. The sSMC has two 
AgNOR positive regions and two CBG positive regions. 
 
FISH using BAC clones confirmed the presence in the marker of two signals for RP11-
172D7(~16.5 Mb) and for RP11-81B3 (~16.8 Mb) in 22q11.21, and two positive regions 
for rRNA regions (corresponding to acrocentric p-arms). The 22q11.22 region 
corresponding to RP11-1058B20 is not present in the sSMC (Fig. 3.10.5.). 
 
D22S75 -
a)
D14Z1/D22Z1x2
b)
 
Figure 3.10.4. – a) Partial metaphase showing the two normal 22 chromosomes and the SMC (white 
circle)  in Case I. The SMC does not present a signal for D22S75 (red), a probe located in the VCFS/DGS 
region; b) Partial metaphase showing the two normal 22 chromosomes and the SMC (white circle) with 
two signals for the centromeric probe specific for chromosomes 14/22 ( ) 
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22 sSMC
22 sSMC
a)
b)
 
Figure 3.10.5. – Normal 22 chromosomes and the sSMC(22) showing the presence in Case I a) 2 
centromeres (cep14/22 in green), two signals (2 signals merged in a bigger signal, when comparing to 
the signal in normal 22 chromosomes) for RP11-172D7 in 22q11.21 (red) and two regions corresponding 
to acrocentric arms (aqua); b) Two signals (2 signals merged in a bigger signal, when comparing to the 
signal in normal 22 chromosomes) in the marker for RP11-81B3 in 22q11.21 (red) and absence of signal 
for RP11-1058B20 in 22q11.22. 
 
The microdissected DNA of the sSMC was hybridized in a full tiling BAC array specific 
for chromosome 22, with a resolution of 100-150 Kb (VIB MicroArrays Facility - 
www.microarrays.be), having material of approximately 2.8 Mb size extension from 
22q (between 14.55 Mb to 17.35 Mb). (Table 3.10.I). The sSMC revealed to be an inv 
dup(22)(q11.21) (Table 3.10.I).  
 
Case II 
A sSMC present in mosaic was detected after prenatal diagnosis. G-banding of 
amniocytes culture revealed a karyotype 47,XY,+mar in 61% of the analyzed cells. The 
study after cordocentesis revealed a percentage of mosaicism of 56%. The presence of 
the marker was confirmed postnatally in peripheral blood in 37% of the 
prometaphases studied. The marker was characterized by CBG and AgNOR banding, 
revealing the presence of one centromere and 2 positive AgNOR regions (Fig. 3.10.6.). 
FISH studies by whole chromosome painting (wcp), revealed that the sSMC was 
derived from chromosome 22; presented two regions corresponding to the acrocentric 
arms (rRNA probes); and two positive regions for D22S75 probe (~17.5 Mb) (Fig. 
3.10.7.). 
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G Band AgNOR C Band
 
Figure 3.10.6. – Karyogram of Case II obtained by GTG-banding showing a 47,XY,+mar. The sSMC s two 
AgNOR positive regions and one C-band positive region. 
 
The boy was clinically assessed after birth and revaluated at 5 years old. He presents a 
“Cat-eye like syndrome”, with normal psychomotor development, normal growth 
development, normal echocardiography, normal renal and abdominal ecography, and 
bilateral preauricular skin pits (Table 3.10.I).  
Additional FISH studies, using BAC clones, revealed the presence in the sSMC of two 
signals for RP11-172D7 in 22q11.21 (~16.5 Mb), two signals for RP11-1058B20 in 
22q11.21 (~19.6 Mb), and apparently two signals for RP11-229C18 in 22q11.23 (~24 
Mb), which appear merged (Fig. 3.10.8.). The sSMC revealed to be an inv 
dup(22)(q11.23~12.1) (Table 3.10.I). 
  
Table 3.10.I. - Description of karyotype and clinical presentation of the sSMC(22)s cases 
characterized by molecular cytogenetics. 
Case 
Karyotype/ 
sSMC characterization M-FISH 
Array CGH result Clinical presentation 
Case I 
47,XY,+mar[100%] 
 
sSMC characterization: 
ish.inv dup(22)(q11.21) 
sSMC size: 2.8 MB 
 
14.55  17.35 MB 
22q11.1 22q11.21 
6 years: Cat-eye syndrome 
Congenital cardiopathy, psychomotor 
development delay, anal atresia, poor 
ponderal progression; bilateral iris coloboma; 
palate groove; lateral ventricles asymmetry; 
small kidneys with deficient cortico-medullar 
differentiation 
Case II 47,XY,+mar[36%]/46,XY[64%] 
 
sSMC characterization: 
ish.inv dup(22)(q11.23~12.1) 
 
n.a. 5 years: Cat-eye like syndrome; normal 
psychomotor development; normal growth 
development; normal ecocardiography; 
normal renal and abdominal ecography;  
Bilateral preauricular skin pits.  
 
n.a. – not available 
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Figure 3.10.7. – FISH images in Case II. a) Partial metaphase showing the two normal 22 chromosomes 
and the marker painted with wcp specific for chromosome 22; b) The SMC has one centromere (aqua) 
and two rRNA positive regions (red); c) Partial metaphase showing the two normal 22 chromosomes and 
the sSMC with apparently two signals for D22S75, a probe located in the VCFS/DGS region. 
 
22 sSMC
22 sSMC
a)
b)
 
Figure 3.10.8. – Normal 22 chromosomes and the sSMC(22) in Case II showing the presence of: a) One 
centromere (cep14/22 in green), two signals for RP11-172D7 in 22q11.21 (red) and two regions 
corresponding to acrocentric arms (aqua); b) Two signals in the marker for RP11-1058B20 in 22q11.22 
(green) and apparently two signals (2 signals merged in a bigger signal, when comparing to the signal in 
normal 22 chromosomes) for RP11-229C18 in 22q11.23. 
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3.10.3. Discussion 
We report two cases with a sSMC(22), studied by molecular cytogenetics, using several 
BAC probes and, in one case, using array CGH after marker microdissection. Using a set 
of probes corresponding to different regions of 22q (Fig. 3.10.9.), and correlating with 
the data obtained by array CGH, we can conclude that the sSMC(22) from case I is a 
type I CES, the most common, and the sSMC(22) from case II corresponds to a type III 
CES chromosome, the rarest type of CES chromosomes. 
Babcock and co-workers defined LCR22 localization, discovering that some LCR22s are 
large, such as LCR22-2 and LCR22-4, which are both 240 kb in size. LCR22-3a, situated 
between the two, contains an uncloned region within; thus, its size is unknown. Some 
LCR22s are quite small—less than 2 kb. LCR22s are composed of blocks or modules 
forming a complex pattern. Most of them appear to be partial duplicates of each 
other. The two greatest in size, LCR22-2 and LCR22-4, contain a large region of overall 
direct orientation [Shaikh et al., 2000]. Homologous recombination events between 
these two LCR22s mediate recurrent 22q11.2 rearrangements associated with 
VCFS/DGS and CES. Thus, these two intervals, due to their high degree of direct 
identity (97%-99%), are excellent substrates for unequal crossing-over events [Babcock 
et al., 2003]. 
Classical CES is characterized by the presence of a dicentric and bisatellite small inv 
dup (22) supernumerary marker chromosome. Thus, patients with CES usually have a 
partial tetrasomy of a region that spans chromosome 22p and part of 22q11.21 
[McDermid and Morrow, 2002; Bartsch et al., 2005; Gentile et al., 2005, Bélien et al., 2008]. 
We can cytogenetically distinguish three types of CES chromosomes (Fig. 3.10.2.), which 
are correlated with breakpoints localization (Fig. 3.10.9). Type I CES chromosomes have 
a breakpoint between 16.688 - 17.690 Mb, corresponding to the LCR22-3a (17.248–
17.433 Mb (previously named LCRA). Type II CES chromosome have their breakpoints 
between 19.466 - 21.847 Mb, matching the molecular positions of LCR-4 and LCR22-6.  
[Babcock et al., 2003; Bartsch et al., 2005; Gentile et al., 2005; Bélien et al., 2008]. Type III CES 
chromosome, is defined by at least one breakpoint outside the LCRs22 [Bartsch et al., 
2005] (Fig. 3.10.9.). 
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22q11.1 22q11.21 22q11.22 22q11.23
LCR22-2 5
229C181058B20
81B3
172B7
Type I CES
Type II CES
Type III CES
D22S75
22q12.1
Case I
Case II
3A 3B 6LCR22-4 7 8
 
 
Figure 3.10.9. – Different types of CES according to LCR22 position and BAC clones position. In Case I of 
this report a type I CES is described with positive signal for 172B7 (~16.4 Mb) and 81B3 (~16.8 Mb) 
clones and negative for D22S75 (~17.5 Mb). In Case II a type III CES is present, with positive signal for 
RP11- 229C18 (24.18 Mb). LCR 22 position is indicated according to Babcock et al., 2003.  
 
Bartsch and co-workers were the first to report a case with a type III CES chromosome. 
It was a case with a SMC present only in a small subset of cells (19% of amniocytes), 
with phenotype of the patient at the age of 6 months being normal. The sSMC in case 
II, that we report, is also present only in a subset of cells. Cytogenetic mosaicism 
significantly influences the clinical outcome of patients with a SMC. This could explain 
the mild phenotype observed, with a normal psychomotor development. Indeed, this 
SMC conferred trisomy of 22p11-q12.3 and would predict, if present in all cells, a 
severe phenotype. Recently, Karcaaltincaba and colleagues reported a non mosaic 
partial trisomy 22q with de novo duplication of chromosomal region 22q11.1-22q13 
and a different phenotype from the reported cat eye syndromes, with absence of heart 
defects and presence of brain anomalies [Karcaaltincaba et al., 2010]. 
For now, a clear delineation of the phenotypes associated with rearrangements of 
22q11.2 cannot be accomplished. CES phenotype is variable and it does not appear to 
correlate with the size of the marker [Bartsch et al., 2005; Bélien et al., 2008]. A careful 
clinical and molecular delineation of additional patients with these disorders is 
necessary to understand the relationship between genotype and phenotype. 
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About 3 million individuals of the whole human population would have one small 
supernumerary marker chromosome (sSMC) additionally to their normal chromosomal 
complement, i.e. 46 normal chromosomes and one sSMC (47,XX,+mar or 47,XY,+mar). 
These sSMCs can originate from each of the 24 human chromosomes and have 
different shapes. Marker chromosomes are of particular interest in clinical 
cytogenetics. They are more frequent in individuals with mental retardation than in 
the normal population. However, they are often found in only a small percentage of 
cells, making them difficult to detect and characterize in a diagnostic setting. About 
30% of the carriers of a sSMC are clinically abnormal and 70% are clinically normal. The 
major problem in connection with sSMC appears when the diagnosis of the sSMC 
presence is made prenatally. A clear prediction about the outcome of the pregnancy is 
difficult to ascertain.  
So, when a sSMC is encountered by classical cytogenetics in a prenatal or postnatal 
diagnosis, the main questions are:  
- What to do next? Should the marker be more extensively characterized? 
- Which techniques should be used for its correct characterization? 
- In prenatal diagnosis, is it possible to predict the outcome of a sSMC? 
- How to interpret its characterization especially in the mosaic states? 
 
In this study we have characterized several cases, prenatal and postnatal, with a small 
Supernumerary Marker Chromosome (sSMC): 
- One de novo case with a sSMC derived from chromosome 1, with a ring shape, 
present in mosaic associated with a mild phenotype (section 3.1.); 
- Two de novo cases detected at prenatal diagnosis with a sSMC derived from 
chromosome 2, present in mosaic and with no apparent phenotype (section 3.2.); 
- One de novo case with a sSMC derived from chromosome 5 in mosaic and with a ring 
shape, present in a female patient with learning difficulties and mild facial 
dysmorphisms (section 3.3.); 
- A case of a sSMC derived from chromosome 11 present in mosaic, in a mother and a 
child with distinct phenotypes (section 3.4.); 
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- A case with a de novo small supernumerary neocentromeric chromosome derived 
from chromosome 13 ascertained prenatally (section 3.5.); 
- Six postnatal cases of SMCs derived from chromosome 15 some associated with 
clinical findings others not (section 3.6.); 
- Two cases of de novo sSMCs derived from chromosome 16, present in mosaic, 
associated with clinical findings (section 3.7.); 
- A prenatal case with a sSMC derived from chromosome 17 with a normal phenotype 
(section 3.8.); 
- Three cases with complex karyotype changes involving the formation of rings of 
chromosome 18, and with the presence of a marker in a small percentage of cells 
(section 3.9.); 
- Two cases with a sSMC derived from chromosome 22 associated with cat-eye 
syndrome (section 3.10.). 
In all these cases we tried to obtain the best possible clinical description of the patients 
or features, and to follow a specific series of methodologies in order to achieve the 
ultimate goal – a strong genotype/phenotype correlation. 
 
Based on our results and experience, we propose approaches for a correct 
management of sSMC cases, which are dependent on a good and motivated clinical set 
up and on the techniques available at the laboratory (Fig. 4.1.). The management of a 
sSMC case depends primarily if it is ascertained pre or postnatally. When the case is 
prenatal, some of the techniques, like microdissection, are not appropriate for the 
diagnosis because they are time consuming, not compatible with the time for 
termination of pregnancy we currently have (24 weeks of gestation). However, they 
should be done later for a more precise characterization of the sSMC, as well as the 
good characterization of the foetuses by the Clinical Geneticist and 
Anatomopathologist, to establish a strong genotype/phenotype correlation.  
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sSMC encountered with conventional cytogenetics
(GTG, CBG, AgNOR banding)
- de novo/Familiar?
- UPD present?
Centromeric FISH, wcp, pcp, 
locus specific or BAC probes, 
rRNA probes
sSMC origin, shape, eu-
heterochromatin presence
1. Lab with single FISH techniques 2. Lab with 1. and M-FISH techniques 3. Lab with 1. and array CGH techniques
Subcentromere FISH 
Multicolour Banding
sSMC origin, shape, eu-
heterochromatin presence,
more precise molecular 
content
Levels of Mosaicism
Microdissection?
Array CGH with platform
with high pericentromeric
coverage
sSMC origin and exact
genetic content
Genotype/Phenotype Correlation  
Figure 4.1. - Management of a sSMC encountered with conventional cytogenetics. The approach for its 
characterization depends on the techniques available and the genotype/phenotype correlation depends 
on a strong clinical set up. 
 
Some main issues should be emphasized: 
1) The follow-up of patients with a sSMC is crucial, either by recurring to autopsy data 
or by collecting data after birth. We have described cases where the phenotype 
becomes milder with age. It is a well know fact that when the sSMC appears in mosaic, 
the percentage of mosaicism could decrease over the years. Patients with a sSMC 
should be followed up, and laboratory testing as well as clinical details at different ages 
are crucial for establishing strong genotype/phenotype correlations. 
 
2) The sSMC should be extensively characterized for its shape, origin and molecular 
content. The cases presented in this work were extensively characterized using 
conventional cytogenetics and molecular cytogenetics. We can conclude that 
molecular cytogenetic analysis is essential for the characterization of a sSMC. A variety 
of molecular cytogenetic techniques for SMC characterization can be used for a more 
comprehensive analysis in a single or a few experiments. Fluorescence in situ 
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hybridization (FISH) approaches, including centromeric FISH, whole-chromosome 
painting, and locus-specific probes, allow the characterization of the chromosomal 
origin of the sSMC. Other FISH strategies can be used, like subcentromere specific 
multicolor FISH (subcenM FISH) and multicolour banding (MCB), detecting the 
presence of euchromatin on a sSMC. These FISH techniques are feasible both in 
prenatal and in postnatal cases. The characterization by glass-needle-based 
chromosome microdissection and reverse painting could also be used, this approach 
being suited for all types of sSMC, including neocentromeric sSMC. Due to short time 
availability that usually is a problem in prenatal diagnosis, microdissection would be 
more suitable for postnatal diagnosis or for latter characterization of the sSMCs 
detected in prenatal cases. 
 
3) As we can observe from our results, these multicolour FISH techniques can not 
precisely determine the chromosome regions or breakpoints involved. Microarray-
based comparative genomic hybridization (array CGH) is a high-resolution and 
comprehensive method for detecting both genome-wide and chromosome-specific 
copy-number imbalance. The use of array CGH seems to be a good strategy for the 
characterization of the genetic content of sSMCs and allows the determination of the 
breakpoints and chromosomal regions present in the marker. Nevertheless, the 
characterization of centromeric and heterochomatic regions is problematic with this 
technique. Additionally, array CGH does not give information in cases with less than 
30% mosaicism, leading to erroneous conclusions, being a major problem in sSMCs 
cases, which often appear in mosaic.  
 
4) This study clearly demonstrates the utility of combining molecular cytogenetic 
analysis, namely with multicolour FISH approaches, and array CGH in the detection and 
characterization of marker chromosomes. Additionally, the use of combined 
microdissection and array CGH allows the determination of molecular breakpoints of 
the marker, even when the sSMC was present in mosaic. The use of conventional 
cytogenetic and M-FISH approaches permits the characterization of the sSMC shape. 
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5) Uniparental disomy should be analysed and excluded, especially when the sSMC is 
derived from chromosomes associated with genomic imprinting. 
 
6) Biological material from the proband, and if possible from the parents, should be 
collected for future studies. For the majority of the cases described in this study an 
EBV-immortalized cell line was established. 
 
 
In conclusion, for a good characterization of a sSMC several approaches should be 
taken, in order to ascertain not only the genetic content but also the shape of the 
sSMC. This information, about the shape and content, is crucial for moving towards a 
correct genotype/phenotype correlation of a sSMC and also for establishing possible 
mechanisms of formation for each marker, essential for risk assessment. The detailed 
molecular characterization of sSMCs will play a valuable role in the diagnosis and 
medical management of both pre- and postnatal cases in which marker chromosomes 
have been identified. Array CGH is a step in answering to the request of aetiological 
diagnosis in families with affected individuals. This technology is being installed in 
laboratories worldwide, including our own. Only with these combined approaches we 
can move forward for a better understanding of the impact of a sSMC on the 
phenotype, especially in prenatal cases.  
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